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“Although we have now learned to synthesize oligosaccharides, it should be emphasized 
that each oligosaccharide synthesis remains an independent problem, whose resolution 
requires considerable systematic research and a good deal of know-how.  There are no 
universal reaction conditions for oligosaccharide synthesis.” 
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Enzyme-catalyzed transformations of carbohydrates proceed through different 
transition states, which may be studied by altering the electron density at various 
positions of the carbohydrate ring.  By placing fluorine near a developing partial charge 
of a donor substrate, the reaction may be inhibited due to destabilization of the transition 
state.  The pKa of an acceptor alcohol is also lowered by fluorine, possibly affecting its 
nucleophilicity.  Epoxide fluoridolysis has been previously used in our lab to synthesize 
(5-F) GlcNAc glycosides and glycosyl phosphates.  This methodology involves a two-
step process of oxidation of a phenylselenide to a selenoxide and thermal elimination 
with DHP.  This thesis extends this fluoridolysis methodology to (5-F) isoLacNAc and 
(5-F) LacNAc glycosides and also investigates fluorination in the GalNAc series.  Results 
from attempts at fluorination of the GalNAc glycosides have resulted in a premature 
epoxide opening hypothesis.  This hypothesis was derived from differences in 
fluorination of glycosyl epoxides containing different neighboring protecting groups. 
In the pursuit of the (iso)LacNAc glycosides, selenium-containing 
monosaccharide acceptor substrates were unsuccessful in glycoside formation.  In 
contrast, glycosylation of non-selenium containing monosaccharide acceptor substrates 
were successful in glycoside formation and were converted to selenium-containing 
disaccharides after glycosylation.  The resulting selenium-containing disaccharides were 
then transformed into their corresponding epoxides and eventually into (5-F) isoLacNAc 
and (5-F) LacNAc glycosides. 
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In addition to studying fluorinated glycosides, formation of a new stable C-C 
bond has been investigated.  This new transformation would increase functionality on the 
carbohydrate ring by installing a CN group at C-5.  The CN group was installed using a 
Lewis acid activator and TMS-CN in cyanosilylation of glycosyl epoxides.  This new 
method allows for subsequent reduction of the CN functional group to an amine, which 







Complex carbohydrates are important components of biological pathways and 
systems, such as blood group antigens, cellular metabolism, intercellular communication, 
and other processes.1  These carbohydrates are involved in glycoconjugates, such as 
glycoproteins and glycolipids, which are found in cell walls of bacteria, in cellular 
adhesion and other sites in various biological systems.  The numbering system 
established for hexopyranoses is shown in Figure 1.1 for D-glucose.  Carbon 1 is referred 
to as the anomeric position, and in the reducing sugar form (as shown in Figure 1.1), the 
carbohydrate exists in both the open (aldohexose) and closed (hexopyranose or 
hexofuranose) forms of the carbohydrate ring.  C-1 of hexopyranosides determines the 
type of linkage in a glycosidic bond, where the C-1 substituent below the plane of the 





















































Figure 1.1:  Numbering for Hexopyranoses 
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Biosynthesis of complex carbohydrates involves several classes of enzymes, such 
as transferases, epimerases, dehydrogenases, oxidases and pyrophosphorylases.  A 
glycosylation reaction between two carbohydrates involves an acceptor, which serves as 
the nucleophile, and the anomeric position of a donor, which serves as the electrophile. 
An example of an enzyme-catalyzed glycosylation reaction of glucose by UDP-galactose 

























Figure 1.2:  Example of a Glycosyltransferase Reaction 
 
Enzyme-catalyzed transformations of carbohydrates proceed through transition 
states, which may be studied by altering the electron density at various positions of the 
carbohydrate ring.  A glycosylation reaction may be considered a nucleophilic 
substitution reaction in that loss of a leaving group and subsequent replacement by the 
nucleophile is observed. The degree of bond formation and bond breaking in the 
transition state is represented in Figure 1.3. A dissociative (exploded) transition state is 
characterized by formation of an oxocarbenium ion resulting from loss of the leaving 
group on the donor substrate and then nucleophilic attack by the acceptor substrate 
(Figure 1.3A).  In an associative transition state, there are shorter bonds associated with 






























































(A) Dissociative Transition State (SN1)









Figure 1.3:  Dissociative vs. Associative Transition States 
 
By placing fluorine near a developing partial positive charge in the transition 
state, the reaction may be inhibited due to destabilization of the transition state.  The pKa 
of the proximal alcohol in the acceptor substrate is also lowered, possibly affecting its 
nucleophilicity (Figure 1.4).  The amount of inhibition by fluorine on the glycosylation 
reactions of interest will provide data towards the mechanism of action (dissociative vs. 
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Figure 1.4:  Proposed Transition States 
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Fluorine is an attractive choice for probing the transition state because of its strong 
electron-withdrawing characteristic, yet minimal steric effect (Table 1.1).4  The size of a 
C-F bond is similar to a C-OH bond and fluorine is a common choice for replacing C-OH 
groups to study carbohydrate metabolizing enzymes.  These fluorinated deoxy sugars 
have been used to evaluate enzyme recognition of substrates by changing the hydrogen-
bonding network from a donor (OH) to an acceptor (F).5  Replacement of a hydroxyl 
group with fluorine can be accomplished in one-step using DAST (diethylaminosulfur 
trifluoride)6 or Selectflour7.   
 
Table 1.1:  Comparison of Fluorine with Hydrogen and OH Bonds 
Element Bond Length 
CH3-X (Å) 
Van der Waals 
Radius (Å) 
Total (Bond 




of H, F, and O 
H 1.09 1.20 2.29 2.1 
F 1.39 1.35 2.74 4.0 
O 
(in OH) 
1.43 1.40 2.83 3.5 
 
A more difficult transformation to obtain is the replacement of a C-H bond with a C-F 
bond.  Fluoridolysis usually requires multiple synthetic transformations (as described 
later).  Additionally, having fluorine at C-5 may lead instability because it is adjacent to 
the carbohydrate ring oxygen.  Donation of the lone pair of the ring oxygen may lead to 















R3O OR1NR2  
Figure 1.5: Formation of Oxocarbenium Ion from Loss of Fluoride 
 
Previous attempts at forming C-5 carbon-fluorine bonds in carbohydrates have 
resulted in poor yields (Figure 1.6).  In the radical halogen exchange method developed 
by Withers and coworkers,9 compound 1 was brominated with NBS to form a C-5 
bromide.  The bromide was then displaced and epimerized with silver fluoride to give 2 
in a poor yield of 8% (2 steps).  Compound 2 had its remaining protecting groups 
removed using methanolic ammonia to form 3.  The (5-F) glycoside was then used as a 






























Figure 1.6: Radical Halogenation at C-5 by Withers and Coworkers 
 
In addition to the displacement of bromide with AgF (Figure 1.5), White and 
coworkers improved the radical halogenation method by using AgBF4 to form the C-F 
bond at C-5 (Figure 1.7).11  The known compound 412 was fluorinated with AgBF4 to 
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Figure 1.7:  Radical Halogenation at C-5 by White and Coworkers 
 
Substitution of fluorine at the C-5 position in the synthesis of 5-fluoro derivatives of 
N-acetylglucosamine (GlcNAc) is also achieved using the epoxide fluoridolysis 
methodology previously developed in our lab (Figure 1.8).8  A 5, 6-epoxide (8 or 10) is 
opened with HF·pyridine to install the desired C-F bond at C-5.  A phenylselenide at C-6 
(6) is oxidized and eliminated in a two-step process to form an olefin (7 or 9), which is 
oxidized to yield the desired 5, 6-epoxide.  Fluoridolysis in the GlcNAc series proceeds 
in good yields (72-83%) and the epoxide intermediates are useful substrates for other 
nucleophilic reactions at C-5.  However, epoxide fluoridolysis has not been reported in 
the GalNAc or (iso)LacNAc series and will be applied to these carbohydrates.  In 
addition to fluoridolysis, acid-catalyzed reactions of hindered 2, 3 glycosyl epoxides are 
attained with TMS-CN or HCN and a Lewis acid.13-16  Acid-catalyzed “C-glycosylation” 
has not been applied to the 5, 6 GlcNAc epoxide 8 (X = OH, Y = H, Z = OH) and will be 
attempted in the GlcNAc series.  The epoxides 8 and 10 are key intermediates because of 


































GlcNAc, X = OH, Y = H, Z = OH
GalNAc, X = H, Y = OH, Z = OH
isoLacNAc, X = OH, Z = Gal−β-1,3
    LacNAc,  X = Gal-β-1,4, Z = OH
R1 = (CH2)7CH3
R = Ac, Bn, BOM, or Gal
GlcNAc, X = OR, Y = H, Z = OR













Figure 1.8:  Epoxide Glycosylation Methodologies 
 
Epoxide fluoridolysis has proven successful in the GlcNAc series (X = OH, Y = 
H, Z = OH).  (5-F)-GlcNAc-β-octyl glycoside was synthesized and evaluated as an 
alternate acceptor substrate for β-1, 4 GalT (EC 2.4.1.38) from bovine milk.  Results 
shows there was minimal effect on the kcat of the reaction for the fluorinated versus non-
fluorinated substrates, suggesting little bond formation between the acceptor and the 
UDP-Gal donor (Table 1.2 and Figure 1.9).17  This result supports a dissociative 
transition state, which contains minimal bond formation between an acceptor and a 
donor. If negligible bond formation between an acceptor and the donor is observed, an 
oxocarbenium ion intermediate resulting from a more significant bond dissociation of the 






Table 1.2:  Comparison of β-1, 4 GalT octyl-GlcNAc Glycoside versus (5-F) Octyl-
GlcNAc Kinetic Data 
Substrate KMapp kcatapp kcat/KM
 (μM) (s-1) (M-1s-1) 
octylGlcNAc 52 ± 4 9.1 ± 0.5 175, 000 









































X = H or F
R = (CH2)7CH3
 
Figure 1.9: β-1, 4 GalT Transition State 
 
In addition, the epoxide fluoridolysis methodology was successful in the synthesis 
of the donor UDP-(5-F)-GlcNAc.  UDP-(5-F)-GlcNAc was studied with CLS (UDP-
GlcNAc:GlcNAc-P-P-Dol N-acetylglucosaminyltransferase, EC 2.4.1.141).17  UDP-
GlcNAc had a Km of 392 ± 83 μM and a Vmax of 27.5 ± 1.9 cpm/min/μg.  However, 
UDP-(5-F)-GlcNAc was inactive as a donor for CLS, suggesting UDP-(5-F)-GlcNAc to 
be an inhibitor.  Figure 1.10 indicates that UDP-(5-F)-GlcNAc at 1.5 mM and 0.25 mM 
concentrations acted as an inhibitor when increasing the amount of UDP-GlcNAc.  For 
both concentrations, increasing the concentration of UDP-GlcNAc lowers the inhibition 
of UDP-(5-F)-GlcNAc.  The data suggests that the fluorinated donor served as a 
competitive inhibitor of UDP-GlcNAc and not as a substrate (Figure 1.10).17  The 
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inactivating effect gives evidence that the electron-withdrawing fluorine is destabilizing a 


































X = H or F
undecaprenyl, n = 7, allylic
dolichyl, n = 13-16, non-allylic
 
 
Figure 1.10:  Inhibition Studies of CLS by UDP-(5-F)-GlcNAc 
 
The UDP-(5-F)-GlcNAc alternate substrate was also evaluated as a mechanistic 
probe with UDP-GlcNAc C-4 epimerase.  UDP-GlcNAc C-4 epimerase is found within 
the biosynthetic pathway of an unusual carbohydrate found in the lipopolysaccharide of 
the waterborne pathogen, Plesiomonas shigelloides.18  The enzyme catalyzes the 
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epimerization of the C-4 hydroxyl group of UDP-GlcNAc to UDP-GalNAc resulting in a 
70:30 equilibrium, favoring UDP-GlcNAc (Figure 1.11).  UDP-(5-F)-GlcNAc was shown 
to be an alternate substrate for the epimerase with a 270-fold decrease in kcat (Table 
1.3).19  The decrease in kcat/Km may be due to the 5-fluoro group hindering the rotation 
about the C-O-P bond during catalysis or due to the 5-fluoro group destabilizing the 
putative positive charge formation during hydride abstraction (Figure 1.11).  More 
experimental data are needed in order to determine which mode of inhibition is occurring.   
 
Table 1.3:  Comparison of UDP-C-4-Epimerase UDP-GlcNAc versus UDP (5-F) 
GlcNAc Kinetic Data 
Substrate KM (µM) kcat (min-1) kcat/KM (M-1s-1) 
UDP-GlcNAc18 137 ± 17 461 ± 33 56100 ± 403 


















































Figure 1.11:  Reaction Catalyzed by UDP-GlcNAc C-4 Epimerase: Proposed Mechanism 
 
An extension of the epoxide fluoridolysis methodology is to study the effects of 
fluorine in the galactosamine (GalNAc) series (Figure 1.8).  Since there was no genuine 
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sample of the UDP-(5-F)-GalNAc, 11, available at the time of the C-4 epimerase research 
described above, 11 was selected as a synthetic target.  This sugar nucleotide could also 
be evaluated as a substrate for the C-4 epimerase and used as a mechanistic probe for 
GalNAcT in O-glycan biosynthesis (Figure 1.12A). 
The biosynthesis of O-glycans, such as, Core 1 and Core 2, plays an important role in 
cellular adhesion, differentiation, invasion and metathesis of tumors.20  Recently, a 
positive correlation between increased GalNAcT activity and invasion and metathesis in 
early stages of gastric cancer has been reported (Figure 1.12A).21  Compound 11 could be 
used to determine the effects of fluorine on the donor substrate of GalNAcT and could 
potentially inhibit the formation of the Core 1 and Core 2 biosynthetic products involved 
in tumor progression of gastric cancer.  Additionally, the effects of fluorine on an 
acceptor substrate in O-glycan biosynthesis, could also be investigated by synthesizing 12 
as a possible β-1, 4 GalT substrate (Figure 1.12B).  β-1, 4 GalT utilizes the acceptor O-
linked glycopeptide, 12, and the donor GDP-Gal in order to form the Core 1 and Core 2 
products.  By inhibiting the β-1, 4 GalT enzymatic reaction, the Core products may be 
decreased and therefore result in a reduction of tumor progression.  Based upon previous 
results, it is expected that the donor UDP-(5-F)-GalNAc should have a greater effect on 

























































(A) GalNAcT (E.C. 2.4.1.41)
(B) β-1,4 GalT (E.C. 2.4.1.122)
11, X = F
12, X = F
R1 = Ser or Thr residue 




Figure 1.12:  Reactions catalyzed by (A) GalNAcT and (B)  β-1, 4 GalT 
 
As well as studying the effects of fluorine on both donor and acceptor substrates in 
the O-glycan biosynthetic pathway, the proximity effect of fluorine could be investigated. 
FucT III (E.C. 2.4.1.65), involved in Lewis B blood group antigens, fucosylates the free 
C-4 or C-3 hydroxyl groups of the two disaccharides type 1 (isoLacNAc) and type 2 
(LacNAc), respectively (Figure 1.13).22  FucT III has been linked to an increase in tumor 
size in prostate cancer cell line PC-3 due to an increase in cellular adhesion in the stromal 
cells.23  Therefore, work towards the inhibition of this enzyme could potentially impede 
prostate cancer progression.  Two fluorinated analogs, 13a and 14a, could aid in 
investigating the effects of fluorine on FucT III glycosyl acceptor substrates by 
differentially affecting the pKa of the C-4 hydroxyl versus the C-3 hydroxyl and 
potentially affect their ability to act as acceptor substrates.   It is also necessary to 
synthesize 13b and 14b in order to have non-fluorinated control substrates as the octyl 
glycoside (R = (CH2)7CH3) is not the natural substrate for the enzyme.  The octyl chain is 
12 
 
necessary for the binding to a reverse-phase solid support in the Sep-Pak assay used to 
evaluate the enzymatic reaction.24  The octyl side chain adheres to the reverse-phase C-18 
column and elution with water results in water-soluble impurities in the column fractions.  
The desired octyl glycosides remain on the column, as they are not water soluble.  The 
resulting glycosides are then eluted using MeOH.  The effect of fluorine on FucT III 
could be analyzed by comparing the rates of 13a and 14a to 13b and 14b, respectively.  If 
FucT III follows a dissociative transition state similar to the β-1, 4 GalT, then there 
should be minimal difference between 13a and 14a as there should be little bond 
formation between the acceptor substrate and the GDP-Fuc donor.  The ability of 13a 
and/or 14a to act as substrates in FucT III catalyzed glycosylation would permit the 































































































13a, X = F







14a, X = F
14b, X = H
δ−
 




In addition to epoxide fluoridolysis, it is possible that 5, 6 epoxides (Figure 1.8) 
could be used to form novel C-glycosides (Figure 1.14).  It is known that 2, 3 epoxides 
can be converted to cyanodeoxy sugars.  Regioisomers 16 and 17 can be formed from the 
2, 3 epoxide 15 with either HCN16 or TMS-CN14 and a Lewis acid.  Currently, there are 
no 5, 6 glycosyl epoxides reported using this type of acid-catalyzed “C-glycosylation”.  
The reaction conditions effective for acid-catalyzed C-glycosylation of 2, 3 epoxides 15 
and 18 will be attempted on the 5, 6 epoxides, 19 (Figure 1.15).  Formation of the (5-
cyano) sugars would broaden the ability to functionalize carbohydrates.  A stable C-C 
bond C-5 could be reduced to an amine, leading to branching of sugars or greater 
functionalization of glycosides (Figure 1.15).  In addition, formation of the free amine 22 
could be useful as a probe for carbohydrate metabolizing enzymes.  A biotin molecule 
may be attached to the amine and used in a biotin/avidin capture assay25 as a new method 






























CH2Cl2, 0 °C, 18h
53%
AlCl3, TMS-CN














































R2 = Pht, HAc
R3 = R4 = Ac or Bn
 
 
Figure 1.15: Formation of 5, 6-C Cyano Sugars 
 
In order to evaluate the enzymes UDP-C-4-GlcNAc epimerase, GalNAcT, β-1, 4 
GalT, and FucT III as described above, compounds 11, 12 (X = F), 13a, 13b, 14a and 
14b have been selected as (5-fluoro) synthetic targets for use with the epoxide 
fluoridolysis methodology (Figure 1.16).  The (5-fluoro) glycosides could be compared to 
their corresponding non-fluorinated, control, substrates in order to determine the effect 
fluorine has on the transition state of the glycosyltransferase reaction of interest.  These 
GalNAc and (iso)LacNAc glycosides may be accessed through the GalNAc epoxide 8 (X 


































11, X = F
13a, X = F
13b, X = H
14a, X = F
14b, X = H




Figure 1.16: Synthetic Targets for (5-Fluoro) Carbohydrates 
In addition to the GalNAc derivatives (11 and 12) and (iso)LacNAc glycosides 
(13 and 14), a new C-C bond formation utilizing an acid-catalyzed “C-glycosylation” 
15 
 
reaction will be attempted on the GlcNAc epoxide 8 (Figure 1.8, X = OH, Y = H, Z = 
OH).  As shown in Figure 1.17, this may form a stable C-C bond at the C-5 position, 20, 
allowing for greater functionalization of carbohydrates or, alternatively the regioisomer, 
21, a reducing sugar.  In addition, it will be important to understand the functional group 
tolerance of the new cyanosilylation reaction in order to determine the scope of this 
methodology.  As a result, both electron-withdrawing and electron-donating protecting 















R2 = Pht, HAc
R3 = R4 = Ac or Bn  
 





REVIEW OF CURRENT DISCUSSIONS OF GALACTO AND GLUCO 
REACTIVITIES AND CURRENT GLYCOSYLATION METHODOLOGIES 
2.1 Discussion of gluco versus galacto reactivites  
Glucose and galactose sugars are structurally very similar; the only difference 
being the position of the C-4 hydroxyl group.  However, this seemingly modest 
distinction imparts a variety of fundamental property changes between the two sugars.  It 
will be of interest to see how the epoxide fluoridolysis reaction may be affected by the C-
4 hydroxyl position, as this has not been reported in the literature. 
Studies have indicated that the electronegativity of the C-4 substituent plays a role 
in the rate of acetolysis of galactopyranosides (Figure 2.1).26  The results show compound 
24 acetolyzes approximately 10 times faster than 25, which is approximately 5 times 
faster than 26.  In contrast, the glucopyranoside series is not as influenced by the 
electronegative nature of the C-4 substituent.  Compound 27 is approximately 2.9 times 
faster than 28 and 3.3 times faster than 29.  The result of the glucopyranoside acetolysis 
rates is hypothesized to be due to a small “through-bond” interaction with the ring 
oxygen.  In the case of the galacto configuration, there is a strong through-space 
interaction between the electronegative C-4 axial substituent and the forming 
oxocarbenium ion.  In neutral galactopyranoside derivatives, the effect is destabilizing 
17 
 
due to electrostatic repulsion.  During oxocarbenium ion formation, the through-space 





























27 28 29  
Figure 2.1: Glycopyranoside Acetolysis Substrates 
2.2 Discussion of reactivity differences of carbohydrate ring positions 
In addition to differences between gluco versus galacto configurations, each of the 
6 positions of the carbohydrate ring have different reactivities.  The α:β selectivity at C-1 
may be influenced by the neighboring C-2 position.27,28  In a gluco configuration, 
neighboring group participation on a donor substrate occurs with a participatory group at 
C-2 that can attack the α-face of the C-1 position.  As a result, glycosylation with an 
acceptor preferentially forms a β-linkage.  The C-3 hydroxyl is known to be a good 
nucleophile, but an electron-withdrawing N-phthalimido group at the C-2 position lowers 
the reactivity of the C-3 hydroxyl.29  The C-4 position is known to be in general a poor 
nucleophile.30  However, a C-3 and C-4 diol acceptor substrate with C-2 N-phthalimido 
or C-2 N-Troc will regioselectively form a 1-4 linkage.29,31  As a result, it is important to 
manipulate the reactivity of each position on donor and acceptor substrates of 
glycosylation reactions in order to attain the desired α:β-selectivity and 1, 3 or 1, 4 
regiochemistry.  In order to synthesize the desired (5-fluoro) (iso)LacNAc octyl 
glycosides 13 and 14, it will be necessary to perform a glycosylation reaction to form the 
18 
 
desired β-1, 3 and β-1, 4 disaccharides.  Therefore, it will be important to design specific 
donors and acceptors to give the desired α:β selectivity and regiochemistry of the 
(iso)LacNAc derivatives.  In addition to manipulating reactivities of the carbohydrate 
positions, the α:β-selectivity may also be influenced by the technique used to promote 
glycosylation. 
2.3 Discussion of current glycosylation methodologies 
Promotion of glycosylation reactions are widely reported in the literature.  The 
earliest glycosylation techniques include the Koenigs-Knorr, Fisher-Raske, or Helfrich 
methods.  The Koenigs-Knorr method involves a glycosyl halide donor and either a silver 





































Additionally, Emil Fisher and Karl Raske developed a glycosylation reaction 
involving a glycosyl halide donor and an alkoxide base.34  A caustic solution was added 





























Helfrich glycosylation utilizes a Lewis acid promoter and a peracetylated 
glycoside donor substrate.  This method forms the α- or β-glycosides in modest yields 

















































Improved α:β selectivity in glycosylation reactions are observed with 
phenylthioglycoside donor substrates (Scheme 2.4).37  Thioglycoside promotion is similar 
to the Koenigs-Knorr promotion methods in that a mercury salt promoter used.  



















































Enhanced thioglycoside activation include the promoters NIS28, BSP30 and 
PhSCl38 (Scheme 2.5).  These conditions generally proceed in good yields, allowing for 
good stereocontrol at C-1.  A glycosyl triflate salt is formed in situ, along with formation 
of a disulfide leaving group upon activation from a sulfur-containing promoter.  The 







































































10:1 (α:β)  
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In general, good to excellent yields and stereoselectivity in glycosylation 
reactions may be attained using a trichloroacetimidate donor developed by Schmidt and 
co-workers.41  This method uses a strong Lewis-acid promoter with improved yields 


































R = Ac, 78%
R = Bz, 90%
R = Ac, 90-92%
R' = a, b
R'-SH
BF3·OEt2













The trichloroacetimidate methodology also allows greater flexibility of selectivity 
at the anomeric position.  This is achieved by controlling the temperature of activation of 
the glycosylation reaction.43  The use of an N-trichloroacetylcarbamate group which is 
analogous to a trichloroacetimidate, resulted in a dramatic difference in α:β-selectivity 
due to the temperature of glycosylation activation (Table 2.1).  A lower temperature of 
activation increases β-selectivity.  A higher temperature of activation predominantly 




































Acceptor (ROH) α-Selective glycosylationa β-Selective glycosylationb
0 ºC, 5h 93%, α/β = 90/10
0 ºC, 3h 86%, α/β = 96/4
-40 ºC, 1.5h then -23 ºC, 16h
83%, α/β = 15/85
-20 ºC, 1h 74%, α/β = 17/83
a Me3SiClO4 (20 mol %) in Et2O
b Me3SiOTf (20 mol %) in EtCN  
 
 The thioglycoside method previously described has been used to synthesize 
compound 13b (Scheme 2.7)44.  The benzylidene acceptor and thioglycoside donor 
formed the desired disaccharide in modest yield and removal of the Troc at N-2 allowed 





















































 The Koenigs-Knorr method was employed in the synthesis of the β-1, 4 octyl 
glycoside 14b45 (Scheme 2.8).  This procedure proceeded in good yields to form 14b.  
The disadvantage of this synthesis is that the acceptor substrate is highly specific.  A 
more divergent acceptor substrate allowing for access to multiple acceptor substrates for 
different regioisomers would be more useful.  Chapter 4 describes syntheses for 
accessing both (5-fluoro) (iso)LacNAc and non-fluorinated (iso)LacNAc-octyl glycosides 


































SYNTHESIS OF C-6 PHENYLSELENIDE-GalNAc-OCTYL GLYCOSIDES AND 
C-6-PHENYLSELELNIDE-GalNAc-GLYCOSYL PHOSPHATES 
3.1 Introduction 
In order to synthesize the desired (5-fluoro) and (5-cyano) GalNAc and GlcNAc 
glycosides 11, 12, 20 and 21, it is necessary to synthesize C-6 phenylselenide-containing 
glycosides (Figure 1.8).  These monosaccharide selenium-containing substrates will then 
be transformed to their corresponding 5, 6 epoxides and subjected to either epoxide 
fluoridolysis or cyanosilylation.  The C-6 phenylselenide-containing GalNAc glycoside 
synthetic targets are shown in Figure 3.1.  Protecting group flexibility at C-4 is desired 
because of the axial –OH substituent in the galacto configuration (Figure 3.1A).  It is 
unknown what affect the axial C-4 –OH substituent will have on fluoridolysis or 
cyanosilylation.  Therefore, it is important to explore electron-withdrawing versus 
electron-donating protecting groups at C-4, as well as the potential for neighboring group 
participation of different protecting groups.  In terms of the cyanosilylation reaction, it is 
unknown what the functional group tolerance of the reaction conditions will be.  As a 
result, it will also be important to investigate the role of electron-withdrawing versus 
































R2 = Pht or HAc
R3 = Ac, Bn or BOM
R4 = Ac or Bn
 
Figure 3.1:GalNAc and GlcNAc C-6 Phenylselenide Synthetic Targets 
 
Introduction of the phenylselenide (Chapter 1, Figure 1.8) can be achieved by two 
different methods (Figure 3.2).  One approach involves displacement of a bromide with 
phenylselenol (Figure 3.2A), whereas an alternative route, developed by Nicolaou and 
Grieco, converts a free alcohol to a phenylselenide using N-phenylseleno phthalimide (N-




























R = Ac, Bn, BOM, or Gal
GlcNAc, X = OR, Y = H, Z = OR
GalNAc, X = H, Y = OR1, Z = OR
 
Figure 3.2:  Formation of 6-SePh 
 




3.2 Synthesis of the β-octyl C-4–OH glycosides  
In the case of the GalNAc-β-octyl glycosides, the phenylselenide has been 
installed via the halide displacement method (Figure 3.2A).  Beginning with the known 
compounds 32a and 32b,47 the benzylidene intermediates were opened using Hanessian-
Hullar conditions48 that produced a C-6 bromide and resulted in selective protection of 
the C-4 position as a benzoyl ester (Scheme 3.1).  A non-amide group, e.g. phthaloyl, at 
the C-2 nitrogen is necessary for Hanessian-Hullar conditions, which proceeds through 
radical abstraction of the benzylidene hydrogen by Br· during the reaction.  Instead of 
abstracting the benzylic hydrogen, the radical could abstract the amide hydrogen on the 
nitrogen, resulting in undesired reaction(s) and/or decomposition.  The bromide was then 
displaced using PhSeH, NEt3 and Bu4NI (as a phase-transfer catalyst) to form the 
phenylselenides, 33a and 33b.  The addition of Bu4NI dramatically decreased the reaction 
time from 5 days to overnight. The free C-3 –OH groups were protected with a 
benzyloxymethyl (BOM) ether group to form 34a and 34b.  Compound 34c was 
synthesized as reported by Matt Hartman.8  The order of the reaction sequence is 
important to avoid formation of an undesired C-6 chloro by-product (Scheme 3.2).  The 
C-6 bromide must be displaced first by PhSeH before the C-3 protection, otherwise the 
release of chloride from the BOM-Cl reagent will displace the bromide and result in a 3:1 
mixture of C-6 Br and C-6 Cl glycoside (Table 3.1).  Attempts at sequestering the 
released chloride with silver salts proved unsuccessful.  The resulting differentially 
protected glycosides 34a, 34b and 34c were transformed to 35a, 35b, and 35c by removal 


























a, R1 = (CH2)7CH3, 83% (2 steps)
b, R1 = TBS, 71% (2 steps)
1. NBS, BaCO3
    CCl4, Δ
2. PhSeH, NEt3,
    Bu4NI, THF, Δ
BOM-Cl, DIEA,
Bu4NI, THF, Δ
a, R1 = (CH2)7CH3, 75%
b, R1 = TBS, 88%
a, R1 = (CH2)7CH3, 89%
b, R1 = TBS, 87%
c, R1 = PMP, 76%
NaOMe, MeOH
32 33



















































Table 3.1:  Attempts at Sequestering Released Chloride During C-3 BOM Protection 
BOM-Cl DIEA Silver Salt Result 
5 (eq.) 5.5 (eq.) None 34b/39 
(3:1) 
2 (eq.) 2.5 (eq.) None 34b/39 
(15:1) 
5 (eq.) 5.5 (eq.) AgCO3 Decomposed 




3.3 Inversion of configuration from gluco to galacto 
The inversion of configuration was accomplished via triflate formation and the 
SN2 displacement of the triflate by Et4NOAc (Scheme 3.3).49  Synthesis of 40c was 
performed once and not optimized, but 40a and 40b proceeded in good yields to form the 
















a, R1 = (CH2)7CH3, 85% (2 steps)
b, R1 = TBS, 87% (2 steps)
c, R1 = PMP, 49% (2 steps)
1. Tf2O, pyr., 




3.4 Synthesis of 6-SePh-GalNAc-β-octyl glycoside 
Protecting group flexibility at the C-4 position was desired since this position 
would be adjacent to the 5, 6 epoxides (as described in 3.1).  The role of an electron-
withdrawing versus electron-donating protecting groups is of interest at C-4 as it is 
unknown how it will affect fluoridolysis and cyanosilylation.  For the C-4 acetate 
(electron-withdrawing) derivative, the phthaloyl and acetyl groups of 40a were removed 
and the resulting 2-amino, 4-hydroxy glycoside was N- and O-acetylated to give 42a 
(Scheme 3.4).  Alternatively, the C-4 acetate was removed by NaOMe and protected as a 
benzyl ether (electron-donating protecting group) using the method developed by Karst 





































a, R4 = Ac
b, R4 = Bn
1. NaOMe
    MeOH/THF
2. NaH, BnBr,








3.5 Synthesis of 6-SePh-GalNAc-α-octyl glycoside 
Installing the phenylselenide on the GalNAc-α-octyl glycoside was investigated 
using both the halide displacement and the N-PSP methods.  First, the α-linkage needed 
to be in place and several methods were investigated. 
Initially, a thioglycoside was used because of the reported high α-selectivity in the 
literature (Scheme 3.5).  Beginning with the glycoside 43, the phenylthio glycoside was 
formed using BF3·OEt2 and PhSH to form 44.51  The benzylidene 45 was then formed 
based on the procedure of Miyajima and coworkers52 by removing the acetyl protecting 
groups to form the triol and then using PhCH(OMe)2 and pTsOH.  After formation of the 
oxazolidinone, 4638, glycosylation to form the α-linkage was attempted using AgOTf, 
PhSCl, DTBMP and 1-octanol.38  However, in contrast to the literature reports, the 
reaction failed to produce the desired α-octyl glycoside and starting materials were 
recovered (Table 3.2, entry 1). Other methods of thioglycoside activation were attempted, 
30 
 
but also failed to produce the desired α-linkage (Table 3.2, entries 2-4).38-40  Starting 





































    MeOH/THF
2. PhCH(OMe)2,
    pTsOH H2O,










46 47  
 











































An alternative to thioglycoside activation involved installing the octyl side chain 
at the beginning of the synthesis by Lewis acid activation of N-acetyl-D-glucosamine, 48, 
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in neat 1-octanol (Scheme 3.6).29,53  The α-glycoside 49, was then converted to the 
benzylidene and the free C-3 alcohol acetylated to yield compound 50.  The 4, 6-
benzylidene of compound 50 was opened with acid catalysis to give the diol and the C-6 
position was selectively protected as a TBS ether to form 51.  The gluco configuration 
was converted to the galacto configuration via triflate formation at the C-4 position and 
displacement of the triflate by Et4NOAc.  The TBS silyl ether was then removed to give 
the free C-6 alcohol, 53.  However, attempts at formation of the phenylselenide with the 
N-PSP method did not form the desired phenylselenide glycoside, 54.  Perhaps the 
reaction failed due to neighboring group participation from the axial C-4 acetate group 




















































1. AcOH, H2O, Δ
2. TBS-Cl, imidazole,
    DMF
1. Tf2O, pyr.,


















In addition to 53, diol 50 was also subjected to the same N-PSP conditions 
(Scheme 3.7).  However, only starting material was recovered.  Alternatively, formation 
of a C-6 Br, 57, was attempted using NBS or CBr4 with PPh3.54  Compound 49 was 
recovered and the desired bromide, 57, was not observed (Scheme 3.7).  The α-linkage 



























CH2Cl2, -20 °C to rt
NBS or CBr4, 
PPh3, DMF, 0 °C
55 56
49 57  
3.6 Synthesis of 6-SePh-GalNAc phosphate 
In pursuit of the 6-SePh-GalNac phosphate glycosides, the BOM group at C-3 of 
40c, was removed with BF3·OEt2 and the resulting hydroxyl group selectively acetylated 
with AcBr in a one-pot procedure to afford 58 (Scheme 3.8).  However, attempts at 
deprotection of the PMP group failed with AcBr, ZnI2 and BF3·OEt2.  Following 
literature procedures, PMP deprotection and conversion to the glycosyl bromide was 
successful in a model reaction.55  However, compound 58 could not be converted to 59 

































40c 58 59  
 
Consequently, the TBS ether was used because of its ease of deprotection 
(Scheme 3.9).  The phthaloyl and acetyl protecting groups on compound 40b were 
removed via hydrazinolysis.  The free C-2 amine was N-trifluoroacetylated with 
trifluoroacetic anhydride (TFAA) and pyridine forming the C-2 trifluoroacetamide as 
well as the TFA ester at C-4.  The C-4 TFA ester was removed with a sodium bicarbonate 
wash to give the free C-4 –OH, 60.  The resulting C-4 –OH group was protected with 
acetic anhydride and pyridine to yield 61a.  Alternatively, the C-4 –OH group was 
protected as a benzyl ether to give 61b.  The TBS silyl ether was removed to form the 
reducing sugar, which was then phosphorylated with tetrabenzyl pyrophosphate (TBPP) 
to give compound 62a.  The C-2 trifluoroacetamide is critical for the stability of the 
glycosyl phosphate at C-1.56  The electron-withdrawing effects of fluorine stabilize the 
phosphate, allowing it to be purified by flash column chromatography and withstand 
multiple synthetic organic reaction conditions.8  When an acetamido group is at C-2, the 
glycosyl phosphate is unstable and cannot be purified via flash column 
chromatography.57  The same sequence of phosphorylation conditions used to form 62a 
was unsuccessful in forming 62b.  Since flexibility was again desired at the C-4 position, 
attempts at removal of the acetate protecting group to form 63 failed using the mild 


















































61a R4 = Ac, 92%








    EtOH, Δ
2. TFAA, pyr., 0 oC
.
80% (2 steps)
1. HF pyr., CH3CN
2. LDA, THF
.
a, R4 = Ac, 70% (2 steps)
b, R4 = Bn, no product formed
(a) Ac2O, pyr.
(b) NaH, BnBr,
     NBu4I, THF
 
 
It is proposed that the failed phosphorylation with O-Bn at C-4 is due to the fact 
that the O-Bn group cannot participate in the reaction at C-1 of the reducing sugar.  A C-
4 acetate in a galactose derivative can participate across the ring59 and possibly is 
coordinating with the Li+ ion generated from the LDA deprotonation (Figure 3.3, A).  
The coordination helps pull the Li+ ion away from the oxyanion at C-1, allowing for 
nucleophilic attack of the TTBP.  The C-4 Bn ether cannot coordinate to the Li+ ion and 
the oxyanion is not as exposed and is unable attack the TTBP (Figure 3.3, B).  A better 
leaving group on the phosphorylating agent, such as a phosphoramidite, may be needed 

























As a result of the failure to obtain 62b as described above, a new method was 
attempted following the work of Thiem and Lazarevic (Scheme 3.10)60, in which the 
reducing sugar 64 was converted to a phosphite using dibenzyl-N, N’-
diisopropylphosphoramidite (iPr)2NP(OBn)2 and 1-H-tetrazole and then oxidized with 




















    CH2Cl2, rt





The C-4 Bn ether protection described in Scheme 3.9 was optimized and a new 
route was developed and is shown in Scheme 3.11.  The C-4 acetate was removed with 
NaOMe and the resulting free alcohol protected with a benzyl ether to give 67.  The 
phthaloyl group was removed and trifluoroacetylated to give 61b, in a higher yielding 
sequence than previously described in Scheme 3.9.  The TBS silyl ether was then 














































    EtOH, Δ





Following the Thiem procedure, phosphorylation of 68 was achieved by 
formation of the phosphite followed by subsequent oxidation of the phosphite to the 
phosphate (Scheme 3.12).  The oxidation conditions (NaIO4 and NaHCO3) resulted in the 
oxidation of both the phenylselenide and phosphite moeities to give the glycosyl 






















    CH2Cl2, rt
2. NaIO4, NaHCO3,




3.7 Synthesis of cyanosilylation precursor phenylselenides 
 Acid-catalyzed glycosylation of 2, 3 epoxides has been achieved using a strong 
Lewis acid with TMS-CN as described in Chapter 1, Figure 1.14.  In order to test acid-
catalyzed glycosylation on 5, 6 epoxides, the phenylselenides 71a and 71b were 
synthesized (Scheme 3.13).  These precursors were designed to incorporate electron-
withdrawing and electron-donating protecting groups in order to explore functional group 























33 70 71a, R3 = R4 = Ac, 99%
71b, R3 = R4 = Bn, 63%
(a) Ac2O, pyr
(b) NaH, BnBr,
    Bu4NI, THF, Δ




 Formation of the C-6 selenium-containing GalNAc-β-octyl glycosides 42a and 
42b with either electron-withdrawing (42a) or electron-donating (42b) protecting groups 
at C-4 proceeded in good yields.  However, installation of the C-6 phenylselenide α-
glycoside was unsuccessful with either thioglycoside activation (Table 3.2), N-PSP 
conversion of a C-6 OH to the C-6 SePh (Scheme 3.6), or formation of a C-6 Br (Scheme 
3.7).  In pursuit of the glycosyl phosphate, the electron-withdrawing C-4 acetate GalNAc 
α-phosphate 63 was formed in good yields from 62a in a 2-step process of deprotonation 
of the C-1 –OH with LDA and phosphorylation with TBPP.  In contrast, attempts at 
phosphorylation of the C-4 Bn ether reducing sugar 68 with TBPP were not successful in 
forming the desired α-phosphate.  Phosphitylation of 68 was successful using 
(iPr)2NP(OBn)2, followed by oxidation of the phosphite to the phosphate.  Synthesis of 
the GlcNAc phenylselenides 71a and 71b was formed in good yields with both electron-
withdrawing and electron-donating protecting groups at C-3 and C-4. 
With the C-6 phenylselenide-containing GalNAc and GlcNAc glycosides (42a, 
42b, 71a and 71b) and glycosyl phosphates (63 and 69) in hand, the phenylselenides will 
be transformed into their corresponding 5, 6 epoxides by a two-step process of oxidation 
of the selenide to the selenoxide and thermal elimination to an olefin (Chapter 5).  
Epoxidation of the resulting olefin with DMDO (Figure 1.8) should yield the desired 
GalNAc and GlcNAc epoxides 8.  Epoxide fluoridolysis and cyanosilylation will be 






SYNTHESIS OF C-6-PHENYLSELENIDE LacNAc DISACCHARIDES AND 
(iso)LacNAc DISACCHARIDES 
4.1 Introduction 
In order to evaluate the (5-fluoro) (iso)LacNAc glycosides (13a and 14a) as 
mechanistic probes of FucT III-catalyzed glycosylation described in Chapter 1, it is 
necessary to synthesize the C-6 phenylselenide-containing β-1, 3 and β-1, 4 octyl 
glycosides (Figure 4.1).  Formation of these target compounds proves synthetically 
challenging as glycosylation has not been reported using selenium-containing glycosides.  
Once installed, the phenylselenide glycosides may be transformed to the desired epoxides 
10, which can undergo epoxide fluoridolysis to form the desired (5-fluoro) glycosides 




















Figure 4.1: isoLacNAc and LacNAc C-6 Phenylselenide Synthetic Targets 
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In addition to an octyl glycoside, an 8-methoxycarbonyloctyl (8-Mco) group 
could also be used at the C-1 position.  The advantages of 8-Mco are the increase 
glycoside solubility when exposed to enzymatic buffer conditions.  The disadvantages of  
8-Mco are it cannot withstand several reaction conditions and 8-methoxycarbonyl octanol 
is costly.  The octyl side chain is a known substrate for glycosyl transferase enzymes and 
can withstand broad synthetic reaction conditions.  An octyl glycoside is necessary for 
the Sep-Pak assay used to evaluate the enzyme as described in Chapter 1. 
There are two possibilities for forming the C-6 selenium-containing disaccharides 
with either an 8-Mco or octyl glycoside (Figure 4.2).  Either phenylselenide 
monosaccharide acceptors (33 or 35), discussed in Chapter 3, are coupled with a 
galactosyl donor, or the phenylselenide is introduced after formation of the desired 
















































































R1  = TBS, (CH2)7Y,
Y  = CH3 or CH2CO2Me










Figure 4.2:  Retrosynthetic Analysis for C-6 Phenylselenide Glycosides as Precursors of 
5-(Fluoro) (iso)LacNAc Glycosides 
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4.2 Attempts at the synthesis of 6-SePh-(iso)LacNAc-β-octyl glycoside with 
selenium-containing acceptor substrates 
The phenylselenide monosaccharide acceptors 731 and 33b were evaluated first as 
they were readily available (Table 4.1).  Using Koenigs-Knorr and trichloroacetimidate 
glycosylation reactions discussed in Chapter 2, no disaccharide formation was observed.  
Compounds 73 and 33b were recovered, along with the hydrolysis products derived from 
the donors 74 and 75.   
 





























































Following the β-1, 3 glycosylation reactions previously attempted in Table 4.1, 
the phenylselenide-containing monosaccharide acceptor substrate 35b was used to 
attempt formation of the desired β-1, 4 disaccharides (Table 4.2).  The results were 
                                                 
1 Compound 73 was isolated as a by-product of a reaction previously performed in our lab by Esther Joo. 
41 
 
identical to the isoLacNAc results and are shown in Table 4.1.  The phenylselenide 
monosaccharide acceptors as well as the donor hydrolysis product were fully recovered. 
 
Table 4.2:  β-1, 4 Glycosylation Attempts with Phenylselenide Containing 




























































A proposed hypothesis as to why the phenylselenide monosaccharide acceptors 
are unable to form the desired disaccharide linkages is shown in Figure 4.3.  It is 
presumed that the nucleophilic nature of C-6 selenium is greater than that of the C-3 or 














































O δ X = Br or OCCCl3
NH
 
Figure 4.3:  Hypothesis for Non-productive Phenylselenide Monosaccharide Acceptors 
Disaccharide Formation 
 
4.3 Synthesis of 6-SePh-(iso)LacNAc-β-octyl glycoside with non-selenium-
containing acceptor substrates 
Given that the C-6 phenylselenide monosaccharide acceptors were unable to form 
the desired disaccharides, attention was turned toward the non-seleno-containing 
acceptors.  The synthesis of the β-1, 3 glycoside with an 8-Mco side chain at C-1 was 
investigated.  This approach utilized a trichloroacetimidate donor substrate, 77.61  In 
order to direct glycosylation towards the β configuration, a Troc group was used at C-2, 
due to its high β selectivity62.  After installation of the β-8-Mco side chain at C-1, the 
Troc group was then removed to form the free amine and N-acetylated to give 79.  The 
benzylidene 80 was formed using benzaldehyde dimethyl acetal (PhCH(OMe)2) and tosic 





























































    pTsOH H2O, 






85% (2 steps)  
 
The Koenigs-Knorr and trichloroacetimidate methodologies (as described in Chapter 2) 
were applied in the formation of the desired β-1, 3 linkage.  The Koenigs-Knorr method 
utilized either Hg(CN)264 or AgOTf65 as an activator with a glycosyl bromide donor ( 
 
Table 4.3).  The best Koenigs-Knorr activator proved to be Hg(CN)2.  However the 
reaction required two days with mild heating.  The trichloroacetimidate donor 75 and 
TMS-OTf activator ( 
 
Table 4.3, entries 4 and 5) produced the desired β-1, 3 disaccharides in the highest 
yields and lowest reaction times.  These reactions were temperature sensitive, with a 
lower activation temperature yielding the desired β-linkage66 (82) versus a warmer 






Table 4.3:  β-1, 3 Glycosylation Attempts with Non-selenium Containing 



















































R2  = NHAc
          (80)
+ Conditions




R2  = NPht













R2  = NHAc







R2  = NPht
        (32)
R1 = (CH2)8CO2Me
R2  = NHAc
          (80)
Disaccharide
R1 = (CH2)8CO2Me
R2  = NHAc
           (81)
R1 = (CH2)8CO2Me
R2  = NHAc
           (81)
R1 = (CH2)7CH3
R2  = NPht
           (82)
R1 = (CH2)7CH3
R2  = NPht
           (82)
R1 = (CH2)8CO2Me
R2 = NHAc




The non-selenium containing disaccharide 82 was converted to the C-6 
phenylselenide with Hannessian-Hullar conditions and displacement of the C-6 bromide 
with PhSeH and NEt3 to give 84 (Scheme 4.2).  The addition of Bu4NI resulted in a 
significant formation of a C-6 methyl by-product, and was avoided during bromide 
displacement.  The N-phthaloyl, O-benzoyl and O-acetyl protecting groups were removed 
by H2NNH2·H2O and a global N- and O-acetylation were performed to yield the desired 


































    CCl4, Δ
2. PhSeH, NEt3,
    THF, Δ
1. H2NNH2 H2O, 









The β-1, 4 non-seleno acceptor substrates were synthesized using the precursors, 
32 and 80, employed in the synthesis of β-1, 3 acceptor substrates.  In order to manipulate 
the C-6 position and introduce a phenylselenide after disaccharide formation, a strategy 
was developed to isolate the C-6 –OH (Scheme 4.3).  Either a reduction of the 
benzylidene 80 to a C-6 benzyl ether or acid-catalyzed opening of the benzylidene 3267 
followed by selective protection with a TBS68 group would differently protect the C-6 
position.  Reduction of the benzylidene using either HCl in ether with NaCNBH3,69 or 
TES and TFA70,71 to form the C-6 Bn ether, 89, proved unreliable and low yielding.  
Opening of the benzylidene with AcOH/H2O and selective protection of the free C-6 
alcohol as a TBS ether to give, 87 or 90, proved to be better yielding and more reliable 










































a, R1 = (CH2)8CO2Me
b, R1 = (CH2)7CH3
R2 = HAc or Pht
80, R1 = (CH2)8CO2Me, 
         R2 = HAc
32, R1 = (CH2)7CH3, 
         R2 = Pht
89
1. AcOH/H2O (1:1), Δ
2. TBS-Cl, imidazole,




(a) HCl ether, NaCNBH3, 
     THF/CH2Cl2, 25%
(b) TES/TFA, CH2Cl2, 50%
        88
a = R1 = (CH2)8CO2Me,
      R2 = HAc,  84%
b = R1 = (CH2)7CH3,










In comparison to the β-1, 3 reactions ( 
 
Table 4.3), similar results were observed with the non-selenium containing 
monosaccharide acceptors for the β-1, 4 glycosylation conditions (Table 4.4).  The 
Koenigs-Knorr method produced the desired β-linked disaccharide but in poor yields, 
even with the addition of 1, 1, 3, 3-tetramethylurea (TMU)72 (Table 4.4, entry 1).  The 
trichloroacetimidate method was again superior to the Koenigs-Knorr method in terms of 
yields and reaction time.  In the case of Table 4.4 entry 4, the TBS glycoside was 
removed with BF3·OEt2 with an extended reaction time of 1 ½ hours.  In the case of 
Table 4.4 entries 2 and 5, the acceptors 91 and 87 and TMS-OTf promoter successfully 




Table 4.4:  β-1, 4 Glycosylation Attempts with Non-selenium Containing 


































CH2Cl2, 0°C to rt
Trace
1. BF3 OEt2, 
    3Å sieves,








         (87)




        (89)
R1 =  (CH2)7CH3
R2 =  NPht
R6  = Ac
            (94)
R1 =  (CH2)8CO2CH3
R2 = NHAc
R6  = Bn
             (92)
+ Conditions












          (91)
R1 =  (CH2)7CH3
R2 = NHAc
R6 = TBS
            (93)
2




        (87)
R1 =  (CH2)7CH3
R2 =  NPht
R6  = TBS
          (95)
5
X =
X = 1. TMS-OTf, 
    3Å sieves,












          (90)
R1 =  (CH2)7CH3
R2 =  NPht
R6  = TBS




In order to evaluate the N-PSP reagent for installation of the C-6 phenylselenide, 
a model reaction was performed on a simple C-6 alcohol (Scheme 4.4).  The octyl 
glycoside 87 was O-acetylated to form 96 and the C-6 TBS ether removed with 
HF·pyridine to give the C-6 alcohol, 97.  The C-6 phenylselenide, 98, was successfully 













































The β-1, 4 C-6 phenylselenide glycoside was then formed using the same 
conditions (Scheme 4.5) as described in Scheme 4.4.  The C-6 –OH, 99, was formed in a 
92% yield, but tconversion to the selenide 100 proceeded in poor yield.  Removal of the 




























































4.4 Synthesis of non-fluorinated (iso)LacNAc-octyl glycosides 
After formation of the desired β glycosidic linkages 82 and 95, the remaining 
protecting groups were removed in order to provide the non-fluorinated alternate 
substrates 13b and 14b (Scheme 4.6).  The TBS ether at C-6 of 95 was removed during 
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hydrazinolysis.  This has not been previously reported in the literature and is a new 






































































41% (3 steps) 100%
70% (2 steps)
1. H2NNH2·H2O
    EtOH, Δ




The non-fluorinated substrates were synthesized in order to compare the 
fluorinated versus non-fluorinated substrates with the FucT III enzyme.  The octyl side 
chain was installed for the Sep-Pak assay used to evaluate the FucT III enzymatic 
reaction (Figure 4.4).74  The glycosides with the octyl side chain adhere to the reverse-
phase column when eluted with water, washing away water-soluble impurities.  Methanol 
is then used to remove the octyl glycosides from the column, allowing recovery and 
analysis of the trisaccharide product.  Compounds 13b and 14b have been submitted to 













































































X = H or F
R1 = (CH2)7CH3
 
Figure 4.4: Sep-Pak Assay 
 
4.5 Conclusions 
Both the β-1, 3 and β-1, 4 C-6 phenylselenide containing glycosides 85 and 101 were 
successfully synthesized by converting the non-selenium containing glycosides 82 and 95 
to the C-6 selenium-containing glycosides.  In contrast, attempts at glycosylation with 
phenylselenide-containing monosaccharide acceptor substrates were unsuccessful in 
disaccharide formation.  Glycosylation reactions containing a C-6 phenylselenide 
containing acceptor have not been reported in the literature and Table 4.1 and Error! 
Reference source not found. provide the first evidence that C-6 phenylselenide 
monosaccharide acceptor substrates are not synthetically viable as acceptor substrates for 
glycosylation reactions.  This problem can be overcome be converting the non-selenium 
containing glycosides to the C-6 phenylselenide glycosides as shown in  
 
Table 4.3 and Table 4.4. 
 In addition to the C-6 phenylselenide glycosides, the non-fluorinated alternate 
substrates 13b and 14b were also synthesized.  Although these glycosides have been 
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previously reported in the literature, the new strategy presented in Section 4.4 is accessed 
from the readily available non-selenium containing disaccharides and is divergent to the 





SYNTHESIS OF 5, 6 EPOXY GLYCOSIDES AND GLYCOSYL PHOSPHATES  
5.1 Introduction 
5, 6 Epoxide installation is performed in a three-step process from the C-6 
phenylselenides 42a, 42b, 71a, 71b, 63, 69, 85 and 101.  The role of the axial C-4 
substituent on the stability of 5, 6 epoxy GalNAc glycosides is of interest as this 
substituent will be adjacent to the 5, 6 epoxide.  Both electron-withdrawing and electron-
donating protecting groups have been investigated at the C-4 position to understand the 
role of the C-4 substituent on epoxide stability.   
Oxidization of the phenylselenide to the selenoxide and thermal eliminatation in 
the presence of dihydropyran (DHP) provides the corresponding olefin (Figure 1.8).  
Epoxidation will be achieved using dimethyldioxirane (DMDO) because of the ease of 
removal of the by-product, acetone (Figure 5.1).  Purification should be simplified 
because DMDO and acetone are easily removed by concentration in vacuo.  The oxidant 
DMDO is synthesized from its parent ketone, acetone, and oxone in a NaHCO3 
solution.75 This reaction is pH-sensitive because of the peroxymonosulfate dianion 
generated during the course of the reaction.  If the pH is too low, the peroxymonosulfate 
dianion concentration falls, causing the reaction to slow.  If the pH is too high, the 
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R = Ac, Bn, BOM, or Gal
GlcNAc, X = OR, Y = H, Z = OR
GalNAc, X = H, Y = OR, Z = OR
+
 
Figure 5.1:  DMDO Epoxidation Reaction 
 
5.2 Synthesis of 5, 6 GalNAc-β-octyl glycoside epoxides 
The phenylselenide-containing compounds 42a and 42b were oxidized to the 
selenoxide and thermally eliminated to give 104a or 104b (Scheme 5.1).  Alternatively, 
the BOM group was selectively removed and the resulting free alcohol protected as an 
acetate using BF3·OEt2 and AcBr to give 105.  The oxidation and elimination were 
performed for both R4 = Ac and Bn.  When R4 = Ac, the olefin, 106a, was found to be 
more stable than R4 = Bn, 106b and 106c.  (The same trend was observed with the 5, 6 
epoxides 107a-c, where R4 = Ac stabilized the epoxide.)  When R4 = Bn, a yellow color 
was observed with both the olefin and epoxide after standing a few hours in a NMR tube.  
Therefore the reaction sequence was performed quickly to avoid decomposition.  Use of 
R4 as an acetyl protecting group was theorized to help stabilize the olefin due to its 
electron-withdrawing nature.   A 3:2 ratio of epoxide glycosides was observed for the C-4 
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OAc epoxide 107a, but the ratio was not determined for the C-4 benzyl ether glycosides, 




























    MeOH/H2O
2. DHP, Δ
CH2Cl2, 0 °C
106a, R3 = BOM, R4 = Ac, 60% (2 steps)
106b, R3 = BOM, R4 = Bn, 56% (2 steps)




. 1. NaIO4, NaHCO3,
    MeOH/H2O
2. DHP, Δ
70%
107a, R3 = BOM, R4 = Ac, 96%
107b, R3 = BOM, R4 = Bn, 97%
107c, R3 = Ac, R4 = Bn, 97%
42a, R4 = Ac
42b, R4 = Bn
105, R4 = Bn
 
 
 Submission of the epoxides for HRMS analysis resulted in decomposition of the 
epoxides.  As a result, the formation of the olefins and epoxides in the reaction sequences 
were performed quickly to avoid formation of any potential decomposition products. 
5.3 Synthesis of 5, 6 GalNAc phosphate epoxides 
The glycosyl phenylselenide phosphate, 62a, was oxidized to the selenoxide and 
eliminated to form the olefin 108 (Scheme 5.2).  The olefin was transformed to the 
epoxide, 109, with DMDO.  The C-4 acetate glycosyl phosphate epoxide was formed in a 














































 In contrast, attempts at formation of the C-4 Bn galactosyl phosphate olefin 110 
were not successful (Scheme 5.3).  Loss of the 31P NMR signal was observed after 
elimination of the selenoxide was attempted.  Given the instability of the C-4 Bn octyl 
glycosides 106b and 106c, it is not surprising that the olefin 110 was not stable since the 


























It is proposed that the electron-donating benzyl ether enhanced nucleophilicity of the 
putative vinyl ether 110, resulting in protonation of the olefin and formation of a 
carbocation at C-5, which could be stabilized by the ring oxygen.  Quenching of the 
carbocation with H2O upon aqueous work-up could result in opening of the carbohydrate, 
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leading to loss of the phosphate leaving group at C-1 and decomposition (Figure 5.2).  


















































Figure 5.2: Hypothesis for Decomposition of 110 
 
5.4 Synthesis of isoLacNAc-octyl glycoside epoxide 
In the case of the β-1, 3 isoLacNAc-octyl glycoside alternate substrate, 
spontaneous loss of the selenoxide to the olefin was observed during the course of the 
oxidation (Scheme 5.4).  If the reaction time was extended, complete elimination to the 
olefin was observed eventually giving an 87% yield.  If the reaction was stopped before 
complete oxidation to give the selenoxides, DHP elimination of the selenoxides resulted 
in a 63%, 2-step yield.  If the elimination went longer than necessary (over 1 hour), 
removal of the acetates was observed.  The resulting free alcohols could then be re-
protected with acetic anhydride and pyridine to form 111 without causing decomposition.  
The epoxide 112 was formed in excellent yield with a 1:1 diastereomeric ratio. Though 
the epoxides would decompose upon submission of HRMS, nominal mass spectra could 













































5.5 Synthesis of LacNAc-octyl glycoside epoxide 
The same spontaneous loss of the selenoxides with direct formation of the olefin 
that was described in the previous section was also observed in the β-1, 4 disaccharide.  
However, complete conversion to the olefin was not observed.  Therefore, the remaining 
selenoxides were thermally eliminated with DHP to afford the olefin 113 (Scheme 5.5).  










































5.6 Synthesis of glucosaminyl epoxides for attempts at cyanosilylation 
 The phenylselenides 71a and 71b were oxidized using NaIO4 to form their 
corresponding selenoxides (Scheme 5.6).  The resulting selenoxides were then converted 
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to the olefins 115a and 115b by thermal elimination with DHP.  The olefins were then 
























    MeOH/H2O
2. DHP, Δ
CH2Cl2, 0 °C
115a, R2 = Pht,
           R3 = R4 = Ac, 65% (2 steps)
115b, R2 = Pht,
           R3 = R4 = Bn, 68% (2 steps)
116a, R3 = R3 = Ac, 95%
116b, R3 = R4 = Bn, 85%
71a, R2 = Pht,
        R3 = R4 = Ac
71b, R2 = Pht,
        R3 = R4 = Bn
 
5.7 Synthesis of galactosaminyl epoxides for attempts at cyanosilylation 
 In addition to synthesizing the epoxides 116a and 116b, the epoxide 118 was also 
investigated.  The galactosyl phenylselenide, 67, used was previously described in 
Chapter 3, Scheme 3.10.  The phenylselenide was oxidized to its corresponding 
selenoxide and then thermally eliminated with DHP to form the olefin 117 (Scheme 5.7).  
Glycoside 117 was transformed to the epoxide 118 in good yield; however the 






































The GalNAc, GlcNAc and (iso)LAcNAc C-6 phenylselenide-containing 
glycosides were successfully transformed to their corresponding epoxides 107, 109, 112, 
114, 116 and 118.  In the case of the GalNAc-octyl glycosides and GalNAc-α-
phosphates, an electron-withdrawing C-4 substituent formed a stable olefin and epoxide 
in a 3:2 diastereomeric ratio.  Use of an electron-donating protecting group at C-4 led to 






ATTEMPTS AT EPOXIDE FLUORIDOLYSIS AND CYANOSILYATION 
6.1 Introduction 
Epoxide fluoridolysis is achieved by using HF·pyridine which protonates the 
epoxide, and then allows the nucleophilic fluoride to attack, opening the epoxide77.  It is 
uncertain what effect an axial C-4 substituent will have on the GalNAc epoxide 
fluoridolysis.  (5-fluoro) GalNAc glycosides have not been reported in the literature and 
our epoxide fluoridolysis methodology will be attempted on the GalNAc epoxides (8) 
previously described.  (5-fluoro) (iso)LacNAc glycosides have not been described in the 
literature and this thesis presents the first attempts at epoxide fluoridolysis on β-1, 3 and 
β1-, 4 glycoosides.  After fluoridolysis, the protecting groups can then be removed to 






























6.2 Attempts at synthesis of (5-F) GalNAc-β-octyl glycosides 
When epoxide fluoridolysis was completed on 107a, 107b and 107c, 
decomposition was observed when R4 = Ac (Scheme 6.1).   When R4 = Bn, as in 107b 
and 107c, fluoridolysis was successful and formed the desired C-F bond at C-5.  
However, the (5-F) GalNAc glycosides were unstable and decomposed upon purification 
on silica gel.  Attempts at neutralizing the silica gel with 2% NEt3 in the column eluent 


















107a, R3 = BOM, R4 = Ac
107b, R3 = BOM, R4 = Bn
107c, R3 = Ac, R4 = Bn
119a, R3 = BOM, R4 = Ac, decomposition
119b, R3 = BOM, R4 = Bn, isolated small amount (
1H, 19F NMR, MS)
119c, R3 = Ac, R4 = Bn, isolated small amount (
1H,19F NMR, MS)  
 
6.3 Attempts at the synthesis of UDP (5-F) GalNAc 
When epoxide fluoridolysis was attempted on 109 using HF·pyridine, loss of the 
C-1 phosphate peak was observed according to 31P NMR (Scheme 6.2).  There was also 
only one fluorine peak according to 19F NMR, corresponding to the N-TFA group.  As 
described above, the same results as the GalNAc-β-octyl glycoside was observed when 



































6.4 Premature epoxide opening hypothesis 
The hypothesis for the decomposition observed with the C-4 aceto-glycoside, 
107a, and glycosyl phosphate, 109, is that premature epoxide opening occurred via 





















































Figure 6.2:  Premature Epoxide Opening Hypothesis 
 
This decomposition seemingly can be avoided by having a non-participatory 
protecting group at the C-4 position, such as benzyl, as observed with the glycosyl 
epoxides 118b and 118c.  However, the electron-donating benzyl ether does not seem to 
be able to stabilize the epoxide as well as the electron-withdrawing C-4 acetate.  Perhaps 
use of an electron-withdrawing and non-participatory protecting group may help stabilize 
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the epoxide and allow for fluoridolysis.  Repeated attempts of using a p-
nitrobenzylbromide and a silver salt promoter78 resulted in decomposition of the model 
substrate 121, perhaps due to the nucleophilic nature of the selenium (Scheme 6.3).  An 
alternative to the p-nitrobenzylbromide would be to use ClAc at C-4.  ClAc is an 
electron-withdrawing protecting group, but potentially would not be involved in 
















R1 = (CH2)7CH3  
6.5 Synthesis of (5-F) isoLacNAc-octyl glycoside 
Since the β-1, 3 and β-1, 4 disaccharides do not have an axial C-4 substituent, 
there should not be any neighboring group participation and epoxide fluoridolysis should 
proceed similarly to the GlcNAc series.  In the case of the (5-F) isoLacNAc-octyl 
glycoside, epoxide fluoridolysis on 112 was achieved using HF·pyridine and the 
remaining acetate protecting groups were removed with methanolic ammonia to give 13a, 
































     CH2Cl2, -78 °C
2. NH3 (g), MeOH
25% (2 steps)
 
6.6 Synthesis of (5-F) LacNAc-octyl glycoside 
 Synthesis of the (5-F) β-1, 4 octyl glycoside proceeded similarly as the β-1, 3 
octyl glycoside (Scheme 6.5).  After epoxide fluoridolysis on the epoxide 114, the O-Ac 

























     CH2Cl2, -78 °C




6.7 Synthesis of 5, 6 glucosaminyl cyano sugars 
The glucosaminyl epoxides 116a, 116b and 1238 were transformed to the 5-(CN), 
6-(OH) sugars, 124a, 124b and 124c, and 5-(OH), 6-(CN) sugars, 125a, 125b and 125c, 
using either AlCl3 or BF3·OEt2 as the Lewis acid activator (Scheme 6.6).  Both Lewis 
acids produced the desired cyano glycosides, however use of AlCl3 in general proceeded 

























116a, R1 = (CH2)7CH3,
          R2 = Pht
          R3 = R3 = Ac
116b, R1 = (CH2)7CH3,
          R2 = Pht 
          R3 = R4 = Bn
123,   R1 = (CH2)7CH3,
          R2 = HAc
          R3 = R4 = Ac
(a) AlCl3, TMS-CN
     CH2Cl2, Δ
(b) BF3·OEt2, TMS-CN
     CH2Cl2
124a, R1 = (CH2)7CH3, 
          R2 = Pht
          R3 = R3 = Ac, (a) 21% 
          (b) 27% 
124b, R1 = (CH2)7CH3, 
          R2 = Pht
          R3 = R4 = Bn, (a) 35% 
          (b) 10%
124c, R1 = (CH2)7CH3,
          R2 = HAc
          R3 = R4 = Ac, (a) 33%
125a, R1 = (CH2)7CH3,
          R2 = Pht 
          R3 = R3 = Ac, (a) trace
          (b) trace
125b, R1 = (CH2)7CH3,
           R2 = Pht 
           R3 = R4 = Bn, (a) trace
           (b) trace
125c, R1 = (CH2)7CH3,
          R2 = HAc 




 The regiochemistry of this reaction has been determined qualitatively using a 2, 4 
dinitrophenylhydrazine (DNP) TLC spray (Figure 6.3).  If there is a free alcohol at the C-
5 position, then the glycoside exists as a reducing sugar in the open and closed forms of 
the carbohydrate.  As a result, the glycoside has a ketone and is DNP-positive.  If there is 
a cyano group at C-5, there is no ketone and therefore should be DNP-negative.  The 
DNP results show that the major product formed was not DNP-positive.  A minor product 
visible by TLC produced a faint DNP-positive stain, indicating formation of the (5-














































Figure 6.3: Determination of C-5 Regioselectivity of (5-Cyano) Glycosides 
 
 After formation of the (5-cyano) glycosides, the CN group of 124c was reduced 
using H2 and PtO2 in MeOH to give the free amine 126 (Scheme 6.7).  The amino group 
could then be potentially coupled to biotin or other compounds useful for assaying 
carbohydrates.  These new glycosides could be useful as mechanistic probes of 























6.8 Attempted synthesis of 5, 6 galactosaminyl cyano sugars 
In the case of the TBS glycoside 118, use of AlCl3 resulted in a small amount of 
product formed by mass spectrum analysis, but mostly resulted in undesired side products 


























118 127 (a) Trace 
       (b) No product
(a) AlCl3, TMS-CN
     CH2Cl2, Δ
(b) BF3·OEt2, TMS-CN
     CH2Cl2
128 (a) Trace 
       (b) No product  
 
6.9 Conclusions 
The GalNAc glycoside epoxides 107b and 107c successfully underwent epoxide 
fluoridolysis to form the (5-fluoro) GalNAc glycosides 119b and 119c.  However, use of 
the C-4 acetate epoxide 107a, resulted in premature epoxide opening of the glycoside, 
presumably by neighboring group participation (Figure 6.2).  This same trend was 
observed with the GalNAc glycosyl phosphate 120.  It is noteworthy that the electron-
withdrawing C-4 acetate had a stabilizing effect on the epoxide, whereas the electron-
donating C-4 benzyl ether did not produce a stable epoxide.   
Neighboring group participation was not observed in the (iso)LacNAc series as 
there is no axial C-4 substituent.  The (5-fluoro) (iso)LacNac glycosides 13a and 14a 
were successfully synthesized. 
In addition to epoxide fluoridolysis, attempts at a new C-C bond formation at C-5 
were attempted using the GlcNAc and GalNAc epoxides 116a, 116b, 118 and 123.  The 
cyanosilylation successfully produced the desired (5-cyano) GlcNAc glycosides.  The 
new method was amenable with electron-withdrawing and electron-donating protecting 
groups such as acetate and benzyl ethers.  However, use of the GalNAc epoxide 118 
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resulted in decomposition of the glycoside, perhaps due to the reactivity of the TBS ether 
and the strong Lewis acids AlCl3 and BF3·OEt2.  A more stable group at C-1, such as a 
GalNAc-octyl glycoside could be used.  This would allow for comparison of the more 






7.1 Synthesis of C-6 phenylselenide-containing monosaccharides and 
disaccharides 
In conclusion, the C-6 phenylselenide monosaccharide glycosides were 
synthesized from the key benzylidene intermediate, 32.  Several orthogonally protected 
phenylselenide glycosides were obtained in order to investigate the effect of electron-
withdrawing versus electron-donating protecting groups at C-2, C-3 and C-4 during 
glycosylation reactions, epoxide fluoridolysis, and cyanosilylation reactions.  
Phenylselenide-containing β-octyl-glycosides and α-phosphates were synthesized as 
precursors to the fluorinated acceptor and donor substrates for the glycosyltransferases of 
interest. 
In pursuit of the β-1, 3 and β-1, 4 disaccharides, the C-6 phenylselenide-
containing monosaccharide glycosides were not acceptor substrates for formation of the 
selenium-containing glycosides (Table 4.1 and Error! Reference source not found.), 
presumably due to the selenium acting as a competitive nucleophile (Error! Reference 
source not found.).  Fortunately, the C-6 phenylselenide-containing (iso)LacNAc-octyl 
glycosides were readily obtained by installing the selenium after disaccharide formation. 
7.2 Synthesis of 5, 6 GalNAc, GlcNAc and (iso)LacNAc epoxides 
 Oxidation of the C-6 phenylselenide-containing glycosides to their 
corresponding selenoxides, followed by thermal elimination in the presence of DHP 
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produced the desired GalNAc, GlcNAc and (iso)LacNAc olefins.  Epoxidation proceeded 
in good to excellent yields.  In general, the GalNAc epoxides were formed in a 3:2 
diastereomeric ratio.  The GlcNAc and isoLAcNAc epoxides were formed in a 1:1 
diastereomeric ratio, whereas the LacNAc epoxide was a single diastereomer.  The role 
of electron-withdrawing versus electron-donating protecting groups was investigated in 
the stability of the olefins and epoxides.  Stability of the olefins and epoxides was 
enhanced with the use of an electron-withdrawing protecting group at C-4.  In contrast, 
an electron-donating protecting group at C-4 resulted in a more labile olefin and epoxide.  
In the case of the C-4 Ac GalNAc α-phosphate, formation of the olefin and epoxides 
proceeded in good yields.  However, the C-4 Bn GalNAc α-phosphate olefin was 
unstable and resulted in decomposition. 
7.3 Attempts at epoxide fluoridolysis and cyanosilylation 
The role of participating versus non-participating protecting groups was 
investigated during attempts at epoxide fluoridolysis.  In the GalNAc series, an axial 
electron-withdrawing C-4 acetate resulted in premature epoxide opening from 
neighboring group participation of the axial C-4 acetate (Figure 6.2).  With a non-
participatory protecting group at C-4, such as benzyl ether, the fluoridolysis was 
successful.  However, the (5-fluoro) GalNAc glycosides were unable to be purified due to 
instability.  In the future, an electron-withdrawing, non-participatory protecting group at 
C-4 may allow for stable C-F bond formation at C-5. 
 In pursuit of the β-1, 3 and β-1, 4 disaccharides, epoxide fluoridolysis was 
successful, allowing for potential evaluation of the FucT III glycosyltransferase.  Since 
there was no axial C-4 substituent adjacent to the 5, 6 epoxides, therefore no premature 
epoxide opening was observed.  Compounds 13a, 13b, 14a and 14b will be sent to our 
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collaborator Hans Lin at the Academia Sinica, Taiwan for biochemical evaluation with 
the FucT III enzyme.  It will be interest to see if 13a and 14a will be substrates for FucT 
III and what effect fluorine has on glycosylation catalyzed by FucT III. 
 In addition to the formation of (5-fluoro) glycosides, the GlcNAc 5, 6 epoxides 
were subjected cyanosilylation conditions to form predominantly give the (5-cyano) 
glycosides.  In the GalNAc series, only trace amounts of a cyano glycoside was detected 
by mass spectrum analysis.  It is proposed that the TBS ether is not compatible with the 
strong Lewis acid conditions and resulted in decomposition.  Perhaps use of an octyl 
glycoside at C-1 would allow for formation of a (5-cyano) GalNAc glycoside.   
The CN group allowed access to the free amine, which may be coupled to biotin, 
fluorocene, KLH, peptides and other synthons used in evaluating glycosyltransferase 
reactions.  Additional future work on the (5-cyano) glycosides should include 
optimization of the reaction conditions to improve yields, as well as further investigation 
of functional group tolerance.  Overall, the cyanosilylation reaction is a promising new 






General Experimental:  All chemicals used were from Aldrich or Acros, except for 
BOM-Cl from TCI America and 8-methoxycarbonyl octanol from TRC.  Water-sensitive 
reactions were conducted under an argon atmosphere and used oven-dried glassware, 
syringes and needles.  Solvents were freshly distilled for moisture-sensitive reactions: 
THF from benzophenone ketyl, MeOH, NEt3, CH2Cl2 and pyridine from CaH2.  CHCl3 
was purified by passing through a column of activated Al2O3.  AgOTf was purified by 
azeotropic removal of impurities with toluene. Flash column chromatography used 230-
400 mesh Whatman silica gel. TLC was run on Whatman 250 μm silica plates with UV 
fluorescence detected by short wave UV.  1H and 13C NMR spectra were recorded on a 
Bruker Avance DRX-500 or 300 spectrometers or Varian 300 or 400 spectrometers.  1H 
NMR chemical shifts (δ) for CDCl3 or CD3OD are in ppm using TMS as the reference at 
0.00 ppm.  1H NMR chemical shifts (δ) for spectra obtained in D2O were referenced to 
HOD at 4.79 ppm.  13C NMR chemical shifts (δ) for CDCl3 or CD3OD are in ppm using 
the center solvent peak of CDCl3 at 77.00 ppm as the reference and CD3OD at 49.00 ppm 
as the reference.  19F NMR chemical shifts were referenced to TFA at 0 ppm as an 
external standard to TFA in CDCl3.  NMR assignments were based upon 1H J values, 1H 
COSY and HETCOR.  Diastereomeric ratio of 5, 6 epoxides were determined by 1H 
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NMR analysis.  Mass spectra were recorded on a Micromass LCT Time-of-Flight mass 
spectrometer by electrospray ionization using sodium as the ion.  
Tetrabenzylpyrophosphate (TTBP) was prepared as described.79  Dimethyldioxirane was 
prepared as described.75  Compounds 43,80 44,51 46,38 74,81 75,81 86,47 91,73 were 
synthesized according to the literature procedures.  Compound 3247 to 348 was 
synthesized following modified procedures based upon the work of Matt Hartman, where 
the bromide was displaced first with phenylselenol before BOM protection at C-3.  
Compound 48 was purchased from Aldrich.  Compound 76 and 77 were in spectral 
agreement with the literature.82  Compounds 76-80 were synthesized from modified 
literature procedures.  Compound 78 was in spectral agreement with the literature.80  
Compound 80 was in spectral agreement with the literature.63  Compound 102 was in 
spectral agreement with the literature.83 
 
Octyl 3-O-[(benzyloxy)methyl]- 2, 6-dideoxy-2-phthalamido-6-phenylseleno-∃-D-









To a stirred solution of 34a8 (1.90 g, 2.42 mmol) in 100 mL of THF:MeOH (1:1) 
was added 0.5M NaOMe solution (0.28 mL, 5.32 mmol).  An additional portion (0.28 
mL, 5.32 mmol) of the NaOMe solution was added after 17 h.  After 45 h, the reaction 
was quenched with 2.0 g of Dowex 50W H+ form resin (2.1 meq/mL) and stirred gently 
for 30 min.  The mixture was filtered and the filtrate concentrated.  The resulting oil was 
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purified by flash column chromatography (hexanes:EtOAc, 3:1) to afford 35a as a 
colorless oil (1.47 g, 89%).  1H NMR (CDCl3) δ 7.71 (d, 2H, NPht), 7.60 (m, 2H, NPht), 
7.14 (m, 5H, SePh), 7.08 (m, 3H, ArH of BOM), 7.00 (m, 2H, ArH of BOM), 5.07 (d, 
1H, J = 8.3 Hz, H1), 4.74 (d, 1H, J = 7.1 Hz, O-CH2-Ph/Bn), 4.58 (d, 1H, J = 7.1 Hz, O-
CH2-Ph/Bn), 4.50 (d, 1H, J = 12.0 Hz, -OH), 4.33 (s, 2H, O-CH2-O-Bn), 4.25 (d, 1H, J = 
10.8 Hz, H4), 4.18 (dd, 1H, J = 8.3 Hz, H3), 3.69-3.62 (dd, 2H, H2/CH2-octyl), 3.49-3.42 
(dd, 2H, H5/CH2-octyl), 3.31 (m, 1H, J = 13.2, 6.6 Hz,H6), 3.11 (m, 1H, J = 12.8, 8.3 Hz, 
H6), 1.32-1.31 (bs, 2H, CH2-octyl), 1.16-0.97 (bs, 10H, CH2-octyl), 0.88 (t, 3H, CH3-
octyl).  13C NMR (CDCl3) δ 171.00, 136.30, 133.93, 132.03, 131.52, 130.99, 128.87, 
128.41, 127.92, 127.72, 126.45, 123.47, 123.01, 98.11, 96.06, 82.53, 75.46, 74.00, 70.31, 
69.50, 60.26, 55.15, 31.54, 31.47, 29.68, 29.01, 25.70, 22.53, 22.48, 20.92, 14.09, 13.95. 
MS (ES, Na+): m/z (relative intensity) 704.2 (100).  HRMS (M + Na+) calcd for 
C36H43NO7SeNa, 704.2102; found 704.2103. 
 
t-Butyldimethylsilyl- 3-O-[(benzyloxy)methyl]- 2, 6-dideoxy-2-phthalamido-6-









To a stirred solution of 34b8 (0.27 g, 0.340 mmol) in 10 mL of THF:MeOH (1:1) 
was added 1M NaOMe solution (0.35 mL, 0.35 mmol).  After 6 h, the reaction was 
quenched with 0.75 g of Dowex 50W H+ form resin (2.1 meq/mL) and stirred gently for 
15 min.  The mixture was filtered and the filtrate concentrated.  The resulting oil was 
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purified by flash column chromatography (hexanes:EtOAc, 3:1) to afford 35b as a 
colorless oil (0.20 g, 87%):  1H NMR (CDCl3) δ 7.89 (d, 2H, NPht), 7.79 (m, 2H, NPht), 
7.62 (m, 2H, SePh), 7.37-2.28 (m, 8H, SePh/ArH of BOM), 5.42 (d, 1H, J = 7.8 Hz, H1), 
4.93 (d, 1H, J = 6.0 Hz, O-CH2-Ph/Bn), 4.73 (d, 2H, O-CH2-Ph/Bn/ O-CH2-O-Bn), 4.33 
(s, 1H, O-CH2-O-Bn), 4.47 (d, 1H, J = 1.4 Hz, -OH), 4.40 (d, 1H, J = 10.9, 8.0 Hz, H3), 
4.31 (dd, 1H, J = 10.8, 7.8 Hz, H2), 3.79 (dd, 1H,J = 9.0, 2.4 Hz, H4), 3.62 (m, 2H, J = 
5,7, 3.0, 2.0 Hz, H5/H6), 3.24 (m, 1H, J = 12.6, 8.8 Hz, H6), 0.75-0.0.71 (bs, 9H, TBS), 
0.13 (m, 3H, TBS) 0.08 (m, 3H, TBS).  13C NMR (CDCl3) δ 168.80, 167.99, 136.53, 
134.25, 132.11, 131.32, 129.17, 128.65, 128.16, 127.96, 127.86, 126.97, 123.58, 123.22, 
96.29, 93.63, 82.48, 75.60, 74.38, 70.51, 57.43, 60.26, 30.07, -3.89, -5.57.  MS (ES, 
Na+): m/z (relative intensity) 706.1 (100).  HRMS (M + Na+) calcd for 
C34H41NO7SeSiNa, 706.1715; found 706.1723. 
 
p-Methoxyphenyl- 3-O-[(benzyloxy)methyl]- 2, 6-dideoxy-2-phthalamido-6-









To a stirred solution of 34c8 (0.83 g, 1.23 mmol) in 100 mL of THF:MeOH (1:1) 
was added 1M NaOMe solution (0.35 mL, 0.35 mmol).  After 21 h, the reaction was 
quenched with 1.75 g of Dowex 50W H+ form resin (2.1 meq/mL) and stirred gently for 
15 min.  The mixture was filtered and the filtrate concentrated.  The resulting oil was 
purified by flash column chromatography (hexanes:EtOAc, 2:1) to afford 35c as a 
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colorless oil (0.53 g, 76%):  1H NMR (CDCl3) δ 8.01 (d, 2H, NPht), 7.75 (m, 2H, NPht), 
7.63-7.48 (m, 5H, ArH of BOM), 7.29 (m, 2H, SePh), 7.10 (m, 3H, SePh), 6.84 (m, 2H, 
PMP), 6.72 (m, 2H, PMP), 5.58 (dd, 1H, J = 8.5 Hz, H1), 4.79 (d, 1H, O-CH2-Ph/Bn), 
4.70-4.61 (m, 3H, H3/H4/ O-CH2-Ph/Bn), 4.49 (s, 2H, O-CH2-O-Bn), 4.33 (m, 1H, H2), 
3.77 (dd, 1H, J = 9.0, 2.5 Hz, H5), 3.75 (s, 3H, OMe), 3.58 (dd, 1H, J = 8.5 Hz, H6), 3.16 
(dd, 1H, J = 13.0, 8.5 Hz, H6).  13C NMR (CDCl3) δ 155.35, 150.78, 136.25, 134.17, 
132.15, 129.10, 129.02, 128.53, 128.42, 128.09, 127.93, 127.86, 126.67, 118.65, 118.51, 
114.35, 97.58, 96.14, 82.51, 75.60, 73.81, 70.48, 55.57, 55.03, 29.61.  MS (ES, Na+): m/z 












To a stirred -5 °C solution of 35a (1.40 g, 2.06 mmol) in 60 mL of CH2Cl2 and 
pyridine (0.75 mL, 9.27 mmol) was added a freshly prepared solution of Tf2O (0.69mL, 
4.12 mmol) in 5 mL of CH2Cl2.  The reaction solution turned a yellow-orange color with 
time and the temperature was maintained between -5 °C and +10 °C.  After 2.25 h, the 
reaction was warmed to room temperature and diluted to 150 mL of CH2Cl2 and washed 
with 150 mL of satd. Cu2SO4, H2O, and satd. NaCl solutions.  The organic extract was 
dried with Na2SO4, filtered and the filtrate concentrated.  The resulting oil (1.60 g) was 
taken on without any purification:  1H NMR (CDCl3) δ 7.75 (d, 2H, NPht), 7.54 (m, 2H, 
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NPht), 7.24 (m, 2H, SePh), 7.08 (m, 3H, SePh), 6.85 (m, 5H, ArH of BOM), 5.11 (d, 1H, 
J = 8.4 Hz, H1), 4.83-4.76 (m, 2H, H3/H4), 4.72 (d, 1H, O-CH2-Ph/Bn), 4.62 (d, 1H, O-
CH2-Ph/Bn), 4.32 (dd, 1H, J = 10.2, 8.4, Hz, H2), 4.15 (s, 2H, O-CH2-O-Bn), 4.92 (dd, 
1H, J = 9.3, 3.0 Hz, H5), 3.70 (m, 1H, J = 9.9, 6.0 Hz, CH2-octyl), 3.38 (m, 1H, CH2-
octyl), 3.29 (dd, 1H, J = 12.9, 2.7 Hz, H6), 3.15 (dd, 1H, J = 13.2, 9.3 Hz, H6), 1.43 (bs, 
2H, CH2-octyl), 1.22-0.96 (bs, 10H, CH2-octyl), 0.80 (t, 3H, CH3-octyl).  19F NMR 
(CDCl3) δ 2.10.  To the triflate glycoside was added a solution of Et4NOAc (2.5 g, 9.85 
mmol) in 25 mL of DMF.  After 1 h, the reaction was concentrated to remove the DMF.  
The resulting red oil dissolved in 250 mL of CH2Cl2 and washed twice with 100 mL of 
H2O and once with satd. NaCl solution.  The organic extract was dried with Na2SO4, 
filtered and the filtrate concentrated. The crude product was purified with flash column 
chromatography (hexanes:EtOAc, 3:1) to afford compound 40a (1.25 g, 85%, 2 steps) as 
a colorless oil:  1H NMR (CDCl3) δ 7.83 (d, 1H, NPht), 7.64 (m, 1H, NPht), 7.60 (s, 2H, 
NPht), 7.54 (m, 2H, SePh), 7.27 (m, 3H, SePh), 7.20 (m, 3H, ArH of BOM), 6.98 (m, 2H, 
ArH of BOM), 5.57 (d, 1H, J = 3.0 Hz, H4), 5.18 (d, 1H, J = 8.5 Hz, H1), 4.78 (d, 1H, J = 
7.4 Hz, O-CH2-Ph/Bn), 4.71 (dd, 1H, J = 11.0, 2.9 Hz, H3), 4.17 (s, 2H, J = 7.8 Hz, O-
CH2-O-Bn), 4.11 (dd, 1H, J = 6.9 Hz, H2), 3.87 (dd, 1H, J = 7.0 Hz, H5), 3.81 (m, 1H, 
CH2-octyl), 3.40 (m, 1H, CH2-octyl), 3.19 (dd, 1H, J = 12.9, 7.7 Hz, H6), 3.00 (dd, 1H, J 
= 12.8, 5.9 Hz, H6), 2.18 (s, 3H, OAc), 1.26-1.23 (bs, 2H, CH2-octyl), 1.16-0.93 (bs, 
10H, CH2-octyl), 0.81 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 170.57, 168.46, 167.63, 
136.97, 133.95, 133.91, 132.85, 131.40, 131.34, 129.60, 129.18, 128.11, 127.35, 127.26, 
127.09, 123.36, 122.98, 98.45, 92.82, 73.31, 71.56, 69.82, 69.49, 68.19, 60.28, 52.56, 
31.53, 29.11, 29.00, 27.78, 25.68, 22.48, 20.95, 20.85, 14.10, 13.96, -0.92.  MS (ES, 
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Na+): m/z (relative intensity) 746.2 (100).  HRMS (M + Na+) calcd for C38H45NO8SeNa, 
746.2208; found 746.2232. 
 
t-Butyldimethylsilyl, 4-O-acetyl, 3-O-[(benzyloxy)methyl], 2, 6-dideoxy-6-








To a stirred -5 °C solution of 35b (0.065 g, 0.095 mmol) in 1.5 mL of CH2Cl2 and 
pyridine (0.030 mL, 0.428 mmol) was added a freshly prepared solution of Tf2O (0.03 
mL, 0.190 mmol) in 0.14 mL of CH2Cl2.  The reaction solution turned a light pink color 
with time and the temperature was maintained between -5 °C and +10 °C.  After 1 h, the 
reaction was diluted to 5 mL of CH2Cl2 and washed with 5 mL of satd. NaHCO3 solution.  
The aqueous extract was washed with 5 mL of CH2Cl2 and the combined organic extracts 
washed with 10 mL of satd. NaCl solution, dried with Na2SO4, filtered and the filtrate 
concentrated.  The resulting oil (0.074 g) was taken on without any purification:  1H 
NMR (CDCl3) δ 7.88 (d, 2H, NPht), 7.59 (m, 2H, NPht), 7.35 (m, 2H, SePh), 7.15 (m, 
3H, SePh), 6.91 (m, 5H, ArH of BOM), 5.40 (dd, 1H, J = 8.0 Hz, H1), 4.86-4.69 (m, 3H, 
H3/H4/H2), 4.67 (d, 2H, O-CH2-Ph/Bn), 4.23 (s, 2H, O-CH2-O-Bn), 3.98 (dd, 1H, J = 9.0 
Hz, H5), 3.32 (dd, 1H, J = 12.7 Hz, H6), 3.19 (dd, 1H, J = 9.6 Hz, H6), 0.71 (s, 9H, tBu), 
0.15 (s, 3H, Me), 0.06 (a, 3H, Me).  19F NMR (CDCl3) δ 1.78.  To the triflate glycoside 
was added a solution of Et4NOAc (0.18 g, 0.681 mmol) in 3 mL of DMF.  After 15 min, 
the reaction was concentrated to remove the DMF.  The crude product was dissolved in 
50 mL of CH2Cl2 and washed twice with 25 mL of H2O and once with satd. NaCl 
solution.  The organic extract was dried with Na2SO4, filtered and the filtrate 
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concentrated. The crude product was purified with flash column chromatography 
(hexanes:EtOAc, 3:1) to afford 40b (0.08 g, 87%, 2 steps) as a colorless oil:  1H NMR 
(CDCl3) δ 7.86 (d, 1H, NPht), 7.70 (m, 1H, NPht), 7.65 (m, 2H, NPht), 7.53 (m, 2H, 
SePh), 7.31 (m, 3H, SePh), 7.22 (m, 3H, ArH of BOM), 7.02 (m, 2H, ArH of BOM), 5.54 
(d, 1H, J = 3.2 Hz, H4), 5.42 (d, 1H, J = 8.1 Hz, H1), 4.79 (d, J = 7.6 Hz, O-CH2-Ph/Bn), 
4.68 (dd, 1H, J = 11.2, 3.4 Hz, H3),  4.52 (d, 1H, J = 7.5 Hz, O-CH2-O-Bn), 4.46 (d, 1H, 
J = 11.3, 8.1 Hz, H2), 4.20 (s, 2H, O-CH2-Ph/BOM), 3.89 (dd, 1H, J = 8.1, 5.2 Hz, H5), 
3.20 (dd, 1H, J = 12.8, 8.4 Hz, H6), 2.96 (dd, 1H, J = 12.8, 5.1 Hz, H6), 2.23 (s, 3H, 
OAc), 0.71 (s, 9H, tBu), 0.13 (s, 3H, Me), 0.02 (s, 3H, Me). 13C NMR (CDCl3) δ 171.20, 
169.01, 168.43, 137.53, 134.46, 133.12, 131.89, 129.69, 128.61, 127.84, 127.67, 127.61, 
123.77, 123.42, 109.98, 94.15, 93.38, 73.70, 71.80, 70.01, 68.89, 55.09, 30.10, 28.46, 
25.77, 21.342, 17.95.  MS (ES, Na+): m/z (relative intensity) 748.1 (100).  HRMS (M + 
Na+) calcd for C36H43NO8SeSiNa, 748.1821; found 748.1819. 
 
p-Methoxyphenyl, 4-O-acetyl, 3-O-[(benzyloxy)methyl], 2, 6-dideoxy, 6-








To a stirred -5 °C solution of 35c (0.027 g, 0.040 mmol) in 0.5 mL of CH2Cl2 and 
pyridine (0.01 mL, 0.18 mmol) was added 0.07 mL of a freshly prepared solution of Tf2O 
(0.01 mL, 0.08 mmol) in 0.6 mL of CH2Cl2. The reaction solution turned a yellow-orange 
color with time and the temperature was maintained between -5 °C and +10 °C.  After 2 
h, the reaction was diluted to 5 mL of CH2Cl2 and washed with 5 mL of satd. NaHCO3 
solution.  The aqueous extract was washed with 5 mL of CH2Cl2 and the combined 
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organic extracts washed with 10 mL of satd. NaCl solution, dried with Na2SO4, filtered 
and the filtrate concentrated.  The resulting oil (0.029 g) was taken on without any 
purification:  1H NMR (CDCl3) δ 7.54 (d, 2H, NPht), 7.51 (m, 2H, NPht), 7.28 (m, 2H, 
SePh), 7.14 (m, 3H, SePh), 6.88 (m, 2H, PMP), 6.85 (m, 2H, PMP), 5.63 (dd, 1H, J = 8.4 
Hz, H1), 4.91-4.69 (m, 3H, H3/H4/H2), 4.63 (d, 2H, J = 8.3 Hz, O-CH2-Ph/Bn), 4.19 (s, 
2H, O-CH2-O-Bn), 4.02 (dd, 1H, J = 9.2, 2.3 Hz, H5), 3.74 (s, 3H, OMe), 3.36 (dd, 1H, J 
= 13.3, 2.5 Hz, H6), 3.15 (dd, 1H, J = 13.2, 9.2 Hz, H6).  19F NMR (CDCl3) δ 1.69.  To 
the triflate glycoside was added a solution of Et4NOAc (0.07 g, 0.269mmol) in 1 mL of 
DMF.  After 15 min, the reaction was concentrated to remove the DMF.  The crude 
product was dissolved in 5 mL of CH2Cl2 and washed twice with 5 mL of H2O and once 
with satd. NaCl solution.  The organic extract was dried with Na2SO4, filtered and the 
filtrate concentrated. The crude product was purified with preparatory thin layer 
chromatography (hexanes:EtOAc, 2:1) to afford 40c (0.014 g, 49%, 2 steps) as a 
colorless oil:  1H NMR (CDCl3) δ 7.87 (d, 1H, J = 7.3 Hz, NPht), 7.67 (m, 1H, NPht), 
7.61 (s, 2H, NPht), 7.52 (m, 2H, SePh), 7.27 (m, 3H, SePh), 7.19 (m, 3H, ArH of BOM), 
6.98 (m, 2H, ArH of BOM), 6.90 (dd, 2H, J = 7.0, 2.0 Hz, PMP), 6.72 (dd, 2H, J = 7.0, 
3.6 Hz, PMP), 5.86 (d, 1H, J = 8.0 Hz, H1), 5.58 (d, 1H, J = 2.9 Hz, H4), 4.77 (dd, 1H, J 
= 9.9, 7.6 Hz, H2), 4.72 (dd, 1H, J = 11.0, 8.0 Hz, H3), 4.50 (d, 2H, J = 7.5 Hz, O-CH2-
Ph/Bn), 4.17 (s, 2H, O-CH2-O-Bn), 3.95 (dd, 1H, J = 8.1, 5.3 Hz, H5), 3.72 (s, 3H, 
OMe), 3.17 (dd, 1H, J = 12.9, 4.6 Hz, H6), 3.00 (dd, 1H, J = 12.9, 5.3 Hz, H6), 2.21 (s, 
3H, OAc). 13C NMR (CDCl3) δ 171.07, 168.94, 168.12, 155.85, 151.26, 137.41, 134.56, 
133.53, 131.77, 129.86, 129.75, 128.64, 127.92, 127.59, 123.99, 123.69, 118.98, 114.80, 
98.28, 93.39, 73.98, 71.97, 70.07, 68.64, 56.00, 52.85, 28.36, 21.35.  MS (ES, Na+): m/z 
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(relative intensity) 740.13 (100).  HRMS (M + Na+) calcd for C37H35NO9SeNa, 740.1375; 
found 740.1378.   
 
Octyl 4-O-benzyl-3-O-[(benzyloxy)methyl]- 2, 6-dideoxy-6-phenylseleno-2-








To a stirred solution of 40a (1.25 g, 1.73 mmol) in 50 mL of THF:MeOH (1:1) 
was added 0.5M NaOMe solution (0.03mL, 0.553 mmol).  After 21 h, the reaction 
solution was quenched with 2.00 g of Dowex 50W H+ form resin (2.1 meq/mL) and 
gently stirred for 15 min.  The suspension was filtered and the filtrate concentrated.  The 
resulting oil was purified using flash column chromatography (hexanes:EtOAc, 3:1) to 
afford the free C-4 OH glycoside (1.11 g, 95%) as a colorless oil:  1H NMR (CDCl3) δ 
7.81 (m, 1H, Pht), 7.66 (m, 3H, Pht), 7.55 (m, 2H, ArH of BOM), 7.27 (m, 3H, ArH of 
BOM), 7.23 (m, 5H, PhSe), 7.21 (m, 3H, Bn), 7.08 (m, 2H, Bn), 5.10 (d, 1H, J = 8.0 Hz, 
H1), 4.77 (d, 1H, J = 7.3 Hz, -O-CH2-O-Bn), 4.65 (d, 1H, J = 11.8 Hz, CH2-Ph), 4.53 (m, 
1H, Hz, H3), 4.39-31 (m, 2H, -O-CH2-Ph), 4.27 (m, 1H, H2), 3.82-3.73 (m, 3H, CH2-
octyl/H4/H5), 3.40-3.31 (m, 2H, CH2-octyl, H6), 3.23 (m, 1H, H6), 2.49 (d, 1H, J = 2.9 
Hz, -OH), 1.39-1.32 (bs, 2H, CH2-octyl), 1.18-0.95 (bs, 10H, CH2-octyl), 0.82 (t, 3H, 
CH3-octyl).  13C NMR (CDCl3) δ 170.92, 168.58, 167.65, 136.81, 133.84, 133.79, 
132.29, 131.39, 129.87, 128.99, 128.14, 127.43, 127.21, 126.83, 123.28, 122.85, 98.24, 
93.69, 75.00, 74.13, 69.67, 69.27, 67.60, 60.18, 51.94, 31.45, 29.05, 28.92, 27.44, 25.62, 
22.39, 20.83, 14.01, 13.87, -0.843.  MS (ES, Na+): m/z (relative intensity) calcd for 
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C35H43NO7SeNa, 706.2; found 706.2 (100).  To a stirred 0 °C solution of the C-4 OH 
glycoside (0.22 g, 0.322 mmol) in 10mL of THF was added NaH (80% in oil, 0.015 g, 
0.645 mmol).  The resulting mixture was stirred for 30 min and had BnBr (0.08 mL, 
0.645 mmol) and NBu4I (0.60 g, 1.610 mmol) added to it.  After 20.5 h, the reaction 
mixture was diluted with 50 mL of EtOAc and washed with 50 mL of H2O, satd. 
NaHCO3 and satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered 
and the filtrate concentrated.  The resulting oil was purified using flash column 
chromatography (hexanes:EtOAc, 5:1) to afford 41 (0.23 g, 92%; 87%, 2 steps) as a 
colorless oil:  1H NMR (CDCl3) δ 7.64 (m, 1H, Pht), 7.47 (m, 3H, Pht), 7.37 (m, 2H, ArH 
of BOM), 7.34 (m, 3H, ArH of BOM), 7.29 (m, 5H, PhSe), 7.22 (m, 3H, Bn), 7.04 (m, 
2H, Bn/Ph), 5.12 (d, 1H, J = 8.4 Hz, H1), 5.00 (d, 1H, J = 11.5 Hz, -O-CH2-O-Bn), 4.75 
(d, 1H, J = 6.9 Hz, CH2-Ph), 4.72 (dd, 1H, J = 10.3, 2.6 Hz, H3), 4.62 (m, 1H, CH2-Ph), 
4.58 (dd, 1H, J = 11.2, 8.4 Hz, H2), 4.55 (d, 1H, J = 11.6 Hz, -O-CH2-Ph), 4.28 (d, 2H, J 
= 12.1, 6.1 Hz, -O-CH2-Ph), 4.10 (d, 1H, J = 2.4 Hz, H4), 3.77 (m, 1H, CH2-octyl), 3.67 
(m, 1H, CH2-octyl), 3.35 (m, 1H, H5), 3.23 (dd, 1H, J = 12.6, 6.3 Hz, H6), 3.02 (dd, 1H, 
J = 12.6, 7.6 Hz, H6), 1.25-1.16 (bs, 2H, CH2-octyl), 1.12-0.97 (bs, 10H, CH2-octyl), 
0.81 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 168.86, 167.76, 138.26, 137.14, 133.08, 
132.51, 131.67, 129.97, 128.16, 128.26, 128.24, 128.22, 127.61, 127.46, 127.17, 127.04, 
123.35, 122.87, 98.50, 93.94, 76.36, 74.72, 73.59, 74.35, 69.73, 69.40, 52.69, 31.59, 
29.20, 29.07, 29.03, 27.98, 25.76, 22.52.  MS (ES, Na+): m/z (relative intensity) 794.2 













To a stirred solution of 40a (0.150 g, 0.207 mmol) in 10 mL of EtOH in a Schlenk 
tube was added H2NNH2·H2O (1.00 mL, 19.7 mmol).  The reaction was placed under a 
gentle vacuum, the tube sealed and heated to 100 °C.  After 43 h, the reaction was cooled, 
the tube opened and the reaction mixture concentrated.  The resulting oil/solid was 
dissolved in 20 mL of EtOAc and washed with 20 mL of satd. NaHCO3 solution.  The 
aqueous extract was washed with 20 mL of EtOAc and the combined organic extracts 
washed with 50 mL of satd. NaCl solution, dried with Na2SO4, filtered and the filtrate 
concentrated.  The resulting colorless oil (0.110 g) was taken on without any purification.  
The resulting oil (0.110 g, 0.200 mmol) was dissolved in 3 mL of pyridine and 3 mL of 
Ac2O.  After 25.5 h, the reaction was diluted with 40 mL of EtOAc and washed with 40 
mL of satd. CuSO4, H2O, satd. NaHCO3, and satd. NaCl solutions.  The organic extract 
was dried with Na2SO4, filtered and the filtrate concentrated.  The crude oil was purified 
using flash column chromatography (hexanes:EtOAc, 1:1) to afford 42a (0.100 g, 76%, 2 
steps) as a colorless oil:  1H NMR (CDCl3) δ 7.51 (m, 3H, ArH of BOM), 7.49 (m, 2H, 
ArH of BOM), 7.33 (m, 5H, PhSe), 5.61 (d, 1H, J = 7.5 Hz, N-H), 5.49 (d, 1H, J = 3.1 
Hz, H4), 4.93 (d, 1H, J = 8.4 Hz, H1), 4.83 (d, 1H, J = 7.2 Hz, -O-CH2-O-Bn), 4.67 (m, 
1H, -O-CH2-OBn), 4.57-4.54 (d, 2H, -O-CH2-Ph),4.50 (dd, 1H, J = 10.8, 3.2 Hz, H3), 
3.87 (dd, 1H, J = 9.5, 6.5 Hz, H2), 3.74 (m, 2H, CH2, octyl), 3.45 (m, 1H, H5), 3.11 (dd, 
1H, J = 12.8, 7.9 Hz, H6), 2.89 (dd, 1H, J = 12.8, 5.7 Hz, H6), 2.05 (s, 3H, NHAc), 1.89 
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(s, 3H, OAc), 1.25 (bs, 12H, CH2-octyl), 0.88 (bs, 3H, CH3).  13C NMR (CDCl3) δ 
170.46, 170.38, 137.37, 132.86, 129.61, 129.14, 128.37, 127.69, 127.60, 127.42, 127.22, 
99.67, 93.04, 73.00, 72.35, 69.99, 69.66, 68.67, 54.45, 31.72, 29.36, 29.24, 29.18, 27.85, 
25.82, 23.44, 22.55, 20.78, 13.99. MS (ES, Na+): m/z (relative intensity) 658.2 (100).  
HRMS (M + Na+) calcd for C32H45NO7SeNa, 658.2259; found 658.2266.   
 
Octyl 2-acetamido-4-O-benzyl-3-O-[(benzyloxy)methyl]- 2, 6-dideoxy-6-








To a stirred solution of 41 (0.080 g, 0.103 mmol) in 4mL of EtOH in a Schlenk 
tube was added H2NNH2·H2O (0.45 mL, 9.323 mmol).  The reaction placed under a 
gentle vacuum, the tube sealed and heated to 100 °C.  After 44 h, the reaction was cooled, 
the tube opened and the reaction mixture concentrated.  The resulting oil/solid was 
dissolved in 30 mL of EtOAc and washed with 15 mL of satd. NaHCO3 solution.  The 
aqueous extract was washed with 25 mL of EtOAc and the combined organic extracts 
washed with 40 mL of satd. NaCl solution, dried with Na2SO4, filtered and the filtrate 
concentrated.  The resulting oil was purified using a short silica gel plug 
(hexanes:EtOAc, 1:1) to afford the free amine (0.060 g) as a colorless oil:  1H NMR 
(CDCl3) δ 7.45 (m, 2H, ArH of BOM), 7.36 (m, 3H, ArH of BOM), 7.30 (m, 5H, PhSe), 
7.25 (m, 5H, Bn), 4.90 (d, 1H, J = 6.6 Hz, CH2-Ph,), 4.88 (d, 1H, J = 11.0 Hz, -O-CH2-O-
Bn), 4.81 (d, 1H, J = 6.8 Hz, O-CH2-Ph), 4.72 (m, 1H, -O-CH2-OBn), 4.63 (d, 1H, J = 
11.8 Hz, -O-CH2-Ph), 4.53 (d, 1H, J = 11.6 Hz, -O-CH2-Ph), 4.09 (d, 1H, J = 7.8 Hz, H1), 
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3.92 (d, 1H, J = 2.3 Hz, H4), 3.87 (m, 1H, CH2-octyl), 3.54 (dd, 1H, J = 10.3, 2.6 Hz, 
H3), 3.47 (m, 1H, H5), 3.87 (m, 1H, CH2-octyl), 3.27 (dd, 1H, J = 10.2, 7.7 Hz, H2), 3.20 
(dd, 1H, J = 12.5, 6.6 Hz, H6), 2. 97 (dd, 1H, J = 12.5, 7.3 Hz, H6), 1.60 (bs, 2H, CH2-
octyl), 1.25 (bs, 10H, CH2- octyl), 0.85 (s, 3H, CH3-octyl).  13C NMR (CDCl3) δ 138.36, 
137.38, 132.59, 130.01, 129.11, 128.49, 128.22, 128.12, 127.85, 127.80, 127.58, 127.00, 
104.49, 93.96, 81.45, 74.55, 73.76, 70.08, 69.89, 52.51, 31.78, 29.53, 29.36, 29.18, 28.19, 
25.99, 22.61.  The amine (0.060 g, 0.093 mmol) was immediately dissolved in 3 mL of 
Ac2O and 3 mL of pyridine and had 10 mg of DMAP added to it.  After 47 h, the reaction 
was diluted to 40 mL of EtOAc and washed with 40 mL of satd. CuSO4, H2O, satd. 
NaHCO3, and satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered 
and the filtrate concentrated.  The resulting oil was purified using flash column 
chromatography (hexanes:EtOAc, 1:1) to afford 42b (0.043 g, 61%, 2 steps):  1H NMR 
(CDCl3) δ 7.43 (m, 2H, ArH of BOM), 7.33 (m, 3H, ArH of BOM), 7.29 (m, 5H, PhSe), 
7.25 (m, 5H, Bn), 5.87 (d, 1H, J = 6.9 Hz, NH), 4.92 (d, 1H, J = 3.6 Hz, H4), 4.91 (d, 1H, 
J = 7.7 Hz, H1), 4.86 (d, 1H, J = 6.3 Hz, CH2-Ph,), 4.76 (d, 1H, J = 6.5 Hz, -O-CH2-Ph), 
4.66 (d, 2H, -O-CH2-OBn), 4.11 (dd, 1H, J = 7.0, 4.0 Hz, H3), 4.00 (d, 1H, -O-CH2-Ph), 
4.48 (d, 1H, J = 10.7 Hz, -O-CH2-Ph), 3.82 (m, 1H, CH2, octyl), 3.57-3.53 (dd, 2H, J = 
12.6, 7.6 Hz, H5/H2), 3.43 (m, 1H, CH2, octyl), 3.19 (dd, 1H, J = 12.4 Hz, H6), 2. 93 (dd, 
1H, J = 12.4, 7.6 Hz, H6), 1.90 (s, 3H, NHAc), 1.54 (bs, 2H, CH2-octyl), 1.25 (bs, 10H, 
CH2-octyl), 0.86 (s, 3H, CH3-octyl).  13C NMR (CDCl3) δ 170.65, 138.22, 137.44, 
132.44, 129.89, 129.07, 128.42, 128.28, 128.18, 128.09, 127.89, 127.72, 127.56, 127.49, 
126.95, 99.35, 94.22, 76.45, 74.86, 74.62, 74.17, 69.82, 69.61, 60.29, 54.73, 31.72, 29.37, 
29.25, 29.19, 27.99, 25.82, 23.50, 22.55, 20.94, 14.09, 14.00.  MS (ES, Na+): m/z 
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(relative intensity) 706.3 (100).  HRMS (M + Na+) calcd for C37H49NO6SeNa, 706.2623; 
found 706.2628. 
 
Phenylthio 4, 6-O-benzylidene-2-deoxy-2-(2, 2, 2-trichloroethoxycarbonyl) amido-∃-







To a stirred 0 °C solution of 44 (3.55 g, 6.20 mmol) in 100 mL of MeOH and was 
added NaOMe powder (0.33 g, 6.197 mmol). After 2 h, 1.8 g of Dowex 50W H+ form 
resin (2.1 meq/mL) was added and the reaction mixture was gently stirred for 20 min.  
The reaction mixture was filtered and the filtrate concentrated.  To a suspension of the 
resulting triol in 75 mL of dry CH3CN was added PhCH(OMe)2 (1.58 mL, 10.5 mmol) 
and pTsOH (0.29 g, 1.55 mmol).  After 20 h, the reaction was placed under a gentle 
vacuum. After 1 h, the reaction had 1 g of K2CO3 added to it and was stirred for 30 min.  
The mixture was filtered and the filtrate concentrated. The crude product was purified 
with flash column chromatography (EtOAc) to afford compound 45 (3.00 g, 90%, 2 
steps) as a colorless oil/solid:  1H NMR (CDCl3) δ 7.45 (m, 5H, Ph), 7.35 (m, 5H, Ph), 
5.54 (s, 1H, benzylidene), 5.25 (d, 1H, H1), 4.83 (d, 1H, J = 7.2, CH2-Troc), 4.83 (d, 1H, 
J = 7.2, CH2-Troc), 4.70 (m, 1H, CH2-Troc), 4.36 (m, 1H, H3), 3.76 (m, 1H, H4), 3.54-
3.45 (m, 4H, H2/H5/H6/H6).  MS (ES, Na+): m/z (relative intensity) calcd for 
C22H23NO6SCl3Na, 566.0; found 566.0 (100). 
 









To a stirred 0 °C suspension of N-acetyl D-glucosamine, 48, (2.00 g, 9.04 mmol) 
in 1-octanol (14 mL, 90.04 mmol) was added BF3·OEt2 (1.14 mL, 9.04 mmol).  The 
reaction mixture was heated to 70 °C.  After 3.5 h, the reaction was concentrated and the 
desired product crystallized with EtOH and ether to afford 49 (0.700 g, 23%) as a white 
powder:  mp 103-106 °C.  1H NMR (CDCl3) δ 4.78 (d, 1H, J = 3.5 Hz, H1), 4.38 (d, 1H, J 
= 8.3 Hz, N-H), 3.86 (dd, 1H, J = 10.6, 3.6 Hz, H2), 3.79 (dd, J = 9.7 Hz, H3), 3.71-3.65 
(m, 3H, H4/H6/H6), 3.56 (m, 1H, H5), 3.53 (m, 1H, CH2-octyl), 3.34 (m, 1H, CH2-octyl), 
1.97 (s, 3H, NHAc), 1.57 (bs, 2H, CH2-octyl), 1.30-1.19 (bs, 10H, CH2-octyl), 0.88 (t, 
3H, CH3-octyl).  13C NMR (CDCl3) δ 96.88, 72.22, 71.24, 70.86, 67.40, 61.50, 61.20, 
54.05, 32.14, 31.52, 29.04, 28.95, 25.79, 25.44, 22.22, 21.04, 12.91. MS (ES, Na+): m/z 
(relative intensity) 356.2 (100). HRMS (M + Na+) calcd for C16H31NO6Na, 356.2049; 
found 356.2058. 
 






To a stirred solution of 49 (0.50 g, 1.50 mmol) in 5 mL of DMF were added 
PhCH(OMe)2 (0.31 mL, 2.099 mmol) and pTsOH·H2O (0.028 mg, 0.150 mmol).  After 
19 h, the reaction was concentrated to remove the DMF.  The crude product was 
crystallized by adding 50 mL of CH2Cl2:MeOH (6:1) and approximately 2 mL of H2O.  
The product was precipitated by slowly adding hexanes to the solution to afford the 
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benzylidene (0.60 g, 95 %) as a white powder:  1H NMR (CDCl3) δ 7.49 (bs, 2H, Ph), 
7.35 (bs, 3H, Ph), 5.83 (d, 1H, J = 7.5 Hz, N-H), 5.56 (s, 1H, benzylidene), 4.81 (d, 1H, J 
= 3.5 Hz, H1), 4.27-4.20 (m, 2H, H3/H2), 3.89 (d, 1H, H4), 3.78 (d, 2H, H6/H6), 3.58 
(dd, 1H, H5), 3.48 (m, 1H, CH2-octyl), 3.39 (m, 1H, CH2-octyl), 2.06 (s, 3H, NHAc), 
1.58-1.55 (bs, 2H, CH2-octyl), 1.28 (bs, 10H, CH2-octyl), 0.88 (s, 3H, CH3-octyl).  13C 
NMR (CDCl3) δ 134.46, 129.74, 129.19, 128.28, 126.29, 101.89, 97.64, 82.12, 70.79, 
68.85, 68.28, 62.42, 54.12, 31.80, 29.35, 29.25, 26.17, 22.64, 14.08, 0.01.  MS (ES, Na+): 
m/z (relative intensity) calcd for C37H35NO9SeNa, 444.2; found 444.2 (100).  The 
resulting benzylidene (0.60 g, 1.423 mmol) was dissolved in pyridine (2.30 mL, 28.5 
mmol) and Ac2O (2.68 mL, 28.467 mmol).  After 19 h, the reaction was diluted with 25 
mL of EtOAc and washed with 25 mL of satd. CuSO4, H2O, satd. NaHCO3 and satd. 
NaCl solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified with flash column chromatography 
(hexanes:EtOAc, 1:2) to afford 50 (0.44 g, 68%; 65%, 2 steps) as a colorless oil:  1H 
NMR (CDCl3) δ 7.41 (bs, 2H, Ph), 7.31 (bs, 3H, Ph), 5.86 (d, 1H, J = 9.5 Hz, N-H), 5.49 
(s, 1H, benzylidene), 5.27 (d, 1H, J = 10.2 Hz, H3), 4.78 (d, 1H, J = 3.6 Hz, H1), 4.28 
(dd, 1H, J = 9.8, 3.8 Hz, H2), 4.24 (d, 1H, J = 10.3, 4.8 Hz, H6), 3.76 (d, 1H, J = 10.3, 6.2 
Hz, H6), 3.74 (m, 1H, H4), 3.68-3.63 (dd, 2H, H5/CH2-octyl), 3.36 (m, 1H, CH2-octyl), 
2.04 (s, 3H, OAc), 1.93 (s, 3H, NHAc), 1.58-1.55 (bs, 2H, CH2-octyl), 1.28-1.21 (bs, 
10H, CH2-octyl), 0.85 (s, 3H, CH3-octyl).  13C NMR (CDCl3) δ 171.29, 169.96, 136.92, 
128.95, 128.08, 126.04, 101.39, 97.72, 78.93, 70.30, 68.77, 68.31, 62.68, 60.25, 52.49, 
31.68, 29.31, 29.19, 26.14, 26.00, 23.04, 22.51, 20.89, 20.78, 14.05, 13.95. MS (ES, 












A solution of 50 (0.44 g, 0.95 mmol) in 15 mL of H2O and AcOH (1:1) was 
heated to reflux.  After 2 h, the reaction was cooled and concentrated.  The crude product 
was diluted with 30 mL of EtOAc and washed with 20 mL of satd. NaHCO3 and satd. 
NaCl solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified with flash column chromatography 
(EtOAc) to afford the diol (0.24 g, 73 %) as a colorless oil:  1H NMR (CDCl3) δ 5.96 (d, 
1H, J = 9.2 Hz, N-H), 4.97 (d, 1H, J = 9.7 Hz, H3), 4.68 (d, 1H, H1), 4.08 (dd, 1H, J = 
8.5 Hz, H2), 3.71 (d, 2H, H6/H6), 3.71 (d, 1H, H4), 3.55 (d, 1H, -OH), 3.45 (dd, 1H, H5), 
3.32-3.26 (dd, 2H, CH2-octyl), 1.98 (s, 3H, NHAc), 1.82 (s, 3H, OAc), 1.47-1.42 (bs, 2H, 
CH2-octyl), 1.13 (bs, 10H, CH2-octyl), 0.77 (s, 3H, CH3-octyl).  To a stirred solution of 
the diol in 5 mL of DMF were added imidazole (0.13g, 1.917 mmol) and TBS-Cl (0.12g, 
0.799 mmol).  After 18 h, the reaction was concentrated to remove the DMF.  The crude 
product was dissolved in 20 mL of EtOAc and washed with 10 mL of H2O and satd. 
NaCl solution.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified with flash column chromatography 
(EtOAc) to afford 51 (0.14 g, 45%; 32%, 2 steps) as a colorless oil:  1H NMR (CDCl3) δ 
5.73 (d, 1H, J = 9.5 Hz, N-H), 5.08 (d, 1H, J = 10.6, 9.1 Hz, H3), 4.72 (d, 1H, J = 3.6 Hz, 
H1), 4.16 (dd, 1H, J = 9.8, 3.6 Hz, H2), 3.87 (d, 1H, J = 10.5, 4.6 Hz, H6), 3.79 (d, 1H, J 
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= 10.5, 5.5 Hz, H6), 3.71 (d, 1H, J = 9.3, 2.7 Hz, H4), 3.66-3.61 (dd, 2H, H5/CH2-octyl), 
3.37-3.33 (dd, 1H, CH2-octyl), 3.28 (d, 1H, J = 2.7 Hz, -OH),  2.01 (s, 3H, NHAc), 1.91 
(s, 3H, OAc), 1.57-1.53 (bs, 2H, CH2-octyl), 1.28-1.21 (bs, 10, CH2-octyl), 0.86 (s, 12H, 
tBu, CH3-octyl), 0.10 (s, 6H, Me).  13C NMR (CDCl3) δ 172.03, 169.94, 96.99, 73.98, 
71.03, 70.31, 68.02, 64.37, 60.32, 51.73, 31.73, 29.27, 29.19, 26.11, 25.78, 23.16, 22.56, 
20.96, 18.19, 14.11, 14.10, -5.54, -5.58.  MS (ES, Na+): m/z (relative intensity) 512.4 










To a stirred -5 °C solution of 51 (0.140 g, 0.285 mmol) in 5 mL of CH2Cl2 and 
pyridine (0.10 mL, 1.28 mmol) was added a freshly prepared solution of Tf2O (0.09 mL, 
0.571 mmol) in 0.85 of mL CH2Cl2. The reaction solution turned a yellow-orange color 
with time and the temperature was maintained between -5 °C and +10 °C.  After 2.5 h, 
the reaction was warmed to room temperature and diluted to 10 mL of CH2Cl2 and 
washed with 10 mL of satd. Cu2SO4, H2O, satd. NaCl solutions.  The organic extract was 
dried with Na2SO4, filtered and the filtrate concentrated.  The resulting oil (0.156 g) was 
taken on without any purification:  1H NMR (CDCl3) δ 5.71 (d, 1H, 9.5 Hz, N-H), 5.34 
(d, 1H, J = 9.9 Hz, H4), 4.77 (d, 1H, J = 3.6 Hz, H1), 4.24 (dd, 1H, J = 10.1, 3.6 Hz, H2), 
3.85-3.80 (m, 2H, H3/H5), 3.79 (d, 2H, J = 2.5 Hz, H6/H6), 3.65 (m, 1H, CH2-octyl), 
3.39 (m, 1H, CH2-octyl), 2.09 (s, 3H, NHAc), 1.86 (s, 3H, OAc), 1.57-1.55 (bs, 2H, CH2-
91 
 
octyl), 1.27-1.25 (bs, 10H, CH2-octyl), 0.87 (s, 12H, tBu, CH3-octyl), 0.06 (s, 6H, Me).  
13C NMR (CDCl3) δ 171.16, 169.86, 96.72, 79.05, 70.59, 69.22, 68.50, 60.77, 52.48, 
31.72, 29.23, 29.16, 26.04, 25.65, 23.09, 22.56, 20.55, 18.21, 13.99, -5.51, -5.67.  19F 
NMR (CDCl3) δ 1.58.  To the crude triflate glycoside was added a solution of Et4NOAc 
(0.33 g, 1.25 mmol) in 5 mL of DMF.  After 40 min, the reaction was concentrated and 
the crude red oil dissolved in 50 mL of EtOAc and washed twice with 25 mL of H2O and 
once with satd. NaCl solution.  The organic extract was dried with Na2SO4, filtered and 
the filtrate concentrated. The crude product was purified with flash column 
chromatography (hexanes:EtOAc, 2:1) to afford 52 (0.050 g, 35%, 2 steps) as an oil:  1H 
NMR (CDCl3) δ 5.59 (d, 1H, J = 10.0 Hz, N-H), 5.39 (d, 1H, J = 2.9 Hz, H4), 5.14 (dd, 
1H, J = 14.4, 3.2 Hz, H3), 4.80 (d, 1H, J = 3.7 Hz, H1), 4.52 (dd, 1H, J = 8.5, 3.6 Hz, 
H2), 3.94 (dd, 1H, J = 12.9, 6.6 Hz, H5), 3.68 (m, 1H, CH2-octyl), 3.59-3.53 (dd, 2H, J = 
10.1, 2.9 Hz, H6), 3.36 (m, 1H, CH2-octyl), 2.12 (s, 3H, NHAc), 2.02 (s, 3H, OAc), 1.95 
(s, 3H, OAc), 1.56-1.55 (bs, 2H, CH2-octyl), 1.26-1.19 (bs, 10H, CH2-octyl), 0.87 (s, 
12H, tBu, CH3-octyl), 0.01 (s, 6H, Me).  13C NMR (CDCl3) δ 171.06, 170.96, 170.12, 
169.84, 97.39, 69.33, 68.92, 68.15, 67.39, 61.12, 60.31, 48.01, 31.73, 29.27, 29.20, 26.14, 
25.67, 23.28, 22.57, 20.97, 20.75, 18.06, 14.12, 14.10, -5.64, -5.71. MS (ES, Na+): m/z 
(relative intensity) 554.4 (100).  MS (ES, Na+): m/z (relative intensity) 554.3 (100).  
HRMS (M + Na+) calcd for C26H46NO8SiNa, 554.3125; found 554.3128. 
 









To a stirred 0 °C solution of 52 (0.050 g, 0.094 mmol) in 3 mL of CH3CN and 
pyridine (0.25 mL, 3.10 mmol) in a Nalgene bottle was added 0.25 mL of HF·pyridine.  
The reaction was allowed to warm to room temperature.  After 3.5 h, the reaction was 
diluted to 5 mL of CH2Cl2 and washed with 5 mL of satd. CuSO4, H2O, satd. NaHCO3 
and satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered and the 
filtrate concentrated.  The crude product was purified by preparatory thin layer 
chromatography (hexanes:EtOAc, 1:1) to afford 53 (0.03 g, 77%) as a colorless oil:  1H 
NMR (CDCl3) δ 5.65 (d, 1H, N-H), 5.30 (d, 1H, J = 2.8 Hz, H4), 5.16 (dd, 1H, J = 11.2, 
3.1 Hz, H3), 4.82 (d, 1H, J = 3.6 Hz, H1), 4.53 (dd, 1H, J = 10.0, 3.6 Hz, H2), 3.97 (dd, 
1H, J = 6.3 Hz, H5), 3.72-3.60 (m, 2H, H6/CH2-octyl), 3.45 (m, 1H, H6), 3.36 (m, 1H, 
CH2-octyl), 2.08 (s, 3H, NHAc), 2.02 (s, 3H, OAc), 1.93 (s, 3H, OAc), 1.52 (bs, 2H, 
CH2-octyl), 1.26 (bs, 10H, CH2-octyl), 0.85 (s, 3H, CH3-octyl). 13C NMR (CDCl3) δ 
97.56, 71.12, 68.46, 68.34, 67.86, 67.51, 63.09, 47.65, 31.82, 29.71, 29.34, 29.28, 26.24, 
23.36, 22.65, 21.01, 20.84, 14.10, 0.00.  MS (ES, Na+): m/z (relative intensity) calcd for 
C20H35NO8SeNa, 440.2; found 440.2 (100).   
 
p-Methoxyphenyl, 3, 4-di-O-acetyl, 3-O-[(benzyloxy)methyl], 2, 6-dideoxy, 6-








To a stirred 0 °C solution of 40c (0.150 g, 0.209 mmol) in 2 mL of CH2Cl2 were 
added AcBr (0.006 mL, 0.413 mmol) and BF3·OEt2 (0.0015 mL, 0.0209 mmol).  After 20 
min, the reaction was warmed to room temperature.  After 5 h, the reaction was diluted to 
5 mL of CH2Cl2 and washed three times with 5 mL of H2O and once with satd. NaCl 
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solution.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified by flash column chromatography 
(hexanes:EtOAc, 2.5:1) to afford 58 (0.106 g, 80%) as a colorless oil:  1H NMR (CDCl3) 
δ 7.82 (d, 2H, NPht), 7.75 (m, 2H, NPht), 7.53 (m, 2H, SePh), 7.29 (m, 3H, SePh), 6.92 
(m, 2H, PMP), 6.75 (m, 2H, PMP), 5.86 (dd, 1H, J = 11.4, 3.3 Hz, H3), 5.77 (d, 1H, J = 
8.5 Hz, H1), 5.60 (d, 1H, J = 5.3 Hz, H4), 4.81 (dd, 1H, J = 11.5, 8.5 Hz, H2), 4.03 (dd, 
1H, J = 8.0, 6.0 Hz, H5), 3.74 (s, 3H, OMe), 3.19 (dd, 1H, J = 12.9, 8.3 Hz, H6), 3.00 
(dd, 1H, J = 12.9, 7.5 Hz, H6), 2.22 (s, 3H, OAc), 1.89 (s, 3H, OAc). MS (ES, Na+): m/z 
(relative intensity) 662.0 (100).  HRMS (M + Na+) calcd for C31H29NO9SeNa, 662.0905; 
found 662.0901. 
 
t-Butyldimethylsilyl, 4-O-acetyl, 3-O-[(benzyloxy)methyl], 2, 6-dideoxy-6-








To a suspension of 40b (0.125 g, 0.170 mmol) in 25 mL of EtOH in a Schlenk 
tube was added H2NNH2·H2O (0.79 mL, 16.2 mmol).  The reaction was placed under a 
gentle vacuum, the tube sealed and heated to 100 °C.  After 68 h, the reaction was cooled, 
the tube opened and the reaction mixture concentrated.  The resulting oil/solid was 
dissolved in 100 mL of EtOAc and washed with 75 mL of satd. NaHCO3 solution.  The 
aqueous extract was washed with 75 mL of EtOAc and the combined organic extracts 
washed with 150 mL of satd. NaCl solution, dried with Na2SO4, filtered and the filtrate 
concentrated.  The resulting oil was purified using a short silica gel plug 
(hexanes:EtOAc, 1:1) to afford the free amino alcohol (0.080g, 85%) as a colorless oil:  
94 
 
1H NMR (CDCl3) δ 7.48 (m, 2H, SePh), 7.33 (m, 5H, ArH of BOM), 7.24 (m, 3H, SePh), 
4.93 (d, 1H, J = 7.0 Hz, O-CH2-O-Bn), 4.86 (d, 1H, J = 7.0 Hz, O-CH2-Ph/Bn), 4.69 (s, 
1H, J = 11.7 Hz, O-CH2-Ph/BOM), 4.65 (s, 1H,  J = 11.7 Hz, O-CH2-Ph/BOM), 4.37 (d, 
1H, J = 7.6 Hz, H1), 4.03 (d, 1H, J = 2.9 Hz, H4), 3.55 (dd, 1H, J = 6.8 Hz, H5), 3.45 (dd, 
1H, J = 10.1, 3.1 Hz, H3), 3.28 (dd, 1H, J = 12.7, 7.3 Hz, H6), 3.14 (dd, 1H, J = 12.7, 6.4 
Hz, H6), 3.02 (dd, 1H, J = 10.1, 7.7 Hz, H2), 0.92 (s, 9H, tBu), 0.17 (s, 3H, Me), 0.01 (s, 
3H, Me).  13C NMR (CDCl3) δ 207.32, 137.51, 132.62, 132.27, 130.53, 129.48, 128.90, 
128.31, 127.26, 99.56, 94.78, 81.59, 76.93, 74.61, 70.57, 67.93, 54.33, 31.27, 28.14, 
26.13, 18.34, -3.48, -4.95.  MS (ES, Na+): m/z (relative intensity) 576.1 (100).  HRMS 
(M + Na+) calcd for C26H40NO5SeSiNa, 576.1660; found 576.1653.  To a stirred 0 °C 
solution of the free amino alcohol in pyridine (0.50 mL, 6.46 mmol) was added TFAA 
(0.09 mL, 0.63 mmol).  After 45 min, the solution was diluted with 25 mL of CH2Cl2 and 
washed with 25 mL of satd. CuSO4, H2O, satd. NaCl solutions.  The organic extract was 
dried with Na2SO4, filtered and the filtrate concentrated.  The resulting oil was dissolved 
in 5 mL of EtOH, 10 mL of H2O and 1 mL of satd. NaHCO3 solution.  After 4 h, the 
solution was neutralized with AcOH to pH = 6 and concentrated to leave the H2O.  The 
aqueous extract was washed with 10 mL of EtOAc two times and the combined organic 
extracts were washed with 20 mL of satd. NaCl solution, dried with Na2SO4, filtered and 
the filtrate concentrated to afford 60 (0.078 g, 95%; 80%, 2 steps) and taken on without 
any purification:  1H NMR (CDCl3) δ 7.49 (m, 2H, SePh), 7.30 (m, 3H, SePh), 7.25 (m, 
5H, ArH of BOM), 6.67 (d, 1H J = 8.1 Hz, N-H), 4.88 (d, 1H, J = 7.9 Hz, H1), 4.81 (d, 
1H, J = 7.0 Hz, O-CH2-Ph/Bn), 4.72 (d, 1H, J = 7.0 Hz, O-CH2-Ph/Bn), 4.57 (m, 2H, O-
CH2-O-Bn), 4.08-4.04 (m, 2H, H5/H4), 3.83 (dd, 1H, J = 9.9 Hz, H2),  3.60 (d, 1H, J = 
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6.8 Hz, H3), 3.27 (dd, 1H, J = 12.7, 7.2 Hz, H6), 3.13 (dd, 1H, J = 12.7, 6.5 Hz, H6), 0.86 
(s, 9H, tBu), 0.13 (s, 3H, Me), 0.07 (s, 3H, Me). 19F NMR (CDCl3) δ 0.23.  
 
t-Butyldimethylsilyl, 4-O-acetyl, 3-O-[(benzyloxy)methyl], 2, 6-dideoxy-6-








Compound 60 (0.077 g, 0.118 mmol) was dissolved in pyridine (0.60 mL, 7.42 
mmol) and Ac2O (0.6 mL, 6.36 mmol).  After 15 h, the reaction was diluted to 25 mL of 
EtOAc and washed with 25 mL of satd. CuSO4, H2O, and satd. NaCl solutions.  The 
organic extract was dried with Na2SO4, filtered and the filtrate concentrated.  The crude 
oil was purified using flash column chromatography to afford 61a (0.076 g, 92%) as a 
colorless oil:  1H NMR (CDCl3) δ 7.47 (m, 2H, SePh), 7.33 (m, 3H, SePh), 7.27 (m, 5H, 
ArH of BOM), 6.39 (d, J = 8.3 Hz, N-H), 5.44 (d, 1H, J = 2.9 Hz, H4), 4.90 (d, 1H, J = 
7.9 Hz, H1), 4.79 (d, 2H,  J = 7.4 Hz, O-CH2-Ph/Bn), 4.57 (m, 2H, O-CH2-O-Bn), 4.49 
(s, 2H, J = 12.1 Hz, O-CH2-Ph/BOM), 4.15 (dd, 1H, J = 11.1, 3.2 Hz, H3),  3.85 (d, 1H, 
H2), 3.68 (m, 1H, H5), 3.10 (dd, 1H, J = 12.8, 8.3 Hz, H6), 2.86 (dd, 1H, J = 12.8, 5.2 
Hz, H6), 2.14 (s, 3H, OAc), 0.87 (s, 9H, tBu), 0.15 (s, 3H, Me), 0.07 (s, 3H, Me).  13C 
NMR (CDCl3) δ 170.97, 157.85, 157.56, 137.47, 133.13, 130.12, 129.73, 128.93, 128.35, 
128.15, 127.77, 117.24, 95.67, 92.96, 73.61, 72.74, 70.30, 68.32, 55.92, 30.12, 28.19, 
25.93, 21.27, 18.22, 1.44, -3.55, -5.08.  19F NMR (CDCl3) δ 0.34.  MS (ES, Na+): m/z 
(relative intensity) 714.1 (100).  HRMS (M + Na+) calcd for C30H40F3NO7SeSiNa, 




t-butyldimethylsilyl 4-O-benzyl- 3-O-[(benzyloxy)methyl], 2,6-dideoxy-6-








To a stirred 0 °C solution of 60 (0.027 g, 0.040 mmol) in 0.7 mL of THF was 
added NaH (80% in oil, 0.003 g, 0.100 mmol).  After 30 min., BnBr (0.0095 mL, 0.08 
mmol) and NBu4I (0.003 g, 0.008 mmol) were added and the temperature maintained at 0 
°C for 1 h.  The reaction was then warmed to room temperature. After 4 h, 0.05 mL of 
AcOH was slowly added at 0 °C and the reaction mixture was diluted with 5 mL of 
EtOAc and washed with 5 mL of H2O, 5 mL of satd. NaHCO3 and 5 mL of satd. NaCl 
solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified by preparative thin layer chromatography 
(hexanes:EtOAc, 4:1) to afford 61b (0.020 g, 67%) as a colorless oil:  1H NMR (CDCl3) δ 
7.37 (m, 10H, Bn/ ArH of BOM), 7.25 (m, 5H, SePh), 5.40 (dd, 1H, J = 6.4, 3.1 Hz, H1), 
4.74 (d, 1H, J = 7.0 Hz, O-CH2-Ph), 4.59 (m, 1H, O-CH2-Ph), 4.53 (m, 4H, CH2-Ph), 
4.68 (s, 2H, O-CH2-O-Bn), 4.67 (m, 1H, H3), 3.90 (d, 1H, J= 2.1 Hz, H4), 3.61 (dd, 1H, 
J= 10.9, 7.9, Hz, H2), 3.54 (m, 1H, H5), 3.12 (dd, 1H, J= 12.6, 6.8 Hz, H6), 2.89 (dd, 1H, 
J= 12.4, 6.7 Hz, H6), 0.86 (s, 9H, tBu), 0.12 (s, 3H, Me), 0.08 (s, 3H, Me).  13C NMR 
(CDCl3) δ 157.84, 157.55, 138.44, 137.59, 132.61, 130.46, 129.64, 128.96, 128.79, 
128.72, 128.35, 128.26, 128.06, 127.45, 117.27, 114.98, 95.43, 94.03, 76.73, 75.26, 
74.92, 74.55, 70.42, 60.82, 56.38, 28.32, 25.96, 18.23, -3.60, -5.02. MS (ES, Na+): m/z 
(relative intensity) 762.1 (100).  HRMS (M + Na+) calcd for C35H44NO6SeSiF3Na, 















To a stirred 0 °C solution of 61a (0.075 g, 0.108 mmol) in 1.5 mL of CH3CN and 
pyridine (0.4 mL, 5.193 mmol) in a Nalgene bottle was added 0.15 mL HF·pyridine and 
the temperature maintained for 1 h.  The reaction was allowed to warm to room 
temperature.  After 5 h, the reaction was diluted with 20 mL of CH2Cl2 and extracted 
with 20 mL of satd. CuSO4, H2O, satd. NaHCO3 and satd. NaCl solutions.  The organic 
extract was dried with Na2SO4, filtered and the filtrate concentrated.  The crude product 
was purified by flash column chromatography (hexanes:EtOAc, 3:1) to afford the free C-
1 alcohol (0.061 g, 86%) as a colorless oil:  1H NMR (CDCl3) δ 7.50 (m, 2H, SePh), 7.34-
7.26 (m, 18H, SePh/ ArH of BOM/Bn), 6.87 (d, 1H, N-H), 5.50 (dd, 1H, J = 2.4 Hz, H1), 
5.28 (d, 1H, J = 3.4 Hz, H4), 4.80 (m, 1H, O-CH2-Ph/Bn), 4.61-4.53 (d, 3H, O-CH2-
Ph/Bn/O-CH2-O-Bn), 4.44 (m, 1H, H2), 4.20 (m, 1H, H5), 4.08 (dd, 1H, J = 3.0 Hz, H3), 
3.68 (d, 1H, J = 2.0 Hz, -OH), 3.02 (dd, 1H, J = 12.7, 8.1 Hz, H6), 2.83 (dd, 1H, J = 12.7, 
5.8 Hz, H6), 2.14 (s, 3H, OAc).  To a stirred -78°C solution of the free alcohol (0.135 g, 
0.23 mmol) in 8 mL of THF was added a freshly prepared solution of 0.21M LDA (1.68 
mL, 0.35 mmol).  After 15 min, a -78°C solution of TBPP (0.164 g, 0.300 mmol) in 4 mL 
of THF was added to the free alcohol solution.  After 15 min, the reaction was warmed to 
0°C.  After 2.5 h, the reaction was warmed to room temperature and diluted with 100 mL 
of CH2Cl2 and washed with 100 mL of satd. NaHCO3 twice and once with 100 mL of 
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satd. NaCl solution.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified with flash column chromatography 
(hexanes:EtOAc, 3:1) to afford 62 (0.161 g, 82%; 70%, 2 steps) as a colorless oil:  1H 
NMR (CDCl3) δ 7.44 (m, 2H, SePh), 7.31 (m, 5H, ArH of BOM), 7.27 (m, 10H, Bn), 
7.20 (m, 3H, SePh), 6.87 (d, 1H, J = 8.5 Hz, N-H), 5.79 (dd, 1H, J = 6.0, 3.2 Hz, H1), 
5.52 (d, 1H, J = 2.3 Hz, H4), 4.49 (m, 4H, O-CH2-Ph/Bn), 4.75 (d, 1H, J = 7.2 Hz, O-
CH2-O-Bn), 4.58 (m, 2H, O-CH2-Ph/BOM), 4.51 (d, 1H, O-CH2-O-Bn), 4.45 (m, 1H, 
H3), 4.11 (m, 1H, J = 6.9 Hz, H5), 3.91 (dd, 1H, J = 11.0, 3.1 Hz, H2), 2.99 (dd, 1H, J = 
12.9, 7.2 Hz, H6), 2.81 (dd, 1H, J = 12.9, 6.9 Hz, H6), 2.12 (s, 3H, OAc).  13C NMR 
(CDCl3) δ 170.76, 158.32, 158.02, 137.46, 135.80, 135.68, 133.64, 133.32, 130.32, 
129.92, 129.47, 129.30, 129.15, 128.77, 128.68, 128.63, 128.30, 128.03, 117.32, 115.03, 
96.67, 93.27, 71.87, 71.38, 70.64, 70.49, 68.17, 49.83, 30.29, 27.56, 21.33, 0.59. 19F 
NMR δ 0.43.  31P NMR δ -1.23.  MS (ES, Na+): m/z (relative intensity) 860.1 (100).  
HRMS (M + Na+) calcd for C38H39F3NO10PSeNa, 860.1327; found 860.1329. 
 
t-Butyldimethylsilyl 3-O-[(benzyloxy)methyl]- 2,6-dideoxy-6-phenylseleno-2-








To a stirred solution of 40b (0.09 g, 0.12 mmol) in 2 mL of dry THF was added 
1M NaOMe solution (0.12 mL, 0.120 mmol).  After 1 h, 0.35 g of Dowex 50W H+ form 
resin (2.1 meq/mL) was added and gently stirred for 20 min.  The mixture was filtered 
and the filtrate concentrated. The crude product was purified by flash column 
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chromatography (hexanes:EtOAc, 4:1) to afford 66 (0.06 g, 71%) as a colorless oil:  1H 
NMR (CDCl3) δ 7.81 (d, 1H, Pht), 7.67 (m, 3H, Pht), 7.51 (m, 2H, ArH of BOM), 7.36 
(m, 1H, ArH of BOM), 7.28 (m, 2H, SePh), 7.25 (m, 3H, SePh), 7.09 (m, 2H, ArH of 
BOM), 5.31 (dd, 1H, J = 7.9 Hz, H1), 4.76 (d, 1H, J = 7.1 Hz, O-CH2-Ph), 4.66 (m, 1H, 
O-CH2-Ph), 4.58 (dd, 1H, J = 11.1, 3.1 Hz, H3), 4.45 (dd, 1H, J= 11.1, 7.9, Hz, H2), 4.41 
(s, 1H, O-CH2-O-Bn), 4.32 (s, 1H, O-CH2-O-Bn), 4.18 (d, 1H, H4), 3.76 (m, 1H, H5), 
3.35 (dd, 1H, J= 12.7, 7.3 Hz, H6), 3.21 (dd, 1H, J= 12.7, 6.4 Hz, H6), 2.47 (d, 1H, J = 
2.5 Hz, -OH), 0.66 (s, 9H, tBu), 0.08 (s, 3H, Me), 0.01 (s, 3H, Me).  13C NMR (CDCl3) δ 
168.80, 167.90, 136.90, 133.97, 132.21, 131.52, 130.18, 129.16, 128.51, 128.32, 127.65, 
127.40, 126.93, 123.33, 122.92, 93.97, 93.60, 74.93, 74.17, 69.91, 68.02, 65.30, 54.15, 
27.71, 25.29, 17.45, -4.07, -5.68. MS (ES, Na+): m/z (relative intensity) 706.1 (100). 
HRMS (M + Na+) calcd for C34H41NO7SeSiNa, 706.1715; found 706.1719. 
 
t-Butyldimethylsilyl 4-O-benzyl- 3-O-[(benzyloxy)methyl]-2,6-dideoxy-6-








To a stirred 0 °C solution of 66 (1.24 g, 1.82 mmol) in 50 mL of THF was added 
NaH (80% in oil, 0.065 g, 2.728 mmol).  After 30 min, BnBr (0.43 mL, 3.64 mmol) and 
NBu4I (0.130 g, 0.364 mmol) were added and the solution was warmed to room 
temperature. After 22 h, the reaction was diluted with 100 mL of EtOAc and washed with 
75 mL of H2O, satd. NaHCO3 and satd. NaCl solutions.  The organic extract was dried 
with Na2SO4, filtered and the filtrate concentrated.  The crude product was purified by 
flash column chromatography (hexanes:EtOAc, 5:1) to afford 67 (1.06 g, 76%) as a 
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colorless oil:  1H NMR (CDCl3) δ 7.70 (m, 2H, Pht), 7.46-7.21 (m, 15H, Pht/SePh/Bn/ 
ArH of BOM), 7.00 (m, 2H, PhSe), 5.33 (dd, 1H, J = 7.3 Hz, H1), 4.98 (d, 1H, J = 11.3 
Hz, O-CH2-Ph), 4.78 (m, 1H, O-CH2-Ph), 4.70-4.59 (m, 3H, H3/H2/H5), 4.55 (m, 4H, 
CH2-Ph), 4.33 (s, 2H, O-CH2-O-Bn), 3.16 (m, 1H, H6), 4.03 (d, 1H, J= 1.9 Hz, H4), 3.24 
(dd, 1H, J= 12.5, 6.9 Hz, H6), 2.92 (dd, 1H, J= 12.5, 6.7 Hz, H6), 0.86 (s, 9H, tBu), 0.12 
(s, 3H, Me), 0.08 (s, 3H, Me).  13C NMR (CDCl3) δ 168.93, 167.94, 138.22, 137.16, 
133.86, 132.23, 132.10, 131.66, 130.27, 129.18, 128.55, 128.40, 128.33, 128.24, 128.14, 
128.07, 128.01, 127.83, 127.72, 127.47, 127.18, 126.89, 123.27, 122.82, 93.98, 93.74, 
76.04, 74.76, 74.53, 74.42, 69.75, 54.74, 53.40, 28.11, 26.18, 17.50, -4.03, -5.58. MS 
(ES, Na+): m/z (relative intensity) 796.2 (100).  HRMS (M + Na+) calcd for 
C39H45NO7SeSiNa, 796.2185; found 796.2181. 
 
t-Butyldimethylsilyl 4-O-benzyl- 3-O-[(benzyloxy)methyl]-2,6-dideoxy-6-








To a stirred suspension of 67 (0.125 g, 0.161 mmol) in 5 mL of EtOH in a 
Schlenk tube was added H2NNH2·H2O (0.73 mL, 15.2 mmol).  The tube was placed 
under a gentle vacuum, the tube sealed, and heated to 100 °C.  After 35 h, the reaction 
was cooled and the tube opened. The reaction mixture was diluted with 40 mL of EtOAc 
and washed with 20 mL of satd. NaHCO3 solution and the aqueous extract washed with 
20 mL of EtOAc.  The combined organic extracts were washed with 50 mL of satd. NaCl 
solution, dried with Na2SO4, filtered and the filtrate concentrated.  The resulting free 
amine was purified using a short silica gel plug (hexanes:EtOAc, 1:1) to afford the free 
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amino alcohol (0.094 g) as a colorless oil:  1H NMR (CDCl3) δ 7.41 (m, 2H, Bn), 7.35-
7.25 (m, 13H, Bn/ ArH of BOM/SePh), 4.90 (d, 2H, O-CH2-Ph), 4.82 (m, 1H, O-CH2-
Ph), 4.72 (d, 1H, CH2-Ph), 4.64 (s, 2H, O-CH2-O-Bn), 4.57 (s, 2H, O-CH2-O-Bn), 4.35 
(d, 1H, J = 7.5 Hz, H1), 3.87 (d, 1H, J= 2.1 Hz, H4), 3.51 (dd, 1H, J = 10.8, 2.6 Hz, H3), 
3.48 (m, 1H, H5), 3.22 (m, 1H, H2), 3.20 (dd, 1H, J= 12.5, 6.9 Hz, H6), 2.90 (dd, 1H, J= 
12.5, 6.6 Hz, H6), 1.57 (bs, 3H, NH2), 0.92 (s, 9H, tBu), 0.16 (s, 3H, Me), 0.08 (s, 3H, 
Me).  13C NMR (CDCl3) δ 137.38, 136.42, 131.10, 129.31, 128.25, 128.11, 127.67, 
127.47, 127.26, 127.18, 127.06, 126.82, 126.77, 126.64, 126.55, 126.27, 125.91, 125.82, 
98.54, 93.13, 80.36, 73.58, 73.04, 69.02, 64.21, 59.34, 52.38, 28.66, 27.22, 24.82, 17.01, 
-4.76, -6.21. MS (ES, Na+): m/z (relative intensity) 644.2 (100). HRMS (M + Na+) calcd 
for C39H45NO5SeSiNa, 644.2305; found 644.2310.  To a stirred 0 °C solution of the free 
amino alcohol (0.094 g, 0.146 mmol) in 1.0 mL of pyridine was added TFAA (0.10 mL, 
0.731 mmol) and the temperature maintained at 0 °C.  After 1 h, the reaction was diluted 
to 25 mL of EtOAc and washed with 25 mL of satd. CuSO4, H2O, satd. NaHCO3, and 
satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified by flash column chromatography 
(hexanes:EtOAc, 3:1) to afford 61b (0.100 g, 83%, 2 steps) as a colorless oil with 













To a stirred 0 °C solution of 61b (0.020 g, 0.027 mmol) in 0.4 mL of dry CH3CN 
and 0.15 mL of pyridine in a Nalgene bottle was added 0.05 mL of HF pyridine. After 1 
h, the reaction was warmed to room temperature.  After 3.5 h, the reaction was diluted 
with 5 mL of CH2Cl2 and washed with 5 mL of satd. CuSO4, satd. NaHCO3, H2O and 
satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
evaporated.  The crude product was purified by flash column chromatography 
(hexanes:EtOAc, 3:1) to afford 3.10C (0.015 g, 89%) as a colorless oil:  1H NMR 
(CDCl3) δ 7.44 (m, 3H, Bn/Ph), 7.32 (m, 12H, Bn/Ph), 7.25 (m, 5H, SePh), 6.77 (d, 1H, 
J= 8.5 Hz, N-H), 5.35 (d, 1H, J= 2.1 Hz, H4), 4.95 (d, 1H, J = 11.3 Hz, O-CH2-Ph), 4.82 
(m, 1H, O-CH2-Ph), 4.75 (m, 1H, O-CH2-Ph), 4.65 (m, 3H, CH2-Ph), 4.59 (m, 1H, H1), 
4.47 (d, 1H, J= 11.4, CH2-Bn), 4.06-4.00 (m, 3H, H5/H2/CH2-Ph), 3.61 (dd, 1H, J= 10.9, 
7.9 Hz, H2), 3.54 (m, 1H, H5), 3.11 (dd, 1H, J = 12.6, 6.4 Hz, H6), 3.05 (m, 1H, H3), 
2.95 (dd, 1H, J= 12.6, 7.8 Hz, H6).  13C NMR (CDCl3) δ 157.73, 157.44, 138.24, 137.24, 
132.88, 130.06, 129.56, 129.06, 128.95, 128.78, 128.61, 128.40, 128.23, 128.16, 127.98, 
127.55, 117.29, 115.00, 93.79, 91.79, 75.92, 75.19, 74.72, 71.13, 70.26, 49.91, 28.10.  
MS (ES, Na+): m/z (relative intensity) 648.2 (100).  HRMS (M + Na+) calcd for 
C29H30NO6SeF3Na, 648.1088; found 648.1095. 
 
4-O-Benzyl, 3-O-[(benzyloxy)methyl]-2, 6-dideoxy-6-phenylselenoxo-2-













To a stirred suspension of 1-H-tetrazole (0.006 mg, 0.080 mmol) in 0.25 mL of 
CH2Cl2 was added (iPr)2NP(OBn)2 (0.014 mL, 0.044 mmol). After 15 min, the reducing 
sugar 68 (0.025 g, 0.040 mmol) in 0.25 mL of CH2Cl2 was added to the stirred solution. 
After 7 h, the reaction was diluted to 3 mL of CH2Cl2 and washed with 3 mL of satd. 
NaHCO3, H2O, and satd. NaCl solutions.  The organic extract was dried with Na2SO4, 
filtered and the filtrate concentrated.  The crude product was purified by flash column 
chromatography (hexanes:EtOAc, 3:1, 1% NEt3) to afford the phosphite (0.02 g, 59%) as 
a colorless oil/solid:  1H NMR (CDCl3) δ 7.64-7.20 (m, 25H, SePh/ ArH of BOM/Bn), 
6.74 (d, 1H, J = 8.1 Hz, N-H), 5.69 (dd, 1H, J = 7.7, 3.2 Hz, H1), 4.96 (d, 1H, J = 5.1 Hz, 
H4), 4.87-4.60 (m, 10H, O-CH2-Ph-Bn/O-CH2-O-Bn/O-CH2-Ph-BOM), 4.45 (m, 1H, 
H3), 4.09 (m, 1H, H5), 3.91 (dd, 1H, J = 6.0 Hz, H2), 3.01 (dd, 1H, J = 12.2, 5.4 Hz, H6), 
2.73 (dd, 1H, H6).  13C NMR (CDCl3) δ 137.55, 132.14, 129.17, 128.55, 128.47, 128.37, 
128.15, 128.00, 127.87, 127.57, 127.38, 127.34, 127.03, 93.58, 75.91, 74.87, 74.04, 
71.88, 69.80, 64.47, 50.73, 49.68, 45.91, 27.07, 0.95.  19F NMR δ 0.74.  31P NMR δ 
141.03.  MS (ES, Na+): m/z (relative intensity) 892.1 (100).  HRMS (M + Na+) calcd for 
C43H43NO8SePF3Na, 892.1741; found 892.1753.  To a stirred solution of the phosphite 
(0.020 g, 0.023 mmol) in 3.5 mL of MeOH:H2O (6:1) were added NaHCO3 (0.004 g, 
0.050 mmol) and NaIO4 (0.014 g, 0.069 mmol).  A white precipitate formed during the 
course of the reaction.  After 1.5 h, the reaction was filtered and the filtrate concentrated 
to leave the H2O.  An additional 3 mL of H2O was added to the filtrate and the aqueous 
extract was washed 2 times with 5 mL of CH2Cl2.  The combined organic layers were 
washed with satd. 10 mL of satd. NaCl solution and dried with Na2SO4, filtered and the 
filtrate concentrated to afford 69 (0.018 g, 90%; 53%, 2 steps) as a colorless oil/solid:  1H 
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NMR (CDCl3) δ 7.54-7.17 (m, 25H, SePh/ ArH of BOM/Bn), 6.95 (d, 1H, N-H), 5.84 
(dd, 1H, J = 9.4, 5.8 Hz, H1), 4.98 (d, 1H, H4), 5.06-4.63 (m, 10H, O-CH2-Ph-Bn/O-
CH2-O-Bn/O-CH2-Ph-BOM), 4.42 (m, 1H, H3), 4.03 (m, 1H, H5), 3.71 (dd, 1H, H2), 
3.00 (dd, 1H, H6), 2.52 (dd, 1H, H6).  13C NMR (CDCl3) δ 137.22, 132.04, 132.30, 
130.06, 129.25, 128.50, 127.89, 127.56, 93.82, 91.72, 75.82, 75.54, 74.79, 73.91, 72.98, 
69.82, 69.29, 68.11, 53.37, 49.71, 0.98.  19F NMR δ 0.77.  31P NMR δ -1.05.  MS (ES, 
Na+): m/z (relative intensity) calcd for C43H43NO10SePF3Na; found 922.4 (100). 
 









To a stirred solution of 33 (0.42 g, 0.63 mmol) in 12 mL of THF:MeOH (1:1) was 
added 0.5M NaOMe solution (0.07 mL, 1.26 mmol).  After 16 h, the reaction was 
quenched with 0.50 g of Dowex 50W H+ form resin (2.1 meq/mL) and stirred gently for 
15 min.  The mixture was filtered and the filtrate concentrated.  The resulting oil was 
purified by flash column chromatography (hexanes:EtOAc, 1:1) to afford 70 as a 
colorless oil (0.23 g, 66%):  1H NMR (CDCl3) δ 7.73 (d, 2H, NPht), 7.62 (m, 2H, NPht), 
7.51 (m, 2H, SePh), 7.20 (m, 3H, SePh), 5.09 (d, 1H, J = 8.4 Hz, H1), 4.23 (m, 1H, H3), 
4.06 (dd, 1H, J = 10.8, 8.4 Hz, H2), 3.67 (d, 2H, J = 5.6 Hz, -OH), 3.64 (m, 1H, CH2-
octyl), 3.62 (d, 1H, J = 8.9, 2.7 Hz, H4), 3.40 (ddd, 1H, J = 8.9, 3.7 Hz, H5), 3.33 (dd, 
2H, J = 12.9, 2.7 Hz, H6), 3.30 (m, 1H, CH2-octyl), 1.36-1.32 (bs, 2H, CH2-octyl), 1.23-
0.96 (bs, 10H, CH2-octyl), 0.92 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 171.31, 168.42, 
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133.97, 132.06, 131.50, 130.95, 128.92, 126.52, 123.32, 98.01, 75.50, 75.47, 71.77, 
69.59, 60.40, 56.74, 31.58, 29.48, 29.15, 29.05, 25.72, 22.51, 20.96, 14.09, 13.99.  MS 
(ES, Na+): m/z (relative intensity) 584.1 (100). HRMS (M + Na+) calcd for 
C28H35NO6SeNa, 584.1527; found 584.1528. 
 
Octyl 3, 4, -di-O-acetyl-2, 6-dideoxy-6-phenylseleno-2-phthalimido-β-D-








Compound 70 (0.09 g, 0.16 mmol) was dissolved in 0.3 mL of Ac2O and 0.3 mL 
of pyridine.  After 5 h, the reaction was diluted with 25 mL of EtOAc and washed with 
satd. NaHCO3, H2O, and satd. NaCl solutions.  The organic extract was dried with 
Na2SO4, filtered and the filtrate concentrated.  The crude product was purified using a 
short silica gel plug (hexanes:EtOAc, 1:1) to afford 71a (0.10 g, 99%) as a white powder.  
1H NMR (CDCl3) δ 7.90-7.83 (m, 5H, Pht/SePh), 7.79-7.76 (m, 3H, SePh), 7.72 (m, 2H, 
Pht), 5.75 (dd, 1H, J = 10.6, 9.1 Hz, H4), 5.30 (d, 1H, J = 8.5 Hz, H1), 5.05 (m, 1H, H3), 
4.30 (dd, 1H, J= 10.7, 8.6 Hz, H2), 3.87 (m, 1H, H5), 3.73 (m, 1H, CH2-octyl), 3.39 (m, 
1H, CH2-octyl), 3.12-3.08 (dd, 1H, J = 12.9, 8.3 Hz, H6), 3.08-3.04 (m, 1H, H6), 2.00 (s, 
3H, OAc), 1.85 (s, 3H, OAc), 1.40 (bs, 2H, CH2-octyl), 1.24-0.95 (bs, 10H, CH2-octyl), 
0.96 (bs, 3H, CH3).  13C NMR (CDCl3) δ 170.23, 169.74, 134.35, 132.66, 129.14, 127.11, 
123.64, 97.94, 73.79, 73.14, 70.73, 69.99, 54.88, 31.66, 29.32, 29.22, 29.13, 25.80, 22.61, 
20.77, 20.52, 14.07. MS (ES, Na+): m/z (relative intensity) 666.1 (100).  HRMS (M + 




Octyl 3, 4, -di-O-benzyl-2, 6-dideoxy-6-phenylseleno-2-phthalimido-β-D-








To a stirred 0 °C solution of 70 (0.135 g, 0.242 mmol) in 8 mL of THF was added 
NaH (0.023 g, 0.970 mmol).  After 30 min, the reaction had BnBr (0.11 mL, 0.97 mmol) 
and Bu4NI (0.44 g, 1.21 mmol) added to it.  The solution was warmed to room 
temperature.  After 17 h, the reaction was diluted with 40 mL of EtOAc and washed with 
20 mL of satd. NaHCO3, H2O, and satd. NaCl solutions.  The organic extract was dried 
with Na2SO4, filtered and the filtrate concentrated.  The crude product was purified using 
flash column chromatography (hexanes:EtOAc, 5:1) to afford 71b (0.110 g, 63%) as a 
colorless oil:  1H NMR (CDCl3) δ 7.65-7.48 (m, 2H, Pht), 7.32 (m, 2H, Pht), 7.30-7.21 
(m, 10H, Bn), 7.00 (m, 2H, SePh), 6.87 (m, 2H, SePh), 5.09 (d, 1H, J = 8.5 Hz, H1), 4.90 
(d, 1H, J= 11.0, CH2-Bn), 4.79 (d, 1H, J= 12.0, CH2-Bn), 4.65 (d, 1H, J= 11.1, CH2-Bn), 
4.42 (d, 1H, J= 12.0, CH2-Bn), 4.33 (dd, 1H, J = 10.7, 8.6 Hz, H4), 4.15 (dd, 1H, J = 10.7 
8.5, Hz, H4), 3.72 (dd, 1H, J= 9.4, 2.5 Hz, H5), 3.56 (m, 1H, CH2-octyl), 3.56 (m, 1H, 
H2), 3.34-3.30 (m, 2H, H6/CH2-octyl), 3.04 (dd, 1H, J = 12.6, 8.4 Hz, H6), 1.56 (bs, 2H, 
CH2-octyl), 1.14-0.90 (bs, 10H, CH2-octyl), 0.80 (bs, 3H, CH3).  13C NMR (CDCl3) δ 
137.81, 137.70, 132.08, 131.03, 128.95, 128.48, 128.00, 127.93, 127.82, 127.29, 126.59, 
97.99, 83.21, 79.34, 75.16, 74.94, 74.79, 69.55, 56.00, 31.57, 29.62, 29.15, 29.03, 25.72, 
22.51, 13.98.  MS (ES, Na+): m/z (relative intensity) 764.2 (100).  HRMS (M + Na+) 




3, 4, 6-tri-O-Acetyl-2-deoxy-2-(2, 2, 2-trichloroethoxycarbonyl) amido-β-D-







To a stirred solution of (H2NCH2)2 (0.21 mL, 3.44 mmol) and AcOH (0.23 mL, 
4.01 mmol) in 100 mL of THF was added 43 (1.50 g, 2.87 mmol). After 25 h, the 
solution was diluted with 60 mL of H2O and the aqueous extract was washed three times 
with 120 mL of CH2Cl2.  The combined organic extracts were washed with 360 mL of 
0.1M HCl solution, 360 mL of satd. NaHCO3 and satd. NaCl solutions.  The organic 
extract was dried with Na2SO4, filtered, and the filtrate concentrated.  The crude product 
was purified with flash column chromatography (hexanes:EtOAc, 1:1) to afford 76 (1.28 
g, 92 %) as a colorless oil:  1H NMR (CDCl3) δ 5.50 (dd, 1H, J= 9.8 Hz, NH), 5.33-5.26 
(m, 3H, H1/H3/H4), 5.09 (dd, 1H, J = 9.5 Hz, H2), 4.77 (d, 1H, J= 12.0 Hz, CH2-Troc), 
4.62 (s, 1H, CH2-Troc), 4.58 (m, 1H, H5), 4.22-4.19 (m, 2H, H6/H6), 3.98 (m, 1H, OH), 
2.09-1.97 (s, 9H, Ac).  13C NMR (CDCl3) δ 169.92, 154.66, 95.75, 92.06, 74.91, 71.25, 
68.71, 67.89, 62.45, 54.58, 14.54. 
 
Trichloroacetimido 3, 4, 6-tri-O-acetyl-2-deoxy-2-(2, 2, 2-trichloroethoxycarbonyl) 










To a stirred solution of 76 (0.183 g, 3.800 mmol) in 20 mL of CH2Cl2 were added 
CCl3CN (9.50 mL, 95.2 mmol) and K2CO3 (0.79 mg, 5.70 mmol).  After 48 h, the 
reaction was filtered and the filtrate concentrated. The crude product was purified with 
flash column chromatography (hexanes:EtOAc, 1.5:1) to afford 77 (0.22 g, 96%) as a 
colorless oil:  1H NMR (CDCl3) δ 8.83 (s, 1H, NH), 5.79 (d, 1H, J = 3.6 Hz, H1), 5.40-
5.20 (m, 3H, H3, H4, H2), 4.66 (m, 2H, CH2-Troc), 4.31-4.11 (m, 3H, H5, H6, H6) 1.94-
1.78 (m, 9H, OAc).  13C NMR (CDCl3) δ 171.29, 170.75, 169.56, 160.54, 154.55, 109.99, 
95.64, 94.74, 90.95, 78.01, 77.58, 77.15, 74.84, 70.45, 67.87, 61.69, 60.60, 54.04, 21.25, 
20.90, 20.83, 14.46.  MS (ES, Na+): m/z (relative intensity) HRMS (M + Na+) calcd for 
C17H22NO10Cl6Na, 646.9; found 646.9 (100). 
 
(8-Methoxylcarbonyloctyl) 3, 4, 6-tri-O-acetyl-2-deoxy-2-(2, 2, 2-









To a stirred 0°C solution of 77 (0.45 g, 0.72 mmol) in 10 mL of THF, 8-
methoxylcarbonyloctanol (0.13 mL, 0.55 mmol) and 0.45 g of 4Å powdered sieves was 
added freshly distilled TMS-OTf (0.013 mL, 0.072 mmol).  After 1 hr, the reaction was 
quenched with 5 drops of NEt3, filtered and the filtrate concentrated.  The resulting 
residue was dissolved in 40 mL of EtOAc and washed with 40 mL of satd. NaHCO3 and 
satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified with flash column chromatography 
(CHCl3:EtOAc, 7:1) to afford 78 (0.38 g, 92%) as an oil:  1H NMR (CDCl3) δ 5.75 (s, 
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1H, J = 9.0 Hz, H1), 5.24 (m, 1H, H4), 4.98 (m, 1H, H3), 4.70 (d, 1H, J = 11.9 Hz, NH), 
4.60-4.57 (m, 2H, CH2-Troc), 4.22 (m, 1H, H2), 4.04 (m, 1H, H5), 3.79 (m, 1H, H6), 
3.59 (s, 3H, OMe), 3.41 (m, 1H, H6), 2.23 (s, 3H, OAc), 2.20-2.01 (m, 6H, OAc), 1.51 
(bs, 7H, octyl), 1.18 (bs, 9H, octyl).  13C NMR (CDCl3) δ 174.81, 171.15, 170.98, 169.92, 
164.13, 154.60, 101.13, 95.92, 92.44, 74.74, 72.70, 72.46, 71.97, 70.54, 69.25, 63.15, 
62.55, 60.79, 56.55, 51.87, 34.36, 33.01, 29.71, 29.53, 29.39-29.18, 28.56, 26.01, 25.77, 
25.16, 21.39, 21.11, 21.01, 14.52. MS (ES, Na+): m/z (relative intensity) calcd for 
C37H35NO9SeNa, 740.1375; found 672.0 (100). 
 
(8-Methoxylcarbonyloctyl)-2-acetamido-3, 4, 6-tri-O-acetyl-2-deoxy-∃-D-









To a stirred solution of 78 (0.15 g, 0.23 mmol) in 3 mL of AcOH was added Zn 
dust (1.01 g, 15.43 mmol).  After 54 hours, Chelex 100 resin was added and the reaction 
was stirred for 1 h, filtered and the filtrate concentrated.  The resulting oil was dissolved 
in 30 mL of EtOAc and washed with 15 mL of satd. NaHCO3 and NaCl solutions.  The 
organic extract was dried with Na2SO4, filtered and the filtrate concentrated. The crude 
product (0.105 g) was taken on without purification as a colorless oil:  1H NMR (CDCl3) 
δ 7.46 (bs, 3H, NH3), 5.38 (m, 1H, H4), 4.97 (m, 1H, H3), 4.73 (d, 1H, J = 7.7 Hz, H1), 
4.24 (dd, 1H, J = 12.3, 4.5 Hz, H6), 4.09 (s, 1H, CH2-octyl), 4.04 (m, 1H, H6), 3.86-3.68 
(m, 2H, H5/H2), 3.62 (s, 3H, OMe), 2.26 (bs, 6H, OAc), 2.06 (s, 3H, OAc), 1.54 (bs, 
10H, octyl), 1.21 (bs, 5H, octyl).  The free amine (0.105 g, 0.22 mmol) was dissolved in 3 
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mL of dry pyridine and 3 mL of Ac2O.  After 20 h, the reaction was diluted with 25 mL 
of EtOAc and washed with 25 mL of satd. CuSO4, satd. NaHCO3, and satd. NaCl 
solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated. The crude product was purified with flash column chromatography 
(hexanes:EtOAc, 5:1) to afford 79 (0.095 g, 78%, 2 steps) as a colorless oil:  1H NMR 
(CDCl3) δ 5.82 (d, 1H, J = 8.6 Hz, NH), 5.29, (m, 1H, H3), 5.02 (m, 1H, H4), 4.68 (d, 
1H, J = 8.3 Hz, H1), 4.23 (dd, 1H, J = 12.3, 4.7 Hz, H6), 4.12-4.05 (m, 2H, H6, CH2-
octyl), 3.83-3.79 (m, 2H, H5/H2), 3.63 (s, 3H, OMe), 3.42 (m, 1H, CH2-octyl), 2.26 (s, 
3H, OAc). 2.01-1.98 (bs, 10H, OAc), 1.54 (bs, 5H, octyl), 1.22 (bs, 5H, OAc).  13C NMR 
(CDCl3) δ 174, 29, 171.10, 170.74, 170.14, 169.38, 100.58, 72.27, 71.62, 69.78, 68.68, 













To a stirred solution of 79 (0.25 g, 0.48 mmol) in 4 mL of MeOH and 1.5 mL of 
THF was added 1M NaOMe solution (0.48 mmol). After 1.25 h, 1.40 g of Dowex 50W 
H+ form resin (2.1 meq/mL) was added and gently stirred for 20 minutes.  The reaction 
mixture was filtered and the filtrate concentrated.  To a suspension of the resulting triol in 
5 mL of CH3CN were added PhCH(OMe)2 (0.12 mL, 0.82 mmol) and pTsOH (0.001 g, 
0.048 mmol).  After 21 h, the reaction was placed under a gentle vacuum. After 1 hour, 
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the reaction had 25 mg of K2CO3 and was stirred for 0.5 hours.  The mixture was filtered 
and the filtrate concentrated. The crude product was purified with flash column 
chromatography (CH2Cl2:MeOH, 15:1) to afford 80 (0.08 g, 85%, 2 steps) as a colorless 
oil:  1H NMR (CDCl3) δ  7.48 (m, 2H, Ph), 7.35 (m, 3H, Ph), 6.02 (d, 1H, J = 6.5 Hz, N-
H), 5.50 (s, 1H, benzylidene), 4.65 (d, 1H, J = 8.3 Hz, H1), 4.30 (dd, 1H, J = 10.4, 5.0 
Hz, H3), 4.08 (m, 1H, octyl), 3.83 (m, 1H, H6), 3.75 (m, 1H, H4), 3.65 (s, 3H, OMe), 
3.52 (m, 1H, octyl), 3.47-3.42 (m, 3H, H2/H5/H6), 2.29 (s, 3H, OAc), 1.57 (bs, 5H, 
octyl), 1.28 (bs, 9H, octyl).  13C NMR (CDCl3) δ 174.29, 171.75, 137.09, 129.11, 128.21, 
126.30, 101.79, 100.68, 81.63, 71.09, 69.97, 68.58, 66.20, 58.80, 51.43, 33.99, 29.38, 
29.07-28.93, 25.74, 24.80, 23.52. MS (ES, Na+): m/z (relative intensity) HRMS (M + 
Na+) calcd for C25H40NO8Na, 502.1; found 502.1 (100).   
 
(8-Methoxylcarbonyloctyl) 2-acetamido-3-O-(2,3,4,6-tetra-O-acetyl-∃-D-














To a stirred solution of acceptor 80 (0.012 g, 0.026 mmol) in 1.0 mL of 
toluene:CH3NO2 (1:1) were added Hg(CN)2 (0.02 g, 0.078 mmol) and 35 mg of CaSO4.  
Donor 7481 (0.017 g, 0.041 mmol) was dissolved in 1.0 mL toluene:CH3NO2 (1:1) and 
added to the acceptor mixture and the reaction heated to 40 °C.  After 47 h, the reaction 
was cooled and diluted with 15 mL of CH2Cl2 and washed with 15 mL of satd. NaHCO3 
solution, H2O and satd. NaCl solution.  The organic extract was dried with Na2SO4, 
filtered and the filtrate concentrated.  The crude oil was purified using flash column 
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chromatography (CH2Cl2:MeOH, 15:1) to afford 81 (0.015 g, 75%) as a colorless oil:  1H 
NMR (CDCl3) δ 5.80 (d, 1H, J=5.6 Hz, N-H), 5.54 (s, 1H, benzylidene), 5.18 (d, 1H, J = 
8.6 Hz, H1), 4.71 (d, 1H, J = 8.2 Hz, H1’), 3.66 (s, 3H, OMe).  13C NMR (CDCl3) δ 
229.59, 174.29, 171.73, 137.05, 129.16, 128.25, 126.32, 101.91, 100.55, 81.71, 71.15, 
70.00, 68.62, 66.27, 59.28, 51.45, 34.01, 29.42, 29.09, 29.01, 28.95, 25.80, 24.82, 23.62, 
23.62, 20.80, 20.63.  MS (ES, Na+): m/z (relative intensity) 832.3 (100).  HRMS (M + 
Na+) calcd for C40H57NO17Na, 832.3368; found 832.3375. 
 
Octyl 3-O-(2,3,4,6-tetra-O-acetyl-∃-D-galactopyranosyl)-4, 6-O-benzylidene-2-deoxy-












To a stirred solution of acceptor 3247 (0.60 g, 1.22 mmol) and donor 7581 (0.684 g, 
1.34 mmol) in 20 mL of CH2Cl2 at -20 °C were added 1.0 g 3Å molecular sieves and 
freshly distilled TMS-OTf (0.05 mL, 0.304 mmol).  The reaction was allowed to warm to 
0 °C for 3 h and then to room temperature.  After 24 h, the reaction was quenched with 
0.05 mL of NEt3 and filtered.  The filtrate was washed with 20 mL of satd. NaHCO3 and 
satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude oil was purified using flash column chromatography 
(hexanes:EtOAc, 2:1) to afford 82 (0.840 g, 83%) as a colorless foam:  1H NMR (CDCl3) 
δ 7.88 (s, 2H, Pht), 7.77 (s, 2H, Pht), 7.49 (s, 2H, Ph), 7.38 (s, 3H, Ph), 5.58 (s, 1H, 
benzylidene), 5.19 (d, 1H, J = 3.1 Hz, H4’), 5.14 (d, 1H, J = 8.5 Hz, H1), 4.99 (dd, 1H, J 
= 10.3, 8.0 Hz, H2’), 4.76-4.71 (m, 2H, H3/H3’), 4.55 (d, 1H, J = 8.0Hz, H1’), 4.37 (dd, 
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1H, J = 10.5, 4.8 Hz, H4), 4.30 (dd, 1H, J = 10.4, 8.6 Hz, H2), 4.03 (dd, 1H, J = 11.0, 8.3 
Hz, H6’), 3.86 (m, 1H, H6’), 3.82-3.77 (m, 3H, H6/H6/CH2-octyl), 3.63 (m, 1H, H5), 
3.49 (m, 1H, H5’), 3.38 (m, 1H, CH2-octyl), 2.08 (s, 3H, OAc), 2.05 (s, 3H, OAc), 1.98 
(s, 3H, OAc), 1.92 (s, 3H, OAc), 1.26-1.13 (bs, 3H, CH2-octyl), 1.03-0.96 (bs, 9H, CH2-
octyl), 0.82 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 170.23, 170.01, 169.98, 168.82, 
137.05, 134.18, 129.22, 128.31, 126.00, 101.43, 100.48, 98.74, 81.08, 75.69, 70.99, 
70.28, 70.01, 69.19, 68.74, 66.63, 66.31, 60.76, 56.38, 31.60, 29.20, 29.03, 29.01, 25.70, 
22.53, 20.56, 20.49, 20.39, 20.06, 14.15, 13.99. MS (ES, Na+): m/z (relative intensity) 
861.9 (100).  HRMS (M + Na+) calcd for C43H53NO16Na, 862.3262; found 862.3259. 
 
(8-Methoxylcarbonyloctyl) 2-acetamido-3-O-(2,3,4,6-tetra-O-acetyl-∃-D-












To a stirred solution of acceptor 80 (0.011 g, 0.023 mmol) in 0.75 mL of CH2Cl2 
was added 15 mg of 4Å molecular sieves.  Donor 7581 (0.015 g, 0.030 mmol) was 
dissolved in 0.75 mL of CH2Cl2 and added to the acceptor mixture and the reaction 
cooled to 0 °C.  Freshly distilled TMS-OTf (0.005 mL) was added.  After 3 h, the 
reaction was quenched with 0.01 mL NEt3, filtered and the filtrate diluted with 5.0 mL of 
CH2Cl2 and washed with 5 mL of satd. NaHCO3 solution, H2O and satd. NaCl solution.  
The organic extract was dried with Na2SO4, filtered and the filtrate concentrated.  The 
crude oil was purified using flash column chromatography (CH2Cl2:MeOH, 15:1) to 
afford 83 (0.020 g, 81%) as a colorless oil:  1H NMR (CDCl3) δ 7.48 (m, 2H, Pht), 7.34 
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(m, 3H, Ph), 5.82 (d, 1H, J = 7.5 Hz, N-H), 5.75 (d, 1H, J = 4.7 Hz, H1’), 5.50 (s, 1H, 
benzylidene), 5.8 (d, 1H, J = 3.1 Hz, H4’), 5.07 (d, 1H, J = 8.3 Hz, H1), 5.01 (dd, 1H, J = 
6.4, 3.4 Hz, H3’), 4.50 (m, 1H, H3), 4.32 (m, 1H), 4.34 (m, 1H, H5), 4.24 (m, 2H, 
H5’/H2’), 4.06 (m, 2H, H6’/H6’), 3.84 (m, 1H, CH2-Mco), 3.76 (m, 1H, H6), 3.66 (s, 3H, 
OMe), 3.52 (m, 3H, CH2-Mco/H4/H6), 3.11 (m, 1H, H2), 2.10 (s, 3H, OAc), 2.06 (s, 3H, 
OAc), 2.04 (s, 3H, OAc), 2.00 (s, 3H, OAc), 1.97 (s, 3H, NHAc), 1.64 (m, 14H, CH2-
Mco).  13C NMR (CDCl3) δ 172.20, 171.05, 169.91, 164.39, 163.25, 129.26, 128.12, 
126.05, 123.52, 109.75, 104.24, 90.69, 84.26, 70.71, 68.88, 67.50, 66.35, 61.30, 59.46, 
51.43, 33.98, 29.38, 28.47, 25.94, 23.64, 20.66.  MS (ES, Na+): m/z (relative intensity) 
832.3 (100).  HRMS (M + Na+) calcd for C40H57NO17Na, 832.3368; found 832.3389. 
 
Octyl 3-O-(2,3,4,6-tetra-O-acetyl-∃-D-galactopyranosyl)-4-O-benzoyl-6 -











To a stirred solution of 82 (0.70 g, 0.83 mmol) in 35 mL of CCl4 were added NBS 
(0.162 g, 0.916 mmol) and BaCO3 (0.493 mg, 2.449 mmol).  The reaction was heated to 
reflux and after a few minutes turned an orange color.  As the reaction progressed, it 
became white.  After 45 min, the reaction was cooled, filtered and the filtrated 
concentrated.  The crude product was dissolved in 50 mL of CH2Cl2 and washed with 25 
mL of H2O 3 times and once with 25 mL of satd. NaCl solution.  The organic extract was 
dried with Na2SO4, filtered and the filtrate concentrated to yield the bromide (0.75 g) as a 
white powder and taken on without any purification:  1H NMR (CDCl3) δ 8.04 (m, 2H, 
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Bz), 7.85 (d, 2H, NPht), 7.77 (m, 2H, NPht), 7.57 (m, 2H, Bz), 7.44 (m, 3H, Bz), 5.14 
(m, 1H, H3), 5.11 (d, 1H, J = 8.5 Hz, H1), 4.97 (d, 1H, J = 4.2 Hz, H4’), 4.83 (dd, 1H, J = 
10.5, 3.7 Hz, H3’), 4.54 (dd, 1H, J = 10.5, 3.5 Hz, H2’), 4.32 (m, 1H, H5’), 4.18 (d, 1H, J 
= 7.8 Hz, H1’), 4.09 (dd, 1H, J = 4.1 Hz, H2), 3.94 (m, 1H, H4), 3.77 (m, 1H, CH2-octyl), 
3.53 (m, 2H, H6’/H6’), 3.49-3.31 (m, 4H, H5/H6/H6/ CH2-octyl), 2.09-1.75 (s, 12H, 
OAc), 1.41 (bs, 3H, CH2-octyl), 1.14-0.98 (bs, 9H, CH2-octyl), 0.80 (t, 3H, CH3-octyl).  
13C NMR (CDCl3) δ 169.92, 168.88, 164.58, 134.40, 133.32, 131.32, 129.91, 129.68, 
128.25, 123.44, 100.09, 97.84, 74.64, 73.68, 72.43, 71.05, 70.65, 70.13, 66.77, 68.76, 
66.09, 60.03, 55.54, 53.30, 31.46, 31.15, 28.99, 28.89, 25.58, 22.40, 20.22, 13.87.  MS 
(ES, Na+): m/z (relative intensity) calcd for C43H52NO16BrNa, 940.2; found 940.2 (100).  
To a stirred solution of the bromide (0.75 g, 0.816 mmol) in 30 mL of THF were added 
NEt3 (0.37 mL, 2.692), PhSeH (0.24 mL, 2.448 mmol) and Bu4NI (0.075 g, 0.204 mmol).  
The reaction was brought to reflux at 65 °C.  After 16 h, the reaction was cooled and 
diluted to 100 mL of CH2Cl2 and washed with 100 mL of satd. NaHCO3, H2O and satd. 
NaCl solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The resulting yellow oil was purified using flash column chromatography 
(hexanes:EtOAc, 2:1) to afford 84 (0.70 g, 82%, 2 steps) as a colorless oil:  1H NMR 
(CDCl3) δ 8.03 (m, 2H, Bz), 7.87 (d, 2H, NPht), 7.79 (m, 2H, NPht), 7.58 (m, 2H, Bz), 
7.46 (m, 4H, Bz/SePh), 7.19 (m, 2H, SePh), 5.23 (m, 1H, H3’), 5.07 (d, 1H, J = 8.5 Hz, 
H1), 5.00 (d, 1H, J = 2.9 Hz, H4’), 4.86 (dd, 1H, J = 10.3, 7.8 Hz, H2’), 4.79 (dd, 1H, J = 
10.7, 8.9 Hz, H3), 4.56 (m, 1H, H5’), 4.34 (dd, 1H, J = 10.7, 8.5 Hz, H2), 4.09 (d, 1H, J = 
7.8 Hz, H1’), 3.94 (m, 1H, H4), 3.72 (m, 2H, H6’/H6’), 3.52 (m, 1H, H5), 3.44 (m, 1H, 
H6), 3.33 (m, 2H, CH2-octyl), 3.13 (m, 1H, H6), 2.08 (s, 3H, OAc), 2.04 (s, 3H, OAc), 
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1.95 (s, 3H, OAc), 1.87 (s, 3H, OAc), 1.27-1.17 (bs, 3H, CH2-octyl), 1.06-1.00 (bs, 9H, 
CH2-octyl), 0.83 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 170.12, 170.04, 169.97, 
169.00, 164.76, 134.49, 133.32, 132.19, 129.74, 128.99, 128.32, 126.79, 123.52, 100.23, 
97.91, 74.97, 74.21, 70.81, 70.13, 69.65, 68.84, 66.18, 60.08, 55.74, 31.61, 29.05, 25.73, 
22.56, 20.58, 20.36, 20.29, 14.03.  MS (ES, Na+): m/z (relative intensity) 1018.2 (100). 
HRMS (M + Na+) calcd for C49H57NO16SeNa, 1018.2740; found 1018.2745. 
 
Octyl 2-acetamido-3-O-(2,3,4,6-tetra-O-acetyl-∃-D-galactopyranosyl)- 4-O-acetyl-6 -











To a stirred solution of 84 (0.045 mg, 0.045 mmol) in 1.0 mL of EtOH in a 
Schlenk tube was added H2NNH2·H2O (0.19 mL, 4.070 mmol).  The reaction was placed 
under a gentle vacuum, the tube sealed and heated to 100 °C.  After 18.5 h, the reaction 
was cooled, the tube opened and the reaction mixture concentrated and placed under 
vacuum for 6 h to afford the free amino alcohol (0.026 g) as a colorless oil.  The product 
was taken on to the next step without any purification.  The resulting free amino alcohol 
(0.026 g, 0.045 mmol) was dissolved in 3.0 mL of pyridine and 3.0 mL of Ac2O.  After 
20.5 h, the reaction was diluted with 10 mL of EtOAc and washed with 10 mL of satd. 
CuSO4, H2O, satd. NaHCO3, and satd. NaCl solutions.  The organic extract was dried 
with Na2SO4, filtered and the filtrate concentrated.  The resulting light yellow oil was 
purified using flash column chromatography (hexanes:EtOAc, 1:4) to afford 85 (0.030 g, 
78%, 2 steps) as a colorless oil/solid:  1H NMR (CDCl3) δ 7.48 (m, 3H, SePh), 7.26 (m, 
117 
 
2H, SePh), 5.89 (d, 1H, J = 7.1 Hz, NH), 5.33 (d, 1H, J = 2.5 Hz, H4’), 5.04 (dd, 1H, J = 
10.1 Hz, H2’), 4.96-4.90 (m, 2H, H3’/H1), 4.80 (dd, 1H, J = 9.1 Hz, H3), 4.55-4.48 (m, 
3H, H1’/H4/H5’), 3.86 (dd, 1H, J = 12.9, 6.4 Hz, H6’), 3.66 (dd, 1H, J = 8.9, 6.1 Hz, 
H6’), 3.74 (m, 1H, H2), 3.42 (m, 1H, CH2-octyl), 3.12 (m, 1H, CH2-octyl), 3.03-2.97 (m, 
3H, H5/H6/H6), 2.16 (s, 3H, OAc), 2.13 (bs, 15H, OAc/NHAc), 1.52 (bs, 3H, CH2-
octyl), 1.25 (bs, 9H, CH2-octyl), 0.86 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 175.13, 
171.13, 170.88, 170.39, 170.18, 170.11, 169.67, 169.01, 132.57, 129.01, 126.91, 100.53, 
98.78, 73.73, 73.04, 71.06, 70.54, 69.87, 69.39, 66.92, 61.05, 60.36, 58.39, 31.79, 29.50, 
29.44, 29.29, 25.89, 23.57, 22.61, 20.99, 20.89, 20.77, 20.60, 20.49, 14.15.  MS (ES, 
Na+): m/z (relative intensity) 868.2 (100). HRMS (M + Na+) calcd for C38H55NO17SeNa, 
868.2635; found 868.2645.   
 








To a stirred solution of compound 8647 (0.150 g, 0.356 mmol) in 1.5 mL of DMF 
were added imidazole (0.072 g, 1.068 mmol) and TBS-Cl (0.067 g, 0.445 mmol).  After 
39 h, the reaction was diluted with 10 mL of EtOAc and washed with 10 mL of H2O and 
saturated NaCl solution.  The organic extract was dried with Na2SO4, filtered and the 
filtrate concentrated.  The crude product was purified using a short silica gel plug 
(EtOAc) to afford 87 (0.140 g, 74%) as a colorless oil.  1H NMR (CDCl3) δ 7.82 (m, 2H, 
Pht), 7.69 (m, 2H, Pht), 5.17 (d, 1H, J = 8.4 Hz, H1), 4.32 (dd, 1H, J = 8.1 Hz, H4), 4.08 
(dd, 1H, J= 8.5, 3.5 Hz, H2), 3.97 (dd, 1H, J = 10.3, 5.0 Hz, H3), 3.87 (m, 1H, H5), 3.75 
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(m, 1H, -CH2-octyl), 3.73 (bs, 1H, -OH), 3.59 (m, 1H, H6), 3.51 (m, 1H, H6), 3.37 (m, 
1H, -CH2-octyl), 2.89 (d, 1H, J = 3.6 Hz, -OH), 1.23 (bs, 2H, CH2-octyl), 1.16-1.00 (bs, 
13H, CH2-octyl), 0.98-0.78 (s, 12H, tBu, CH3-octyl), 0.07 (s, 6H, Me).  13C NMR 
(CDCl3) δ 168.28, 134.63, 133.33, 131.74, 123.96, 122.62, 98.78, 97.51, 75.81, 74.66, 
74.14, 73.00, 72.17, 71.04, 69.64, 65.06, 56.70, 55.56, 30.25, 29.25, 28.23, 26.32, 25.32, 
22.55, 21.52, 18.18, 14.50, 13.51, -5.04, -5.99. MS (ES, Na+): m/z (relative intensity) 
558.2 (100).  HRMS (M + Na+) calcd for C28H45NO7Na, 558.2863; found 558.2869. 
 
(8-Methoxylcarbonyloctyl)-2-acetamido-3-O-acetyl-4, 6-O-benzylidene-2-deoxy-∃-D-









Compound 80 (0.018 g, 0.370 mmol) was dissolved in pyridine (1.00 mL, 0.77 
mmol) and Ac2O (1.00 mL, 1.10 mmol).  After 27 h, the reaction was diluted with 5 mL 
of EtOAc and washed with 5 mL of satd. CuSO4, H2O, satd. NaHCO3 and satd. NaCl 
solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The resulting white oil/solid 88a (0.016 g, 84%) was taken on without any 
purification:  1H NMR (CDCl3) δ 7.43 (m, 2H, Ph), 7.34 (m, 3H, Ph), 5.74 (d, 1H, J = 9.3 
Hz, NH), 5.50 (s, 1H, benzylidene), 5.27 (m, 1H, H4), 4.50 (d, 1H, J = 8.3 Hz, H1), 4.33 
(dd, 1H, J = 10.5, 4.9 Hz, H3), 4.08 (m, 1H, H2), 3.81 (m, 2H, H5/CH2-octyl), 3.69 (m, 
1H, CH2-octyl), 3.67 (s, 3H, OMe), 3.52 (dd, 1H, J = 9.8, 4.9 Hz, H6), 3.39 (dd, 1H, J = 
6.8, 2.8 Hz, H6), 2.07 (s, 3H, OAc), 1.95 (s, 3H, OAc), 1.59 (bs, 5H, CH2-octyl), 1.28 
(bs, 10H, CH2-octyl). 13C NMR (CDCl3) δ 229.59, 174.27, 171.24, 170.00, 136.97, 
129.05, 128.19, 126.08, 102.00, 101.36, 78.71, 71.87, 69.95, 66.38, 54.70, 51.42, 34.02, 
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29.36, 29.36, 29.09, 29.00, 28.96, 25.67, 24.84, 23.27, 20.88.  MS (ES, Na+): m/z 
(relative intensity) 544.2 (100).  HRMS (M + Na+) calcd for C27H39NO9Na, 544.2523, 
found; 544.2535. 
 
Octyl 3-O-Acetyl-4, 6-O-benzylidene-2-deoxy-2-phthalimido-β-D-glucopyranoside 







Compound 3247 (2.25 g, 2.45 mmol) was dissolved in 10 mL of Ac2O and 10 mL 
of pyridine.  After 19 h, the reaction was diluted to 75 mL of EtOAc and washed with 50 
mL of satd. CuSO4, H2O, satd. NaHCO3, and satd. NaCl solutions.  The organic extract 
was dried with Na2SO4, filtered and the filtrate concentrated.  The crude product was 
purified by flash column chromatography (hexanes:EtOAc, 3:1) to afford 88b (1.12 g, 
83%) as a colorless oil:  1H NMR (CDCl3) δ 7.81 (bs, 2H, NPht), 7.66 (bs, 2H, NPht), 
7.43 (bs, 2H, Ph), 7.30 (bs, 3H, Ph), 5.89 (d, 1H, J = 9.8 Hz, H4), 5.51 (s, 1H, 
benzylidene), 5.43 (d, 1H, J = 8.4 Hz, H1), 4.37 (d, 1H, J = 10.2, 4.1 Hz, H3), 4.29 (dd, 
1H, J = 9.1 Hz, H2), 3.83-3.74 (m, 3H, H6/H6/H5), 3.71 (m, 1H, CH2-octyl), 3.42 (m, 
1H, CH2-octyl), 2.04 (s, 3H, OAc), 1.93 (s, 3H, NHAc), 1.58-1.55 (bs, 2H, CH2-octyl), 
1.28-1.21 (bs, 10H, CH2-octyl), 0.85 (s, 3H, CH3-octyl).  13C NMR (CDCl3) δ 170.03, 
136.99, 134.28, 134.14, 128.14, 126.22, 123.44, 101.49, 98.65, 79.28, 77.50, 77.25, 
76.99, 70.13, 69.76, 68.59, 66.18, 55.39, 31.55, 29.19, 29.14, 29.10, 29.01, 25.70, 22.50, 
20.47, 14.01.  MS (ES, Na+): m/z (relative intensity) 574.2 (100).  HRMS (M + Na+) 














To a stirred solution of 88a (0.022g, 0.042 mmol) in 1.0 mL of THF:CH2Cl2 (1:1) 
were added 0.02 g of 3Å molecular sieves and NaCNBH3 (23mg, 0.379 mmol).  Freshly 
prepared HCl (g) in ether was added at 0 °C until no gas was evolved.  After 5 h, the 
reaction was filtered and the filtrate diluted to 10 mL of CH2Cl2 and washed with 10 mL 
of H2O, satd. NaHCO3, and satd. NaCl solutions.  The organic extract was dried with 
Na2SO4, filtered and the filtrate concentrated.  The crude product was purified using 
preparatory thin layer chromatography (CH2Cl2:MeOH, 15:1) to afford 89 (0.004 g, 25%) 
as a colorless oil:  1H NMR (CDCl3) δ 7.33 (m, 5H, Ph), 5.52 (d, 1H, J = 9.1 Hz, NH), 
5.05 (dd, 1H, J = 10.5, 9.1 Hz, H3), 4.59 (q, 2H, J = 11.9 Hz, CH2-Ph), 4.48 (d, 1H, J = 
8.3 Hz, H1), 3.89 (m, 1H, H2), 3.82 (m, 2H. H5/CH2-octyl), 3.76 (m, 2H, H4/CH2-octyl), 
3.66 (s, 3H, OMe), 3.53 (m, 1H, H6), 3.42 (m, 1H, H6), 2.30 (d, 1H, J = 3.0 Hz, -OH), 
2.30 (bs, 2H, CH2-octyl), 2.10 (s, 3H, OAc), 1.93 (s, 3H, OAc), 1.58 (bs, 5H, CH2-octyl), 
1.27 (bs, 10H, CH2-octyl).  13C NMR (CDCl3) δ 174.29, 171.88, 169.99, 137.50, 128.50, 
127.90, 127.74, 101.12, 75.40, 73.81, 73.77, 71.17, 70.64, 69.53, 54.70, 51.11, 51.43, 
34.03, 29.39, 29.11, 29.03, 28.98, 25.75, 24.85, 23.33, 20.92. MS (ES, Na+): m/z (relative 
















To a stirred 0 °C solution of 88a (0.01 g, 0.06 mmol) in 0.25 mL of CH2Cl2 were 
added dropwise TES (0.0091 mL, 0.113 mmol) followed by drop wise addition of TFA 
(0.0087 mL, 0.114 mmol).  The reaction was allowed to stir overnight at 4 °C.  After 30 
h, the reaction was filtered and the filtrate diluted to 5 mL of CH2Cl2.  The filtrate had 5 
mL of satd. NaHCO3 solution slowly added to neutralize the TFA.  The aqueous extract 
was washed with 5 mL of CH2Cl2 and the combined organic extracts washed with sat 
NaCl solution.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified using preparatory thin layer 
chromatography (CH2Cl2:MeOH, 15:1) to afford 89 (0.005 g, 50%) as a colorless oil with 
identical 1H NMR, 13C NMR and mass spectrum data as identical to those reported for 89 










Compound 88b (1.10 g, 1.99 mmol) was suspended in 50 mL of AcOH:H2O (1:1) 
and heated to 100 °C.  After 4.5 h, the reaction was cooled and concentrated.  The crude 
product was diluted in 75 mL of EtOAc and washed with 50 mL of satd. NaHCO3 and 
satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated to afford the diol (0.89 g) as a colorless oil and taken on without any 
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purification.  To a stirred solution of the crude diol (0.10 g, 0.22 mmol) in 2.0 mL of 
DMF were added TBS-Cl (0.040 g, 0.269 mmol) and imidazole (0.044mg, 0.645 mmol).  
After 20 h, the DMF was concentrated.  The crude product was diluted to 20 mL of 
EtOAc and washed with 10 mL of H2O, and satd. NaCl solution.  The organic extract was 
dried with Na2SO4, filtered and the filtrate concentrated.  The crude product was purified 
using a short silica gel plug (EtOAc) to afford 90 (0.105 g, 81%, 2 steps) as a colorless 
oil:  1H NMR (CDCl3) δ 7.86 (bs, 2H, NPht), 7.74 (bs, 2H, NPht), 5.65 (d, 1H, J = 10.6, 
8.9 Hz, H4), 5.35 (d, 1H, J = 8.5 Hz, H1), 4.21 (dd, 1H, J = 10.6, 8.5 Hz, H3), 3.97-3.83 
(m, 2H, H5/H2), 3.78 (m, 2H, H6/H6), 3.61 (m, 1H, CH2-octyl), 3.42 (m, 1H, CH2-octyl), 
2.94 (d, J = 4.9 Hz, OH), 2.04 (s, 3H, OAc), 1.93 (s, 3H, NHAc), 1.58-1.55 (bs, 2H, CH2-
octyl), 1.28-1.21 (bs, 10H, CH2-octyl), 0.85 (s, 3H, CH3-octyl).  13C NMR (CDCl3) δ 
171.40, 170.32, 168.18, 167.78, 134.18, 134.11, 133.87, 131.37, 123.47, 123.41, 123.30, 
98.09, 97.46, 76.23, 75.37, 73.77, 70.30, 70.07, 69.25, 69.04, 60.35, 55.42, 31.60, 29.29, 
29.09, 25.87, 25.60, 22.52, 20.66, 17.94, 14.13.  MS (ES, Na+): m/z (relative intensity) 
calcd for C30H47NO8Na, 512.3; found 512.3 (100). 
 
Octyl 4-O-(2,3,4,6-tetra-O-acetyl-∃-D-galactopyranosyl)-2-acetamido-3-O-acetyl-6-











To a stirred solution of acceptor 9173 (0.028 g, 0.057 mmol) and donor 7581 (0.03 
g, 0.06 mmol) in 3 mL of CH2Cl2 was added 0.10 g 3Å molecular sieves.  The reaction 
was cooled to -30°C and freshly distilled TMS-OTf (0.002 mL, 0.045 mmol) was added 
123 
 
and the reaction allowed to warm to room temperature.  After 24 h, the reaction was 
quenched with 2 drops of NEt3, filtered and diluted to 20 mL of CH2Cl2.  The filtrate was 
washed with 20 mL of satd. NaHCO3 and satd. NaCl solutions.  The organic extract was 
dried with Na2SO4, filtered and the filtrate concentrated.  The crude oil was purified using 
flash column chromatography (hexanes:EtOAc, 2:1) to afford 93 (0.017 g, 37%) as a 
colorless oil/solid:  1H NMR (CDCl3) δ 5. 74 (bs, 1H, N-H), 5.47-5.39 (m, 2H, H4’/H1), 
4.99-4.92 (m, 3H, H2’/H3/H3’), 4.38-4.30 (m, 3H, H1’/H4/H2), 4.18-4.08 (m, 2H, 
H6’/H6’), 3.85-3.73 (m, 3H, H6/H6/CH2-octyl), 3.51-3.41 (m, 3H, H5/H5’/CH2-octyl), 
2.13-1.95 (s, 18H, NHAc/OAc), 1.23 (bs, 3H, CH2-octyl), 1.03-0.92 (bs, 9H, CH2-octyl), 
0.82 (t, 3H, CH3-octyl).  MS (ES, Na+): m/z (relative intensity) HRMS (M + Na+) calcd 
for C47H65NO16Na, 842.3; found 842.3 (100).  
 
Octyl 4-O-(2,3,4,6-tetra-O-acetyl-∃-D-galactopyranosyl)-3, 6-di-O-acetyl-2-deoxy-2-











To a stirred solution of acceptor 87 (0.01 g, 0.018 mmol) and donor 7581 (0.05 g, 
0.10 mmol) in 6.0 mL of CH2Cl2 was added 0.06 g, of 3Å powdered molecular sieves and 
the mixture heated to reflux.  After 1h, the reaction was cooled to -50 °C and BF3·OEt2 
(0.0012 mL, 0.010 mmol) was added. After 1.5h, the reaction was quenched with 2 drops 
of NEt3, the reaction solution was filtered and the filtrate concentrated. The resulting oil 
was diluted with 5mL of EtOAc and washed with 5mL of satd. NaHCO3 and satd. NaCl 
solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
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concentrated.  The crude oil was purified using preparative thin layer chromatography 
(hexanes:EtOAc, 1:1) to afford a partially deprotected disaccharide with complete loss of 
TBS group and partial loss of OAc groups (0.01 g) as a colorless oil.  The resulting crude 
product was dissolved in 0.5 mL of pyridine and 0.5 mL of Ac2O.  After 20 h, the 
reaction was diluted with 5.0 mL EtOAc and washed with 5.0 mL of satd. CuSO4, satd. 
NaHCO3, H2O, and satd. NaCl solutions.  The organic extract was dried with Na2SO4, 
filtered and the filtrate concentrated.  The crude oil was purified using preparative thin 
layer chromatography (hexanes:EtOAc, 1:1) to afford 94 (0.008 g, 55%, 2 steps) as a 
colorless oil:  1H NMR (CDCl3) δ 7.80 (bs, 2H, Pht), 7.76 (s, 2H, Pht), 5.22 (d, 1H, J = 
3.7 Hz, H4’), 5.20 (d, 1H, J = 9.0 Hz, H1), 5.17 (dd, 1H, J = 9.8 Hz, H2’), 5.15 (d, 1H, J 
= 8.5 Hz, H1’), 5.10 (dd, 1H, J = 9.2, 3.2 Hz, H5’), 5.03 (dd, 1H, J = 10.7, 3.8 Hz, H3’), 
4.71 (dd, 1H, J = 10.6, 9.1 Hz, H3), 4.33 (dd, 1H, J = 10.5, 8.6 Hz, H2), 4.21 (dd, 1H, J = 
12.3, 4.9 Hz, H6’), 4.10 (dd, 1H, J = 12.3, 2.6 Hz, H6’), 3.78 (m, 1H, CH2-octyl), 3.74-
3.69 (m, 3H, H4/H5/H6), 3.40-3.33 (m, 2H, CH2-octyl/H6), 2.15-2.00 (bs, 12H, OAc), 
1.91 (bs, 3H, OAc), 1.81 (bs, 3H, OAc), 1.37-1.30 (bs, 12H, CH2-octyl), 0.89 (t, 3H, 
CH2-octyl).  13C NMR (CDCl3) δ 171.00, 170.73, 169.73, 169.53, 169.42, 134.36, 
131.41, 98.11, 96.44, 74.42, 71.92, 69.95, 67.43, 67.13, 66.77, 66.59, 62.26, 55.36, 31.62, 
29.18, 29.04, 25.76, 22.55, 20.88, 20.78, 20.49, 14.00, -0.03. MS (ES, Na+): m/z (relative 

















To a stirred solution of donor 7581 (0.15 g, 0.304 mmol) and acceptor 87 (0.10 g, 
0.19 mmol) in 20 mL of CH2Cl2 was added 0.25 g 3Å molecular sieves.  The reaction 
was refluxed for 1h and then cooled to -50°C and freshly distilled TMS-OTf (0.0099 mL, 
0.045 mmol) was added.  After 20 min, the reaction was quenched with 0.1 mL of NEt3 
and filtered.  The filtrate was washed with 20 mL of satd. NaHCO3 and satd. NaCl 
solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude oil was purified using flash column chromatography 
(hexanes:EtOAc, 2:1) to afford a disaccharide, with partial deprotection of acetates, as a 
colorless oil/solid (0.10g):  MS (ES, Na+): m/z (relative intensity) 846.2 (100).  The 
partially deprotected glycoside (0.59 g, 0.682 mmol) was dissolved in 10 mL of pyridine 
and 10 mL of Ac2O.  After 20 h, the reaction was diluted to 50 mL of EtOAc and washed 
with 50 mL of satd. CuSO4, H2O, satd. NaHCO3 and satd. NaCl solutions.  The organic 
extract was dried with Na2SO4, filtered and the filtrate concentrated.  The crude oil was 
purified using flash column chromatography (hexanes:EtOAc, 2:1) to afford 95 (0.21 g, 
36%; 22%, 2 steps) as a colorless oil/solid:  1H NMR (CDCl3) δ 7.79 (bs, 2H, Pht), 7.69 
(s, 2H, Pht), 5.67 (dd, 1H, J = 10.7, 9.0 Hz, H3’), 5.31 (d, 1H, J =3.1 Hz, H4’), 5.26 (d, 
1H, J = 8.4 Hz, H1), 5.07 (dd, 1H, J = 10.3, 8.0 Hz, H2’), 4.91 (dd, 1H, J = 10.4, 3.5 Hz, 
H3), 4.69 (d, 1H, J = 7.9 Hz, H1’), 4.13-4.02 (m, 4H, H4/H2/H6/H6), 3.94-3.89 (m, 2H, 
H6’/H6’), 3.84 (m, 1H, H2), 3.81 (m, 1H, H5’), 3.71 (m, 1H, CH2-octyl), 3.47 (m, 1H, 
Hz, H5), 3.36 (m, 1H, CH2-octyl), 2.13-1.86 (s, 18H, NHAc, OAc), 1.67 (bs, 2H, CH2-
octyl), 1.24-1.00 (bs, 12H, CH2-octyl), 0.87 (s, 12H, tBu, CH3-octyl), 0.06 (s, 6H, Me).  
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13C NMR (CDCl3) δ 171.08, 170.30, 170.17, 170.08, 170.05, 168.85, 167.93, 167.93, 
167.57, 134.11, 133.94, 131.33, 123.38, 100.32, 97.61, 75.13, 75.08, 71.10, 70.96, 70.49, 
69.40, 69.13, 68.67, 66.79, 66.35, 61.02, 60.95, 60.31, 54.99, 31.57, 29.23, 29.04, 25.84, 
25.79, 22.50, 20.96, 20.66, 20.57, 20.49, 18.24, 14.11, 13.97, -4.97, -5.33. MS (ES, Na+): 
m/z (relative intensity) 930.3 (100). HRMS (M + Na+) calcd for C38H65NO17SiNa, 
930.3919; found 930.3926. 
 
Octyl 3, 4, -di-O-acetyl-6-O-t-butyldimethylsilyl-2-deoxy-2-phthalimido-β-D-








Compound 87 (0.03 g, 0.06 mmol) was dissolved in Ac2O (1.00 mL) and pyridine 
(1.00 mL).  After 11 h, the reaction was diluted with 10 mL of EtOAc and washed with 
10 mL of satd. CuSO4, H2O, satd. NaHCO3, and satd. NaCl solutions.  The organic 
extract was dried with Na2SO4, filtered and the filtrate concentrated.  The crude product 
was purified using a short silica gel plug (hexanes:EtOAc, 1:1) to afford 96 (0.034 g, 
100%) as a colorless oil:  1H NMR (CDCl3) δ 7.83 (m, 2H, Pht), 7.71 (m, 2H, Pht), 5.77 
(dd, 1H, J = 10.8, 9.0 Hz, H4), 5.29 (d, 1H, J = 8.4 Hz, H1), 5.05 (m, 1H, H3), 4.24 (dd, 
1H, J= 10.7, 8.4 Hz, H2), 3.79 (m, 1H, CH2-octyl), 3.72 (m, 2H, H6/H6), 3.67 (m, 1H, 
H5), 3.40 (m, 1H, CH2-octyl), 2.01 (s, 3H, OAc), 1.88 (s, 3H, OAc), 1.23 (bs, 2H, CH2-
octyl), 1.16-1.01 (bs, 13H, CH2-octyl), 0.96-0.79 (s, 12H, tBu, CH3-octyl), 0.06 (s, 6H, 
Me).  13C NMR (CDCl3) δ 170.29, 169.46, 134.82, 133.51, 131.44, 124.15, 122.79, 
98.48, 75.28, 74.13, 71.73, 69.16, 62.67, 55.37, 30.21, 29.22, 28.22, 26.34, 25.78, 25.34, 
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21.26, 21.03, 20.23, 19.99, 13.52, -4.88, -5.82. MS (ES, Na+): m/z (relative intensity) 
642.3 (100).  HRMS (M + Na+) calcd for C32H49NO9Na, 642.3074; found 642.3074. 
 








To a stirred 0 °C solution of compound 96 in 1.00 mL of CH3CN and pyridine 
(0.30 mL) was added HF·pyridine (0.30 mL).  The reaction was allowed to warm to room 
temperature.  After 4.5 h, the reaction was diluted to 5 mL of EtOAc and washed with 5 
mL of satd. CuSO4, H2O, satd. NaHCO3 and satd. NaCl solutions.  The organic extract 
was dried with Na2SO4, filtered and the filtrate concentrated.  The crude product was 
purified using preparative thin layer chromatography (hexanes:EtOAc, 1:2) to afford 97 
(0.025 g, 92%) as a colorless oil:  1H NMR (CDCl3) δ 7.84 (m, 2H, Pht), 7.71 (m, 2H, 
Pht), 5.82 (dd, 1H, J = 10.6, 9.2 Hz, H4), 5.36 (d, 1H, J = 8.5 Hz, H1), 5.09 (m, 1H, H3), 
4.27 (dd, 1H, J= 10.7, 8.5 Hz, H2), 3.85-3.76 (m, 2H, H5/OH), 3.70-3.62 (m, 3H, CH2-
octyl/H6/H6), 3.41 (m, 1H, CH2-octyl), 2.11 (s, 3H, OAc), 1.92 (s, 3H, OAc), 1.37 (bs, 
2H, CH2-octyl), 1.11-0.99 (bs, 10H, CH2-octyl), 0.81 (bs, 3H, CH3).  13C NMR (CDCl3) δ 
170.18, 134.30, 131.43, 123.60, 98.20, 74.07, 70.66, 70.13, 69.42, 61.49, 54.84, 31.69, 
29.20, 25.81, 22.65, 22.53, 20.75, 20.45, 14.08. MS (ES, Na+): m/z (relative intensity) 
528.2 (100).  HRMS (M + Na+) calcd for C26H35NO9Na, 528.2210; found 528.2224. 
 
Octyl 3, 4, -di-O-acetyl-2, 6-dideoxy-6-phenylseleno-2-phthalimido-β-D-










To a stirred -20 °C solution of 97 (0.025 g, 0.049 mmol) in 0.01 mL of CH2Cl2 at 
were added N-PSP (0.029 g, 0.098 mmol) and PBu3 (0.024 mL, 0.098 mmol).  The 
solution was warmed to 0 °C and the temperature maintained.  After 24 h, the reaction 
was diluted with 3 mL of CH2Cl2 and washed with satd. NaHCO3, H2O, and satd. NaCl 
solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified using preparative thin layer 
chromatography (hexanes:EtOAc, 2:1) to afford 98 (0.019 g, 60%) as a white powder:  
1H NMR (CDCl3) δ 7.90-7.83 (m, 5H, Pht/SePh), 7.79-7.76 (m, 3H, SePh), 7.72 (m, 2H, 
Pht), 5.75 (dd, 1H, J = 10.6, 9.1 Hz, H4), 5.30 (d, 1H, J = 8.5 Hz, H1), 5.05 (m, 1H, H3), 
4.30 (dd, 1H, J= 10.7, 8.6 Hz, H2), 3.87 (m, 1H, H5), 3.73 (m, 1H, CH2-octyl), 3.39 (m, 
1H, CH2-octyl), 3.12-3.08 (dd, 1H, J = 12.9, 8.3 Hz, H6), 3.08-3.04 (m, 1H, H6), 2.00 (s, 
3H, OAc), 1.85 (s, 3H, OAc), 1.40 (bs, 2H, CH2-octyl), 1.24-0.95 (bs, 10H, CH2-octyl), 
0.96 (bs, 3H, CH3).  13C NMR (CDCl3) δ 170.23, 169.74, 134.35, 132.66, 129.14, 127.11, 
123.64, 97.94, 73.79, 73.14, 70.73, 69.99, 54.88, 31.66, 29.32, 29.22, 29.13, 25.80, 22.61, 
20.77, 20.52, 14.07. MS (ES, Na+): m/z (relative intensity) 666.1 (100).  HRMS (M + 
Na+) calcd for C32H39NO8Na, 668.1739; found 668.1740. 
 
Octyl 4-O-(2,3,4,6-tetra-O-acetyl-∃-D-galactopyranosyl)-3-O-acetyl-2-deoxy-2-













To a stirred 0 °C solution of 95 (0.22 g, 0.24 mmol) in 8.0 mL of CH3CN and 
pyridine (1.0 mL) in a Nalgene bottle was added 1.0 mL HF·pyridine.  The reaction was 
allowed to warm to room temperature.  After 2.5 h, the reaction was diluted to 25 mL of 
CH2Cl2 and washed with 25 mL of satd. CuSO4, H2O, satd. NaHCO3, and satd. NaCl 
solutions.  The organic extract was dried with Na2SO4, filtered and the filtrated 
concentrated. The crude oil was purified using a short silica gel plug (EtOAc) to afford 
99 (0.177 g, 92%) as a colorless oil:  1H NMR (CDCl3) δ 7.80 (bs, 2H, Pht), 7.76 (s, 2H, 
Pht), 5.47 (m, 1H, H3’), 5.36 (d, J = 8.3 Hz, H1), 5.32 (d, 1H, H4’), 5.28 (m, 2H, 
H3/H2’), 5.11 (m, 1H, H3), 4.99 (m, 1H, H4), 4.66 (d, 1H, J = 7.7 Hz, H1’), 4.16 (dd, 
1H, J = 10.0 Hz, H2), 4.10-3.98 (m, 3H, H6/H6/CH2-octyl), 3.94-3.88 (m, 2H, H6’/H6’), 
3.78 (m, 2H, H5/H5’), 3.58 (m, 1H, CH2-octyl), 3.40 (d, 1H, J = 8.0 Hz, -OH), 2.12-1.89 
(s, 18H, NHAc, OAc), 1.67 (bs, 2H, CH2-octyl), 1.24-1.12 (m, 10H, CH2-octyl), 0.80 (t, 
3H, CH3-octyl).  13C NMR (CDCl3) δ 170.35, 170.21, 170.11, 169.87, 169.21, 167.97, 
134.27, 132.65, 123.56, 100.97, 98.11, 75.61, 74.68, 71.36, 70.97, 70.48, 70.26, 69.21, 
66.69, 60.76, 60.50, 55.03, 53.40, 31.59, 29.22, 29.06, 25.75, 22.54, 20.69, 20.64, 20.60, 
20.58, 20.52, 14.01, 13.60. MS (ES, Na+): m/z (relative intensity) 816.3 (100). HRMS (M 
+ Na+) calcd for C38H50NO17Na, 816.3055; found 816.3079.   
 
Octyl 4-O-(2,3,4,6-tetra-O-acetyl-∃-D-galactopyranosyl)-3-O-acetyl-2, 6-dideoxy-6-













To a stirred -20 °C solution of 99 (0.030 g, 0.037 mmol) in 0.10 mL of CH2Cl2 
was added N-PSP (0.022 g, 0.075 mmol) and PBu3 (0.018 mL, 0.075 mmol).  The 
reaction was warmed to 0 °C and the temperature maintained at 0 °C.  After 41 h, the 
reaction was diluted to 5 mL of CH2Cl2 and washed with 5 mL of H2O and satd. NaCl 
solution.  The organic extract was dried with Na2SO4, filtered and the filtrated 
concentrated. The crude oil was purified using preparative thin layer chromatography 
(hexanes:EtOAc, 2:1) to afford 100 (0.014 g, 40%) as a colorless oil:  1H NMR (CDCl3) δ 
7.83 (bs, 2H, Pht), 7.71 (m, 2H, Pht), 7.57 (m, 2H, SePh), 7.27 (m, 3H, SePh), 5.71 (dd, 
1H, J = 10.6, 8.0 Hz, H2’), 5.33 (d, J = 8.4 Hz, H1), 5.27 (d, 1H, J = 3.4 Hz, H4’), 5.07 
(dd, 1H, J = 10.4, 8.4 Hz, H2), 4.81 (dd, 1H, J = 10.4, 3.5 Hz, H3’), 4.46 (d, 1H, J = 8.0 
Hz, H1’), 4.20 (dd, 1H, J = 10.6, 8.5 Hz, H3), 4.08 (m, 2H, H6’/H6’), 3.83 (m, 2H, 
H4/H5’), 3.75 (m, 1H, H5), 3.71 (m, 1H, CH2-octyl), 3.43 (d, 1H, J = 12.4, 2.4 Hz, H6), 
3.37 (m, 1H, CH2-octyl), 3.14 (d, 1H, J = 12.3, 6.7 Hz, H6), 2.14-1.90 (s, 18H, NHAc, 
OAc), 1.41 (bs, 3H, CH2-octyl), 1.24-1.03 (m, 9H, CH2-octyl), 0.82 (t, 3H, CH3-octyl).  
13C NMR (CDCl3) δ 170.35, 170.18, 170.03, 169.84, 168.92, 132.93, 129.24, 127.27, 
101.01, 97.79, 80.16, 74.13, 71.06, 70.92, 70.53, 69.91, 69.16, 66.61, 60.78, 55.14, 53.41, 
31.64, 29.39, 29.22, 25.79, 22.58, 20.63, 20.57, 20.51, 14.04, 13.62. MS (ES, Na+): m/z 
(relative intensity) 956.2 (100). HRMS (M + Na+) calcd for C44H55NO16SeNa, 956.2584; 
found 956.2607. 
 
Octyl 2-acetamido-4-O-(2,3,4,6-tetra-O-acetyl-∃-D-galactopyranosyl)- 3-O-acetyl-6 -














To a stirred solution of 100 (0.050 g, 0.053 mmol) in 1 mL of EtOH in a Schlenk 
tube was added H2NNH2·H2O (0.23 mL, 4.823 mmol).  The reaction was placed under a 
gentle vacuum, the tube sealed and heated to 100 °C.  After 15 h, the reaction was cooled, 
the tube opened and the reaction mixture concentrated and placed under vacuum for 6 h 
to afford the free amine as an oil/solid.  The product was taken on to the next step without 
any purification.  The crude product was dissolved in 1.0 mL of pyridine and 1.0 mL of 
Ac2O.  After 17.5 h, the reaction was diluted with 10 mL of EtOAc and washed with 10 
mL of satd. CuSO4, H2O, satd. NaHCO3, and satd. NaCl solutions.  The organic extract 
was dried with Na2SO4, filtered and the filtrate concentrated.  The resulting light yellow 
oil was purified using flash column chromatography (hexanes:EtOAc, 1:2) to afford 101 
(0.040 g, 88%, 2 steps) as a colorless oil/solid:  1H NMR (CDCl3) δ 7.58 (m, 3H, SePh), 
7.35 (m, 2H, SePh), 5.60 (d, 1H, J = 9.5 Hz, NH), 5.29 (d, 1H, H4’), 5.04 (dd, 1H, J = 9.0 
Hz, H2’), 4.82 (dd, 1H, J = 10.4, 3.3, Hz, H3’), 4.42 (d, 1H, J = 7.5 Hz, H1’), 4.37 (d, 1H, 
J = 8.0 Hz, H1), 4.08 (m, 2H, H6’/H6’), 4.04 (m, 1H, H5’), 3.81 (m, 1H, H3), 3.78-3.72 
(m, 3H, H4/H2/H5), 3.64 (m, 1H, CH2-octyl), 3.38 (m, 2H, H6/H6), 3.14 (m, 1H, CH2-
octyl), 2.17 (s, 3H, OAc), 2.13-1.91 (bs, 15H, OAc/NHAc), 1.52 (bs, 3H, CH2-octyl), 
1.25 (bs, 9H, CH2-octyl), 0.87 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 170.67, 170.03, 
169.21, 133.48, 132.19, 130.24, 129.19, 128.60, 127.95, 126.67, 100.44, 100.16, 74.77, 
73.66, 72.88, 71.19, 70.19, 69.69, 68.45, 67.25, 66.05, 60.87, 53.73, 52.58, 29.39, 25.90, 
23.75, 22.73, 21.36, 21.14, 21.02, 20.32, 20.10, 19.99.  MS (ES, Na+): m/z (relative 
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intensity) 868.3 (100). HRMS (M + Na+) calcd for C38H55NO17SeNa, 868.2635; found 
868.2671.   
 
Octyl 2-acetamido-3-O-(2,3,4,6-tetra-O-acetyl)-∃-D-galactopyranosyl-4, 6-O-











A solution of 82 (0.022 g, 0.026 mmol) in 1.0 mL of H2O and AcOH (1:1) was 
heated to reflux.  After 2 h, the reaction was cooled and concentrated.  The crude product 
was diluted with 30 mL of EtOAc and washed with 20 mL of satd. NaHCO3 and satd. 
NaCl solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified with a short silica gel plug (EtOAc) to 
afford the diol (0.020 g) as a colorless oil.  To a stirred solution of the diol (0.020 g, 
0.026 mmol) in 0.5 mL of EtOH in a Schlenk tube was added H2NNH2·H2O (0.11 mL, 
2.35 mmol).  The reaction was placed under a gentle vacuum, the tube sealed and heated 
to 100 °C.  After 41 h, the reaction was cooled, the tube opened and the reaction mixture 
concentrated and placed under vacuum for 6.5 h to afford the free amino alcohol (0.01 g) 
as a colorless oil.  The product was immediately taken on to the next step without any 
purification.  The crude product (0.0.1 g, 0.022 mmol) was dissolved in 1.0 mL of 
pyridine and 1.0 mL of Ac2O.  After 18.5 h, the reaction was diluted with 5 mL EtOAc 
and washed with 5 mL of satd. CuSO4, H2O, satd. NaHCO3, and satd. NaCl solutions.  
The organic extract was dried with Na2SO4, filtered and the filtrate concentrated.  The 
resulting light yellow oil was purified using preparative thin layer chromatography to 
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afford 102 (0.008 g, 41%, 3 steps) as a colorless oil:  1H NMR (CDCl3) δ 5.65 (d, 1H, J = 
7.1 Hz, NH), 5.33 (d, 1H, J = 3.3 Hz, H4’), 5.06 (dd, 1H, J = 10.3, 7.9 Hz, H2’), 4.98-
4.91 (m, 3H, H1/H3/H3’), 4.56-4.52 (m, 2H, H4/H1’), 4.13-4.06 (m, 4H, 
H2/H5’/H6’/H6’), 3.87-3.81 (m, 2H, H6/H6), 3.66 (m, 1H, H5), 3.46 (m, 1H, CH2-octyl), 
3.13 (m, 1H, CH2-octyl, 2.14 (s, 3H, OAc), 2.09 (s, 3H, OAc), 2.03 (s, 3H, OAc), 2.00 (s, 
3H, OAc), 1.96 (s, 3H, NHAc), 1.55 (bs, 3H, CH2-octyl), 1.25 (bs, 9H, CH2-octyl), 0.85 
(t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 170.73, 170.37, 170.27, 169.50, 168.90, 100.49, 
98.96, 71.75, 71.03, 70.62, 70.05, 69.47, 69.11, 66.90, 62.55, 61.04, 60.35, 58.23, 53.37, 
31.77, 29.44, 29.28, 25.87, 23.62, 22.60, 20.80, 20.61, 14.03. MS (ES, Na+): m/z (relative 
intensity) 770.1 (100). HRMS (M + Na+) calcd for C34H53NO17Na, 770.3229; found 
770.3211.   
 












To a stirred solution of 102 (0.005 g, 0.0066 mmol) in 0.5 mL of MeOH:THF 
(1:1) was added 0.5M NaOMe solution (0.0028 mL, 0.0535 mmol).  After 4 d, the 
reaction was quenched with 0.050 g of Dowex 50W H+ form resin (2.1 meq/mL) and 
stirred gently for 20 min.  The mixture was filtered and the filtrate concentrated.  The 
resulting white powder was purified using a short silica gel plug with CHCl3:MeOH (4:1) 
to afford 13b (0.003 g, 100%) as a white powder:  1H NMR (D2O) δ 4.40 (d, 1H, J = 7.7 
Hz, H1), 4.29 (d, 1H, J = 7.7 Hz, H1’), 3.79-3.74 (m, 3H, H2’/H3/H3’), 3.67-3.62 (m, 
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6H, H4’/H4/H2/H5/H6’/H6’), 3.57-3.43 (m, 2H, H6/H6), 3.41-3.34 (m, 3H, H5/-CH2-
octyl), 1.90 (s, 3H, NHAc), 1.40 (bs, 3H, CH2-octyl), 1.14 (bs, 9H, CH2-octyl), 0.72 (t, 
3H, CH3-octyl).  13C NMR (D2O) δ 174.48, 103.51, 100.87, 82.49, 75.35, 75.27, 72.49, 
70.68, 70.59, 68.75, 68.53, 61.01, 60.77, 54.62, 31.08, 28.55, 28.47, 28.32, 25.07, 22.27, 
22.00, 13.37.  MS (ES, Na+): m/z (relative intensity) 518.3 (100).  HRMS (M + Na+) 
calcd for C22H41NO11Na, 518.2577; found 518.2576. 
 
Octyl 2-acetamido-4-O-(2,3,4,6-tetra-O-acetyl-∃-D-galactopyranosyl)- 3, 6-O-acetyl-











To a stirred solution of 95 (0.10 g, 0.12 mmol) in 4.0 mL of EtOH in a Schlenk 
tube was added H2NNH2·H2O (0.53 mL, 10.4 mmol).  The reaction was placed under a 
gentle vacuum, the tube sealed and heated to 100 °C.  After 15 h, the reaction was cooled, 
the tube opened and the reaction mixture concentrated and placed under vacuum for 6 h 
to afford the free amino alcohol (0.026 g) as a colorless oil.  The product was taken on to 
the next step without any purification.  The crude product was dissolved in 3 mL of 
pyridine and 3 mL of Ac2O.  After 30 h, the reaction was diluted with 20 mL of EtOAc 
and washed with 20 mL of satd. CuSO4, H2O, satd. NaHCO3, and satd. NaCl solutions.  
The organic extract was dried with Na2SO4, filtered and the filtrate concentrated.  The 
resulting yellow oil was purified using flash column chromatography (hexanes:EtOAc, 
1:1) to afford 103 (0.06 g, 70%, 2 steps) as a colorless oil/solid:  1H NMR (CDCl3) δ 5.63 
(d, 1H, N-H), 5.35 (d, 1H, H4’), 5.23 (dd, 1H, J = 10.2 Hz, H2’),  5.19 (m, 1H, H3’), 5.04 
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(dd, 1H, J = 10.8, 7.8 Hz, H3), 4.82 (dd, 1H, J = 9.6 Hz, H4), 4.57 (d, 1H, J = 8.3 Hz, 
H1), 4.53 (dd, 1H, H2), 4.42 (d, 1H, J = 7.4 Hz, H1’), 4.10 (dd, 1H, H6’), 4.00 (m, 1H, 
H6’), 3.83-3.73 (m, 3H, H6/H6/CH2-octyl), 3.64 (m, 1H, H5), 3.57 (m, 1H, Hz, H5’), 
3.40 (m, 1H, CH2-octyl), 2.07-1.88 (s, 21H, NHAc, OAc), 1.53-1.51 (bs, 3H, CH2-octyl), 
1.30-1.10 (bs, 9H, CH2-octyl), 0.85 (t, 3H, CH3-octyl).  MS (ES, Na+): m/z (relative 
intensity) 770.3 (100). HRMS (M + Na+) calcd for C32H53NO17Na, 770.3211; found 
770.3220. 
 











To a stirred solution of 103 (0.055 g, 0.073 mmol) in 3.0 mL of MeOH was added 
NaOMe powder (0.008 g, 0.148 mmol).  After 3 d, the reaction was quenched with 0.10 g 
of Dowex 50W H+ form resin (2.1 meq/mL) and stirred gently for 20 min.  The mixture 
was filtered and the filtrate concentrated.  The resulting white powder was purified using 
a short silica gel plug (CHCl3:MeOH, 4:1) to afford 14b (0.015 g, 42%) as a white 
powder:  1H NMR (D2O) δ 4.70-4.60 (m, 2H, H1/H1’), 3.95-3.92 (m, 3H, H2’/H3/H3’), 
3.79 (m, 6H, H4’/H4/H2/H5’/H6’/H6’), 3.54-3.45 (m, 5H, H6/H6/H5/-CH2-octyl), 2.07 
(s, 3H, NHAc), 1.63 (bs, 3H, CH2-octyl), 1.32 (bs, 9H, CH2-octyl), 0.89 (t, 3H, CH3-
octyl).  13C NMR (D2O) δ 133.86, 126.09, 101.71, 75.14, 72.53, 71.75, 70.86, 70.70, 
68.86, 66.01, 62.66, 60.98, 56.79, 47.68, 31.10, 28.37, 25.25, 25.07, 22.00, 21.87, 19.95, 
13.38. MS (ES, Na+): m/z (relative intensity) 518.2 (100).  HRMS (M + Na+) calcd for 











To a stirred 0 °C solution of 42b (0.145 g, 0.212 mmol) in 3.0 mL of CH2Cl2 were 
added AcBr (0.076 mL, 1.061 mmol) and BF3·OEt2 (0.013 mL, 0.106 mmol).  After 3.5 
h, the reaction was dissolved in 30 mL of CH2Cl2 and washed with 30 mL of satd. 
NaHCO3, H2O, satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered 
and the filtrate concentrated.  The resulting oil was purified using flash column 
chromatography (hexanes:EtOAc, 1:1) to afford 105 (0.09 g, 70%) as a colorless oil:  1H 
NMR (CDCl3) δ  7.48 (m, 2H, PhSe), 7.29 (m, 3H, PhSe), 7.24 (m, 5H, Bn), 5.39 (d, 1H, 
J = 8.4 Hz, NH), 5.24 (d, 1H, J = 9.2, 2.9 Hz, H4), 4.79 (d, 1H, J = 11.5 Hz, -O-CH2-Ph,), 
4.60 (d, 1H, J = 8.3 Hz, H1), 4.49 (d, 1H, J = 11.5 Hz, -O-CH2-Ph), 4.06-4.03 (m, 2H, 
H3/H2), 3.82 (m, 1H, CH2-octyl), 3.58 (m, 1H, H5), 3.42 (m, 1H, CH2-octyl), 3.18 (dd, 
1H, J = 12.6, 6.5 Hz, H6), 2. 94 (dd, 1H, J = 12.6, 7.4 Hz, H6), 2.00 (s, 3H, OAc), 1.93 
(s, 3H, NHAc), 1.53 (bs, 2H, CH2-octyl), 1.25 (bs, 10H, CH2-octyl), 0.87 (t, 3H, CH3-
octyl).  13C NMR (CDCl3) δ 170.75, 170.06, 137.84, 132.66, 129.70, 129.19, 128.36, 
128.23, 127.82, 127.15, 100.59, 75.06, 74.50, 74.28, 73.24, 69.46, 53.37, 52.10, 31.78, 
29.41, 29.30, 29.24, 27.68, 25.87, 23.46, 22.61, 20.87, 14.05.  MS (ES, Na+): m/z 





Octyl 2-acetamido-3-O-[(benzyloxy)methyl]- 5, 6-dehydro-2, 6-dideoxy-∃-D-






To a stirred solution of 42a (0.100 g, 0.157 mmol) in 21 mL of MeOH:H2O (6:1) 
were added NaHCO3 (0.014 g, 0.173 mmol) and NaIO4 (0.050 g, 0.235 mmol).  A white 
precipitate formed during the course of the reaction.  After 2.5 h, the reaction was filtered 
and the filtrate concentrated to leave the H2O.  The H2O had an additional 30 mL of H2O 
added and the aqueous extract was washed 3 times with 30 mL of CH2Cl2.  The 
combined organic extracts were washed with 90 mL of satd. NaCl solution and dried with 
Na2SO4, filtered and the filtrate concentrated to afford the selenoxide as a white oil/solid 
and taken on without any purification (0.100 g):  1H NMR (CDCl3) δ  7.68 (m, 3H, 
SePh), 7.54 (m, 2H, SePh), 7.33 (m, 5H, ArH of BOM), 5.98 (d, 1H, N-H), 5.28 (d, 1H, J 
= 3.1 Hz, H4), 4.91 (d, 1H, J = 8.5 Hz, H1), 4.83-4.77 (m, 2H, BOM), 3.64 (m, 1H, H3), 
4.55 (m, 1H, H2), 4.32 (m, 1H, H5), 3.94 (m, 1H, H6), 3.80 (m, 1H, H6), 3.57 (m, 2H, 
CH2-octyl), 2.15 (s, 3H, NHAc), 1.92 (s, 3H, OAc), 1.27 (bs, 12H, CH2-octyl), 0.86 (bs, 
3H, CH3-octyl).  The crude product (0.100 g, 0.153 mmol) was then dissolved in 5 mL of 
DHP and heated to reflux at 100 °C.  After 1.5 h, the reaction was cooled and diluted 
with 15 mL CH2Cl2 and washed with 15 mL of H2O, satd. NaHCO3, and satd. NaCl 
solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified using flash columng chromatography 
(hexanes:EtOAc, 1:2) to afford 106a (0.042 g, 60%, 2 steps) as a colorless oil:  1H NMR 
(CDCl3) δ 7.59 (m, 3H, ArH of BOM), 7.36 (m, 2H, ArH of BOM), 4.88 (d, 1H, J=7.4 
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Hz, N-H), 4.80 (m, 1H, H1), 4.00 (m, 2H, H6), 3.63-3.54 (m, 3H, H4/H3/H5), 3.37 (m, 
2H, CH2-octyl), 3.14 (m, 1H, H2), 2.05 (s, 3H, NHAc), 1.76 (s, 3H, OAc), 1.29 (bs, 12H, 
CH2-octyl), 0.92 (bs, 3H, CH3-octyl).  13C NMR (CDCl3) δ 135.50, 134.00, 129.45, 
129.17, 120.01, 127.87, 127.62, 97.83, 93.74, 78.09, 63.25, 45.58, 28.83, 28.43, 25.57, 
24.15.  
 
Octyl 4-O-benzyl-3-O-[(benzyloxy)methyl]- 5, 6-dehydro-2, 6-dideoxy-∃-D-






To a stirred solution of 42b (0.14 g, 0.20 mmol) in 28 mL of MeOH:H2O (6:1) 
were added NaHCO3 (0.019 g, 0.225 mmol) and NaIO4 (0.065 g, 0.307 mmol).  A white 
precipitate formed during the course of the reaction.  After 1 h, the reaction was filtered 
and the filtrate concentrated to leave the H2O.  An additional 30 mL of H2O was added to 
the filtrate and the aqueous extract was washed 3 times with 30 mL of CH2Cl2.  The 
combined organic extracts were washed with 75 mL of NaCl saturated solution and dried 
with Na2SO4, filtered and the filtrate concentrated to afford a 4:1 diastereomeric mixture 
of selenoxides as a white oil/solid (0.135 g) and taken on without any purification:  1H 
NMR (CDCl3) δ 7.62 (m, 3H, SePh), 7.59 (m, 2H, SePh), 7.33 (m, 5H, ArH of BOM), 
7.13 (m, 5H, Bn), 6.06 (d, 1H, J = 7.9 Hz, NH), 5.86 (d, 1H, J = 7.5 Hz, NH), 5.35 (d, 
1H, J = 2.9 Hz, H4), 5.22 (d, 1H, J = 2.2 Hz, H4), 4.98-4.72, (m, 5H, H1/-O-CH2-OBn/-
O-CH2-Ph), 4.63 (m, 2H, -O-CH2-Ph), 4.35 (m, 1H, H3), 3.92 (m, 1H, H2), 3.69-3.43 (m, 
5H, H5, H6, H6, CH2-octyl), 2.14 (s, 3H, NHAc), 1.56 (bs, 2H, CH2-octyl), 1.27 (bs, 9H, 
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CH2-octyl), 0.84 (bs, 3H, CH3-octyl).  The crude selenoxides (0.135 g, 0.193 mmol) were 
dissolved in 10 mL of DHP and heated to reflux at 100 °C.  After 2 h, the reaction was 
cooled and diluted with 25 mL of CH2Cl2 and washed with 25 mL of H2O, satd. 
NaHCO3, and satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered 
and the filtrate concentrated.  The crude product was purified using flash column 
chromatography (hexanes:EtOAc, 1:2) to afford 106b (0.060 g, 56%, 2 steps) as a 
colorless oil:  1H NMR (CDCl3) δ 7.54 (m, 1H, ArH of BOM), 7.32-7.20 (m, 9H, ArH of 
BOM, Bn), 5.86 (d, 1H, J=7.2 Hz, NH), 5.25 (d, 1H, J = 7.6 Hz, H1), 4.86-4.65 (m, 5H, -
O-CH2-OBn/-O-CH2-Ph), 4.51 (m, 2H, H6), 4.59 (dd, 3H, J = 10.3, 3.1 Hz, H3), 4.34 (m, 
1H, -O-CH2-Ph), 4.11 (m, 1H, H4), 3.92 (m, 1H, CH2-octyl), 3.79 (m, 1H, H2), 3.92 (m, 
1H, CH2-octyl), 1.88 (s, 3H, NHAc), 1.58 (bs, 2H, CH2-octyl), 1.25 (bs, 10H, CH2-octyl), 
0.87 (bs, 3H, CH3-octyl).  13C NMR (CDCl3) δ 170.52, 169.32, 152.05, 137.80, 137.61, 
133.02, 131.96, 128.98, 128.38, 128.34, 128.27, 127.94, 127.83, 127.76, 127.71, 127.64, 
127.50, 127.14, 100.70, 97.73, 93.79, 74.42, 73.76, 73.32, 71.02, 70.01, 69.62, 69.48, 
69.40, 50.06, 43.86, 31.79, 29.46, 29.30, 29.25, 25.88, 23.50, 22.62, 14.06. MS (ES, 
Na+): m/z (relative intensity) 548.3 (100). HRMS (M + Na+) calcd for C31H43NO6Na, 
548.2988; found 548.2998. 
 






To a stirred solution of 105 (0.090 g, 0.148 mmol) in 21 mL of MeOH:H2O (6:1) 
were added NaHCO3 (0.013 g, 0.163 mmol) and NaIO4 (0.047 g, 0.223 mmol).  A white 
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precipitate formed during the course of the reaction.  After 1 h, the reaction was filtered 
and the filtrate concentrated to leave the H2O.  An additional 20 mL of H2O was added to 
the filtrate and the aqueous extract was washed 3 times with 20 mL of CH2Cl2.  The 
combined organic layers were washed with 50 mL of satd. NaCl solution and dried with 
Na2SO4, filtered and the filtrate concentrated to afford a 3:1 diastereomeric mixture of 
selenoxides as a colorless oil/solid (0.070 g) and taken on without any purification:  1H 
NMR (CDCl3) δ  7.61 (m, 3H, SePh), 7.52 (m, 2H, SePh), 7.35 (m, 5H, Bn), 6.79 (d, 1H, 
J = 9.1 Hz, NH), 6.07 (d, 1H, J = 8.6 Hz, NH), 5.16 (d, 1H, J = 7.9, 2.8 Hz, H4), 4.74, (d, 
1H, J = 11.7 Hz, -O-CH2-Ph), 4.65 (d, 1H, J = 8.3 Hz, H1), 4.38 (m, 1H, -O-CH2-Ph), 
4.12 (m, 1H, H3), 3.88 (dd, 1H, J = 9.6, 6.4 Hz, H2), 3.78-3.71 (m, 2H, H5/CH2-octyl), 
3.24 (m, 1H, H6), 2.49 (d, 1H, J = 9.8 Hz, H6), 2.03 (s, 3H, OAc), 1.93 (s, 3H, NHAc), 
1.58 (bs, 2H, CH2-octyl), 1.27 (bs, 10H, CH2-octyl), 0.84 (bs, 3H, CH3-octyl).  13C NMR 
(CDCl3) δ 170.81, 170.22, 140.67, 137.40, 131.33, 129.67, 128.55, 128.30, 128.26, 
127.90, 126.02, 125.77, 102.05, 100.84, 75.19, 75.08, 73.75, 70.05, 68.77, 55.09, 50.35, 
31.80, 29.51, 29.34, 29.26, 25.87, 23.33, 22.61, 20.68, 14.04.  The crude selenoxides 
(0.070 g, 0.112 mmol) were dissolved in 8 of mL DHP and heated to reflux at 100 °C.  
After 2.5 h, the reaction was cooled and diluted with 10 mL of CH2Cl2 and washed with 
10 mL of H2O, satd. NaHCO3, and satd. NaCl solutions.  The organic extract was dried 
with Na2SO4, filtered and the filtrate concentrated.  The crude product was purified using 
flash column chromatography (hexanes:EtOAc, 1:2, 1% NEt3) to afford 106c (0.045 g, 
70%, 2 steps) as a colorless oil:  1H NMR (CDCl3) δ 7.34-7.25 (m, 5H, Bn), 5.57 (d, 1H, 
J=8.5 Hz, NH), 5.19 (dd, 1H, J = 10.1, 3.3 Hz, H4), 4.74 (s, 1H, J = 7.4 Hz, -O-CH2-Ph), 
4.69 (d, 1H, J = 8.7 Hz, H1), 4.39 (m, 1H, -O-CH2-Ph ), 4.28 (m, 1H, H3), 4.08 (m, 1H, 
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H6), 3.91 (m, 1H, CH2-octyl), 3.49 (m, 1H, CH2-octyl), 3.08 (m, 1H, H2), 2.07 (s, 3H, 
OAc), 1.94 (s, 3H, NHAc), 1.59 (bs, 2H, CH2-octyl), 1.26 (bs, 10H, CH2-octyl), 0.87 (bs, 
3H, CH3-octyl).  13C NMR (CDCl3) δ 170.71, 169.97, 151.55, 137.71, 128.26, 127.68, 
127.61, 101.64, 100.61, 73.39, 70.16, 69.68, 69.54, 53.37, 51.27, 45.81, 31.78, 29.43, 
29.29, 29.22, 25.86, 23.38, 22.60, 20.98, 20.87, 14.03. MS (ES, Na+): m/z (relative 
intensity) 470.2 (100). HRMS (M + Na+) calcd for C31H43NO6Na, 470.2519; found 
470.2516. 
 
Octyl 2-acetamido-4-O-acetyl-3-O-[(benzyloxy)methyl]-2, deoxy-5, 6-epoxy-∃-D-







To a stirred 0 °C solution of 106a (0.030 g, 0.062 mmol) in 1.5mL of CH2Cl2 was 
added DMDO (approximately 15 mL).  The reaction was placed in the cold box 
overnight at 4 °C.  After 21 h, the solution was dried with Na2SO4, filtered and the filtrate 
concentrated to afford 107a (0.03 g, 96%) as a colorless oil:  1H NMR (CDCl3) δ 7.62-
7.57 (m, 5H, ArH of BOM), 5.74 (bs, 1H, N-H), 5.67 (d, 1H, J = 2.4 Hz, H4), 5.14 (d, 
1H, J = 8.0 Hz, H1), 4.63 (s, 2H, -O-CH2-O-Bn), 4.24 (s, 2H, CH2-Ph), 3.98-3.88 (m, 4H, 
H3/H5/CH2-octyl), 3.68 (dd, 1H, J = 7.9, 4.3 Hz, H2), 3.58-3.52 (m, 2H, H6/H6), 2.07 (s, 
3H, OAc), 1.97 (s, 3H, NHAc), 1.92-1.88 (bs, 3H, CH2-octyl), 1.76-1.66 (bs, 9H, CH2-
octyl), 1.23 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 140.16, 134.18, 129.97, 129.90, 
128.58, 128.29, 127.70, 126.20, 93.38, 88.14, 73.62, 73.46, 68.63, 68.26, 65.37, 59.10, 




Octyl 4-O-benzyl-3-O-[(benzyloxy)methyl]-2, deoxy-5, 6-epoxy-∃-D-glucopyranoside 







To a stirred 0 °C solution of 106b (0.035 g, 0.066 mmol) in 1.0 mL of CH2Cl2 
was added DMDO (approximately 10 mL).  The reaction was placed in the cold box 
overnight at 4 °C.  After 21 h, the solution was dried with Na2SO4, filtered and the filtrate 
concentrated to afford 107b (0.035 g, 97%) as a colorless oil:  1H NMR (CDCl3) δ  7.32-
7.23 (m, 10H, ArH of BOM/Bn), 4.90-4.32 (m, 14H, NH/H4/H1/O-CH2-O-Bn/CH2-
Ph/H3/H5/CH2-octyl/H2/H6/H6), 1.75 (s, 3H, NHAc), 1.60 (bs, 3H, CH2-octyl), 1.24 (bs, 
9H, CH2-octyl), 0.87 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 177.99, 133.48, 130.13, 
129.79, 129.02, 128.50, 127.87, 127.39, 126.53, 96.27, 94.03, 84.24, 75.09, 69.66, 68.62, 
63.03, 58.14, 33.88, 32.73, 31.82, 29.28, 25.73, 25.30, 24.73, 22.86, 14.13.   
 







To a stirred 0 °C solution of 106c (0.045 g, 0.100 mmol) in 2.0 mL of CH2Cl2 was 
added DMDO (approximately 10 mL).  The reaction was placed in the cold box 
overnight at 4 °C.  After 17 h, the solution was dried with Na2SO4, filtered and the filtrate 
concentrated to afford 107c (0.045 g, 97%) as a colorless oil:  1H NMR (CDCl3) δ  7.49-
7.32 (m, 5H, Bn), 5.72-5.80 (m, 7H, NH/H4/H1/O-CH2Ph/CH2-Ph), 4.86-4.76 (m, 2H, 
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H3/H5), 4.07-3.73 (m, 5H, CH2-octyl/H2/H6/H6), 2.03 (s, 3H, OAc), 1.75 (s, 3H, 
NHAc), 1.59 (bs, 3H, CH2-octyl), 1.24 (bs, 9H, CH2-octyl), 0.86 (t, 3H, CH3-octyl).  
 
4-O-Acetyl, 3-O-[(benzyloxy)methyl]-5, 6-dehydro, 2, 6-dideoxy-2-









To a stirred solution of 62a (0.10 g, 0.120 mmol) in 25 mL of MeOH:H2O (6:1) 
were added NaHCO3 (0.011 g, 0.132 mmol) and NaIO4 (0.038 g, 0.180 mmol).  A white 
precipitate formed during the course of the reaction.  After 3.5 h, the reaction was filtered 
and the filtrate concentrated to leave the H2O.  The filtrate had 20 mL of H2O added and 
the aqueous extract was washed 3 times with 20 mL of CH2Cl2.  The combined organic 
extracts were washed with 60 mL of satd. NaCl solution and dried with Na2SO4, filtered 
and the filtrate concentrated to afford a 3:2 diastereomeric mixture of selenoxides a white 
oil/solid (0.085 g) and taken on without any purification:  1H NMR (CDCl3) δ  7.68 (m, 
1H, SePh), 7.51 (m, 1H, SePh), 7.47 (m, 3H, SePh), 7.30 (m, 5H, ArH of BOM), 7.27 (m, 
10H, Bn/Ph), 5.84 (m, 1H, H1), 5.40 (d, 1H, J = 2.2 Hz, H4), 5.15 (m, 4H, O-CH2-
Ph/Bn), 5.07 (dd, 1H, J = 9.3, 1.9 Hz, H3), 4.73-4.62 (d, 2H, O-CH2-O-Bn/ O-CH2-Ph/ 
ArH of BOM), 4.12 (dd, 1H, J = 11.0, 2.9 Hz, H2), 3.93 (m, 1H, H5), 2.97 (dd, 1H, J = 
12.3, 7.8 Hz, H6), 2.79 (dd, 1H, J = 12.3, 4.2 Hz, H6), 2.09 (s, 3H, OAc).  13C NMR 
(CDCl3) δ 170.72, 170.54, 141.13, 137.34, 137.15, 135.89, 135.80, 135.48, 131.90, 
130.22, 129.48, 129.20, 129.14, 129.06, 128.99, 128.92, 128.83, 128.68, 128.62, 128.54, 
128.48, 128.36, 128.17, 128.14, 126.45, 126.11, 95.89, 95.80, 93.50, 93.39, 71.05, 70.82, 
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70.63, 70.56, 70.35, 70.25, 69.49, 68.78, 67.53, 66.90, 55.04, 53.84, 49.54, 21.23, 21.16.   
19F NMR δ -75.94.  31P NMR δ -1.20.  The crude selenoxides (0.085 g, 0.10 mmol) were 
dissolved in 3.0 mL of DHP and heated to reflux at 100 °C.  After 4.5 h, the reaction was 
cooled and diluted with 25 mL of CH2Cl2 and washed with 25 mL of H2O, satd. 
NaHCO3, and satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered 
and the filtrate concentrated.  The crude product was purified using preparative thin layer 
chromatography (hexanes:EtOAc, 1:2) to afford 108 (0.053 g, 67 %, 2 steps) as a 
colorless oil:  1H NMR (CDCl3) δ  7.34 (m, 5H, ArH of BOM), 7.28 (m, 10H, Bn/Ph), 
5.88 (dd, 1H, J = 6.4, 3.1 Hz, H1), 5.73 (d, 1H, J = 3.4 Hz, H4), 5.02 (m, 4H, O-CH2-
Ph/Bn), 4.76 (s, 2H, O-CH2-O-Bn), 4.74 (d, 1H, J = 7.0 Hz, O-CH2-O-Bn), 4.70 (d, 1H, J 
= 7.0 Hz, O-CH2-Ph/BOM), 4.67 (m, 1H, H2), 4.55 (m, 2H, H6), 4.07 (dd, 1H, J = 11.0, 
3.4 Hz, H3), 2.12 (s, 3H, OAc).  13C NMR (CDCl3) δ 170.16, 157.89, 149.76, 137.09, 
135.36, 129.22, 129.17, 129.02, 128.91, 128.83, 128.42, 128.39, 128.29, 128.16, 128.09, 
117.07, 114.78, 105.17, 95.58, 93.95, 71.13, 70.36, 70.30, 69.07, 49.52, 21.36.   19F 
NMR δ 0.48.  31P NMR δ -1.67.  MS (ES, Na+): m/z (relative intensity) 702.1 (100).  
HRMS (M + Na+) calcd for C32H33F3NO10PNa, 702.1692; found 702.1703. 
 
4-O-Acetyl, 3-O-[(benzyloxy)methyl]-2-deoxy, 5, 6-epoxy-2-trifluroracetamido-∀-D-










To a stirred 0 °C solution of 108 (0.05 g, 0.07 mmol) in 0.5 mL of CH2Cl2 was 
added DMDO (approximately 11 mL).  After 7.5 h, an additional 10 mL of DMDO was 
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added to the reaction mixture.  After 23 h, the solution was dried with Na2SO4, filtered 
and the filtrate concentrated to afford a 1:0.7 ratio of epoxides 109 (0.049 g, 85%) as a 
colorless oil:  1H NMR (CDCl3) δ 7.17 (m, 5H, ArH of BOM), 7.06 (m, 10H, Bn/Ph), 
6.15 (dd, 1H, H1), 5.98 (dd, 1H, J = 7.5, 3.3 Hz, H1), 5.41 (d, 1H, J = 3.2 Hz, H4), 5.38 
(d, 1H, J = 3.3 Hz, H4), 5.04-4.92 (m, 8H, O-CH2-Ph/Bn/ O-CH2-O-Bn/ O-CH2-Ph/ ArH 
of BOM), 4.67 (dd, 1H, J = 11.9, 6.8 Hz, H2), 4.40 (m, 1H, H3), 2.45 (m, 2H, H6), 2.41 
(dd, 2H, J = 8.7, 4.5 Hz, H6), 1.74 (s, 3H, OAc). 13C NMR (CDCl3) δ 168.98, 158.85, 
158.56, 137.99, 129.14, 129.01, 128.99, 128.93, 128.90, 128.43, 128.61, 128.56, 128.50, 
128.40, 128.31, 128.26, 128.21, 128.12, 128.02, 115.85, 97.01, 95.18, 81.73, 81.44, 
73.36, 72.06, 70.68, 70.52, 70.28, 70.21, 68.19, 50.24, 49.50, 25.33, 20.47, 20.40, 20.16.    
 
Octyl 2-acetamido-3-O-(2,3,4,6-tetra-O-acetyl-∃-D-galactopyranosyl)- 4-O-acetyl-5, 











To a stirred solution of 85 (0.010 g, 0.012 mmol) in 1.75 mL of MeOH:H2O (6:1) 
were added NaHCO3 (0.001 g, 0.0129 mmol) and NaIO4 (0.004 mg, 0.018 mmol).  A 
white precipitate formed during the course of the reaction.  After 2 h, the reaction was 
filtered and the filtrate concentrated to leave the H2O.  The filtrate had 5 mL of H2O 
added and the aqueous extract was washed 3 times with 5 mL of EtOAc.  The combined 
organic extracts were washed with 10 mL of satd. NaCl solution and dried with Na2SO4, 
filtered and the filtrate concentrated.  The crude product was purified using flash column 
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chromatography (hexanes: EtOAc, 1:1) to afford 111 (0.007 g, 87%) as a white oil/solid:  
1H NMR (CDCl3) δ 6.03 (d, 1H, J = 9.8 Hz, N-H), 5.88 (d, 1H, J = 8.1 Hz, H1), 5.64 (m, 
1H, H3), 5.37 (d, 1H, J = 3.2 Hz, H4’), 5.14 (dd, 1H, J = 10.3, 8.0 Hz, H2’), 5.01 (dd, 1H, 
J = 10.4, 3.4 Hz, H3’), 4.92 (dd, 2H, J = 3.1 Hz, H6/H6), 4.81 (d, 1H, J = 7.9 Hz, H1’), 
4.65 (m, 1H, H4), 4.43-4.40 (m, 3H, J =  6.5 Hz, H5’/H6’/H6’), 3.92 (m, 1H, H2), 3.78 
(m, 1H, CH2-octyl), 3.45 (m, 1H, CH2-octyl), 2.10 (s, 3H, OAc), 2.07-1.98 (bs, 15H, 
OAc/NHAc), 1.55 (bs, 3H, CH2-octyl), 1.19 (bs, 9H, CH2-octyl), 0.85 (t, 3H, CH3-octyl).  
13C NMR (CDCl3) δ 171.12, 170.37, 170.27, 170.06, 169.54, 169.09, 168.88, 150.88, 
145.59, 121.66, 99.74, 95.28, 77.91, 70.98, 70.59, 69.84, 68.96, 68.62, 66.95, 66.42, 
60.96, 60.34, 52.72, 31.77, 29.22, 29.13, 25.87, 23.97, 23.30, 22.58, 21.00, 20.93, 20.72, 
20.64, 20.60, 20.53, 14.14, 14.05.  MS (ES, Na+): m/z (relative intensity) 710.3 (100).  
HRMS (M + Na+) calcd for C32H49NO15Na, 710.3000; found 710.2993. 
 
Octyl 2-Acetamido-3-O-(2,3,4,6-tetra-O-acetyl-∃-D-galactopyranosyl)- 4-O-acetyl-2-











To a stirred 0 °C solution of 111 (0.045 g, 0.065mmol) in 2.0 mL of CH2Cl2 was 
added DMDO (approximately 8 mL).  After 13 h, the reaction was dried with Na2SO4, 
filtered and the filtrate was concentrated to afford 112 (0.044 g, 95%) as a colorless oil:  
1H NMR (C6D6) δ 5.78 (m, 1H, H3’), 5.56 (d, 1H, H4’), 5.50 (dd, 1H, H2’), 5.31 (d, 1H, 
H1), 5.02 (m, 1H, H3), 4.44 (d, 1H, H1’), 4.30 (m, 1H, H4), 4.18 (m, 1H, H5’), 3.75 (m, 
2H, Hz, H6’/H6’), 3.43 (m, 1H, H2), 3.43 (m, 1H, CH2-octyl), 3.13 (m, 1H, CH2-octyl), 
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2.78 (d, 1H, H6), 2.53 (d, 1H, H6), 2.12-1.69 (bs, 18H, OAc/NHAc), 1.62 (bs, 3H, CH2-
octyl), 1.25 (bs, 9H, CH2-octyl), 0.90 (t, 3H, CH3-octyl).  13C NMR (C6D6) δ 170.61, 
170.44, 170.23, 78.43, 71.66, 69.93, 69.58, 68.09, 67.64, 63.07, 61.58, 33.56, 32.55, 
30.44, 30.17, 30.05, 26.65, 26.54, 23.39, 21.20, 21.12, 21.02, 20.64, 20.41, 20.28, 20.21, 
14.67, -1.71.  MS (ES, Na+): m/z (relative intensity) HRMS (M + Na+) calcd for 
C32H49NO16Na, 726.3; found 726.3 (100). 
 
Octyl 2-acetamido-4-O-(2,3,4,6-tetra-O-acetyl-∃-D-galactopyranosyl)- 3-O-acetyl-5, 










To a stirred solution of 101 (0.04 g, 0.05 mmol) in 7.0 mL of MeOH:H2O (6:1) 
were added NaHCO3 (0.005 g, 0.058 mmol) and NaIO4 (0.017 g, 0.080 mmol).  A white 
precipitate formed during the course of the reaction.  After 2.5 h, the reaction was filtered 
and the filtrate concentrated to leave the H2O.  The filtrate had 5.0 mL of H2O added and 
the aqueous extract was washed 3 times with 5.0 mL of EtOAc.  The combined organic 
extracts were washed with 10 mL of satd. NaCl solution and dried with Na2SO4, filtered 
and the filtrate concentrated.  The resulting mixture of olefin and selenoxides (0.031 g) 
was taken on without any purification.  The crude selenoxides (0.031 g) was dissolved in 
3.0 mL of DHP and heated to reflux at 100 °C.  After 45 min, the reaction was cooled 
and diluted with 5.0 mL of CH2Cl2 and washed with 5.0 mL of H2O, satd. NaHCO3, and 
satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered and the filtrate 
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concentrated.  The crude product was purified using flash column chromatography 
(hexanes:EtOAc, 2:1) to afford 113 (0.012 g, 40%, 2 steps) as a colorless oil:  1H NMR 
(CDCl3) δ 6.55 (d, 1H, J = 9.6 Hz, N-H), 5.37 (d, 1H, J = 3.0 Hz, H4’), 5.29 (d, 1H, H1), 
5.20 (dd, 1H, J = 8.0 Hz, H2’), 5.06 (dd, 1H, J = 10.5, 3.4 Hz, H3’), 4.92 (s, 1H, H6’), 
4.88 (s, 1H, H6’), 4.68 (s, 1H, H6), 4.63 (s, 1H, H6), 4.54 (d, 1H, J = 7.9 Hz, H1’), 4.30 
(m, 1H, H4), 4.21 (dd, 1H, J = 4.9 Hz, H3), 4.13 (m, 1H, H5’), 3.89 (m, 1H, H2), 3.75 
(m, 1H, CH2-octyl), 3.36 (m, 1H, CH2-octyl), 2.17 (s, 3H, OAc), 2.09-1.96 (bs, 15H, 
OAc/NHAc), 1.53 (bs, 3H, CH2-octyl), 1.35 (bs, 9H, CH2-octyl), 0.86 (t, 3H, CH3-octyl).  
13C NMR (CDCl3) δ 171.13, 170.17, 170.09, 169.95, 169.33, 149.46, 103.87, 101.85, 
97.76, 73.29, 70.86, 70.28, 69.44, 68.59, 68.05, 66.57, 60.88, 46.82, 31.82, 29.42, 29.32, 
29.29, 26.10, 22.88, 22.63, 21.04, 20.85, 20.64, 14.18.  MS (ES, Na+): m/z (relative 















To a stirred 0 °C solution of 113 (0.011 g, 0.016mmol) in .01 mL of CH2Cl2 was 
added DMDO (approximately 8 mL).  After 1 h, the reaction was dried with Na2SO4, 
filtered and the filtrate was concentrated to afford 114 (0.044 g, 95%) as a colorless oil:  
1H NMR (C6D6) δ 6.37 (d, 1H, J = 9.7 Hz, N-H), 5.60 (m, 1H, H3), 5.49 (d, 1H, J = 3.0 
Hz, H4’), 5.27 (d, 1H, J = 8.7 Hz, H1), 5.25 (dd, 1H, J = 10.6, 3.4 Hz, H3’), 4.82 (dd, 1H, 
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J = 2.8 Hz, H2’), 4.79 (m, 1H, H5’), 4.74 (d, 1H, J = 7.9 Hz, H1’), 4.12 (m, 2H, Hz, 
H6’/H6’), 3.85 (m, 1H, H4), 3.54 (m, 1H, CH2-octyl), 3.36 (m, 1H, H2), 3.18 (m, 1H, 
CH2-octyl), 2.82 (d, 1H, J = 4.7 Hz, H6), 2.43 (d, 1H, J = 4.7 Hz, H6), 2.01-1.61 (bs, 
18H, OAc/NHAc), 1.53 (bs, 3H, CH2-octyl), 1.28 (bs, 9H, CH2-octyl), 0.91 (t, 3H, CH3-
octyl).  13C NMR (C6D6) δ 171.06, 170.41, 170.00, 169.56, 169.22, 103.69, 101.62, 
79.06, 74.08, 71.96, 71.49, 71.08, 69.91, 69.73, 67.49, 61.45, 51.45, 49.24, 32.51, 30.11, 
30.06, 30.01, 26.64, 23.39, 23.20, 21.04, 20.76, 20.56, 20.48, 20.23, 14.67, -1.73.  MS 
(ES, Na+): m/z (relative intensity) calcd for C32H49NO16Na, 726.3; found 726.3 (100). 
 
Octyl 3, 4-O-di acetyl 5, 6-dehydro-2, 6-dideoxy-2-phthalamido-∃-D-glucopyranoside 






To a stirred solution of 71a (0.052 g, 0.008 mmol) in 7 mL of MeOH:H2O (6:1) 
were added NaHCO3 (0.007 g, 0.088 mmol) and NaIO4 (0.025 g, 0.121 mmol).  A white 
precipitate formed during the course of the reaction.  After 2 h, the reaction was filtered 
and the filtrate concentrated to leave the H2O.  An additional 10 mL of H2O was added to 
the filtrate and the aqueous extract was washed 3 times with 15 mL of CH2Cl2.  The 
combined organic extracts were washed with 50 mL of satd. NaCl solution and dried with 
Na2SO4, filtered and the filtrate concentrated to afford a 3:1 diastereomeric mixture of 
selenoxides as a white oil/solid (0.047 g) and taken on without any purification:  1H NMR 
(CDCl3) δ 7.84 (m, 2H, NPht), 7.72 (m, 2H, NPht), 7.54 (m, 5H, SePh), 5.78 (d, 1H, J = 
10.3 Hz, H4), 5.65 (d, 1H, J = 10.3 Hz, H4), 5.53 (d, 1H, J = 8.5 Hz, H1), 5.35 (d, 1H, J = 
8.5 Hz, H1), 4.97 (m, 1H, H3), 4.28 (m, 1H, H2), 3.89-3.83 (m, 2H, H5/H5), 3.55 (m, 
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1H, CH2-octyl), 3.29 (m, 1H, CH2-octyl), 3.09 (m, 1H, H6), 2.93 (m, 1H, H6), 1.98 (s, 
3H, OAc), 1.84 (s, 3H, OAc), 1.43 (bs, 2H, CH2-octyl), 1.24-0.94 (bs, 9H, CH2-octyl), 
0.85 (bs, 3H, CH3-octyl).  13C NMR (CHCl3) δ 169.94, 168.36, 167.68, 134.91, 134.79, 
133.48, 132.78, 131.34, 130.50, 129.22, 126.45, 124.23, 122.77, 98.86, 72.85, 71.70, 
70.95, 70.64, 69.75, 69.01, 55.32, 54.19, 31.66, 30.08, 29.11, 28.05, 26.75, 25.75, 22.61, 
21.17, 20.89, 20.13, 19.85, 13.50.  The crude selenoxides (0.047 g, 0.071 mmol) was 
dissolved in 3.0 mL of DHP and heated to reflux at 100 °C.  After 1.25 h, the reaction 
was cooled and diluted with 5 mL of CH2Cl2 and washed with 5 mL of H2O, satd. 
NaHCO3, and satd. NaCl solutions.  The organic extract was dried with Na2SO4, filtered 
and the filtrate concentrated.  The crude product was purified using preparative thin layer 
chromatography (hexanes:EtOAc, 2:1) to afford 115a (0.022 g, 65%, 2 steps) as a 
colorless oil:  1H NMR (CDCl3) δ 7.85 (m, 2H, NPht), 7.32-7.73 (m, 2H, NPht), 5.69 (dd, 
1H, J = 10.2, 8.6 Hz, H3), 5.52 (m, 1H, H4), 5.37 (d, 1H, J = 8.3 Hz, H1), 4.88 (m, 1H, 
H6), 4.64 (m, 1H, H6), 4.42 (dd, 1H, J = 10.2, 8.3 Hz, H2), 3.87 (m, 1H, CH2-octyl), 3.46 
(m, 1H, CH2-octyl), 2.12 (s, 3H, OAc), 1.88 (s, 3H, OAc), 1.44 (bs, 1H, CH2-octyl), 1.18-
0.95 (bs, 12H, CH2-octyl), 0.80 (bs, 3H, CH3-octyl).  13C NMR (CDCl3) δ 169.94, 
169.34, 167.54, 150.75, 134.94, 134.88, 133.58, 131.39, 124.24, 122.89, 99.71, 98.32, 
97.55, 71.37, 70.89, 70.46, 70.24, 69.69, 69.19, 55.22, 54.09, 30.20, 29.20, 21.28, 21.02, 
20.25, 19.98, 14.53. MS (ES, Na+): m/z (relative intensity) 510.2 (100). HRMS (M + 
Na+) calcd for C26H33NO8Na, 510.2104; found 510.2098. 
 
Octyl 3, 4-O-di benzyl 5, 6-dehydro-2, 6-dideoxy-2-phthalamido-∃-D-








To a stirred solution of 71b (0.030 g, 0.040 mmol) in 3.5 mL of MeOH:H2O (6:1) 
were added NaHCO3 (0.004 mg, 0.044 mmol) and NaIO4 (0.013 g, 0.060 mmol).  A 
white precipitate formed during the course of the reaction.  After 4 h, the reaction was 
filtered and the filtrate concentrated to leave the H2O.  An additional 5 mL of H2O was 
added to the filtrate and the aqueous extract was washed 3 times with 10 mL of EtOAc.  
The combined organic extracts were washed with 30 mL of satd. NaCl solution and dried 
with Na2SO4, filtered and the filtrate concentrated to afford a 2:1 diastereomeric mixture 
of selenoxides as a white oil/solid (0.025 g) and taken on without any purification:  1H 
NMR (CDCl3) δ 7.71 (m, 2H, NPht), 7.65 (m, 2H, NPht), 7.32 (m, 5H, SePh), 6.90 (m, 
5H, Bn), 6.86 (m, 5H, Bn), 5.27 (d, 1H, J = 8.5 Hz, H1), 5.14 (d, 1H, CH2-Bn), 5.09 (d, 
1H, CH2-Bn), 5.01 (d, 1H, CH2-Bn), 4.91 (d, 1H, CH2-Bn), 4.33 (d, 1H, J = 4.0 Hz, H3), 
4.33 (m, 1H, H4), 3.79 (m, 1H, CH2-octyl), 3.54 (m, 1H, H2), 3.44 (m, 1H, CH2-octyl), 
3.39-3.30 (m, 2H, H5/H5), 2.97 (dd, 1H, J = 12.0, 2.9 Hz, H6), 2.65 (m, 1H, H6), 1.26 
(bs, 2H, CH2-octyl), 1.14-0.90 (bs, 9H, CH2-octyl), 0.80 (bs, 3H, CH3-octyl).  13C NMR 
(CHCl3) δ 137.76, 133.78, 132.16, 131.19, 129.78, 129.67, 129.03, 128.64, 128.55, 
128.40, 128.31, 128.24, 128.12, 128.07, 127.97, 127.89, 127.46, 127.38, 126.67, 126.21, 
125.85, 123.29, 98.41, 98.25, 83.29, 82.68, 77.41, 75.27, 75.04, 73.93, 70.31, 69.85, 
69.62, 57.02, 55.98, 32.58, 31.70, 29.08, 25.80, 22.74, 20.99, 14.05.  The crude 
selenoxides (0.025 g, 0.033 mmol) was dissolved in 2.0 mL of DHP and heated to reflux 
at 100 °C.  After 1 h, the reaction was cooled and diluted with 5 mL of CH2Cl2 and 
washed with 5 mL H2O, satd. NaHCO3, and satd. NaCl solutions.  The organic extract 
was dried with Na2SO4, filtered and the filtrate concentrated.  The crude product was 
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purified using preparative thin layer chromatography (hexanes:EtOAc, 5:1) to afford 
115b (0.013 g, 68%, 2 steps) as a colorless oil:  1H NMR (CDCl3) δ 7.68 (m, 4H, NPht), 
7.40-7.25 (m, 5H, Bn), 6.98 (m, 2H, Bn), 6.86 (m, 3H, Bn), 5.18 (d, 1H, J = 7.9 Hz, H1), 
4.87 (bs, 2H, H6/H6), 4.83 (d, 2H, J = 11.4 Hz, CH2-Bn), 4.73 (d, 2H, J = 11.4 Hz, CH2-
Bn), 4.44 (d, 1H, J = 12.2 Hz, H3), 4.24 (dd, 1H, J = 10.4, 8.2 Hz, H2), 4.06 (m, 1H, H4), 
3.81 (m, 1H, CH2-octyl), 3.40 (m, 1H, CH2-octyl), 1.39 (bs, 2H, CH2-octyl), 1.16-0.98 
(bs, 10H, CH2-octyl), 0.80 (bs, 3H, CH3-octyl).  13C NMR (CDCl3) δ 167.72, 153.72, 
137.98, 133.75, 131.63, 128.51, 128.03, 127.95, 127.93, 127.89, 127.33, 123.27, 99.33, 
97.19, 80.98, 77.03, 74.27, 73.51, 69.95, 55.69, 54.09, 31.22, 29.20, 24.28, 21.53, 20.35, 
14.05.  MS (ES, Na+): m/z (relative intensity) 606.2 (100).  HRMS (M + Na+) calcd for 
C34H37NO6Na, 606.2832; found 606.2844. 
 
Octyl 3, 4-O-di-acetyl-2-deoxy-5, 6-epoxy-2-phthalamido-∃-D-glucopyranoside 







To a stirred 0 °C solution of 115a (0.022 g, 0.045 mmol) in 1.0 mL of CH2Cl2 
was added DMDO (approximately 10 mL).  The reaction was placed in the cold box 
overnight at 4 °C.  After 19 h, the solution was dried with Na2SO4, filtered and the filtrate 
concentrated to afford 116a (0.021 g, 95%) as a colorless oil:  1H NMR (CDCl3) δ 7.62-
7.59-7.46 (m, 4H, Pht), 6.22 (d, 1H, H3), 5.67 (d, 1H, J = 8.4 Hz, H1), 5.18 (m, 1H, H4), 
3.94 (dd, 1H, J = 8.9, 5.0 Hz, H2), 3.53 (m, 1H, CH2-octyl), 3.43 (m, 1H, CH2-octyl), 
2.82 (m, 1H, H6), 2.44 (m, 1H, H6), 1.75 (s, 3H, OAc), 1.66 (s, 3H, OAc), 1.58 (bs, 3H, 
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CH2-octyl), 1.27-0.99 (bs, 9H, CH2-octyl), 0.88 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 
169.91, 168.82, 167.52, 133.53, 131.79, 128.11, 123.31, 123.08, 98.26, 79.73, 73.42, 
72.11, 71.02, 69.93, 67.54, 55.34, 33.77, 31.15, 29.41, 26.14, 22.87, 20.04, 14.16.  MS 
(ES, Na+): m/z (relative intensity) calcd for C26H33NO9Na, 526.1; found 526.1 (100). 
 







To a stirred 0 °C solution of 115b (0.013 g, 0.022 mmol) in 0.75 mL of CH2Cl2 
was added DMDO (approximately 5 mL).  The reaction was placed in the cold box 
overnight at 4 °C.  After 19 h, the solution was dried with Na2SO4, filtered and the filtrate 
concentrated to afford a 1:1 diastereomeric ratio 116b (0.011 g, 85%) as a colorless oil:  
1H NMR (CDCl3) δ 7.59-7.44 (m, 4H, Pht), 7.19-6.93 (m, 10H, Bn), 6.18 (d, 1H, J = 9.3 
Hz, H1), 6.12 (d, 1H, J = 9.1 Hz, H1), 5.14 (d, 2H, J = 9.7 Hz, H4/H4), 4.92-4.71 (d, 4H, 
CH2-Bn), 4.60-4.47 (m, 2H, H3/H2), 4.08 (m, 1H, CH2-octyl), 3.87 (m, 1H, CH2-octyl), 
3.44 (m, 1H, H6), 3.33 (m, 1H, H6), 1.58 (bs, 2H, CH2-octyl), 1.25-1.03 (bs, 10H, CH2-
octyl), 0.93 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 133.34, 128.11, 127.23, 123.10, 
123.08, 96.54, 81.23, 75.38, 69.93, 56.21, 32.02, 29.41, 26.14, 22.87, 14.16.  MS (ES, 
Na+): m/z (relative intensity) calcd for C36H41NO7Na, 546.2679; found 622.2 (100). 
 
t-Butyldimethylsilyl 4-O-benzyl-3-O-[(benzyloxy)methyl]- 5, 6-dehydro-2, 6-dideoxy-








To a stirred solution of 67 (0.055 g, 0.071 mmol) in 7 mL of MeOH:H2O (6:1) 
were added NaHCO3 (0.007 g, 0.078 mmol) and NaIO4 (0.022 g, 0.106 mmol).  A white 
precipitate formed during the course of the reaction.  After 5 h, the reaction was filtered 
and the filtrate concentrated to leave the H2O.  An additional 10 mL of H2O was added to 
the filtrate and the aqueous extract was washed 2 times with 10 mL of CH2Cl2.  The 
combined organic extracts were washed with 20 mL of satd. NaCl solution and dried with 
Na2SO4, filtered and the filtrate concentrated to afford a 1:1 diastereomeric mixture of 
selenoxides as a white oil/solid (0.052 g) and taken on without any purification:  1H NMR 
(CDCl3) δ 7.82 (m, 2H, NPht), 7.65 (m, 2H, NPht), 7.53 (m, 3H, SePh), 7.40-7.03 (m, 
12H, SePh/ ArH of BOM/Bn), 5.52 (d, 1H, H1), 5.38 (d, 1H, H1), 4.99 (d, 1H, -O-CH2-
OBn), 4.96 (d, 1H, -O-CH2-OBn), 4.76-4.61, (m, 11H, -O-CH2-OBn/-O-CH2-
Ph/H4/H4/H3/H3), 4.49 (m, 1H, -O-CH2-Ph), 4.29 (m, 2H, -O-CH2-Ph), 4.12 (m, 1H, 
H2), 4.07 (m, 1H, H2), 3.76 (m, 1H, H5), 3.73 (m, 1H, H5), 3.60 (m, 1H, H6), 3.22 (m, 
1H, H6), 0.71 (bs, 18H, tBu), 0.11 (s, 3H, tBu), 0.09 (s, 3H, tBu), 0.06 (s, 3H, tBu), 0.03 
(s, 3H, tBu).  13C NMR (CDCl3) δ 133.93, 129.60, 128.61, 128.36, 128.31, 128.29, 
128.24, 128.22, 127.47, 127.15, 125.60, 94.63, 93.96, 93.79, 76.14, 75.64, 75.25, 74.96, 
74.78, 73.12, 69.78, 68.85, 55.93, 54.71, 54.50, 42.09, 25.29, 17.47, -3.95, -4.16, -5.61.  
The crude selenoxides (0.052 g, 0.066 mmol) were dissolved in 5 mL of DHP and heated 
to reflux at 100 °C.  After 2 h, the reaction was cooled and diluted with 20 mL of EtOAc 
and washed with 20 mL of H2O, satd. NaHCO3, and satd. NaCl solutions.  The organic 
extract was dried with Na2SO4, filtered and the filtrate concentrated.  The crude product 
was purified using preparative thin layer chromatography (hexanes:EtOAc, 3:1) to afford 
117 (0.03 g, 75 %, 2 steps) as a colorless oil:  1H NMR (CDCl3) δ 8.82 (bs, 2H, NPht), 
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7.66 (m, 2H, NPht), 7.40-7.20 (m, 8H, ArH of BOM/Bn), 7.06 (m, 2H, Bn), 5.39 (d, 1H, 
J = 8.0 Hz, H1), 4.89 (d, 1H, -O-CH2-Ph), 4.85 (dd, 1H, J = 11.2, 3.1 Hz, H4), 4.76 (d, 
1H, J = 10.5 Hz, -O-CH2-Ph/CH2-Bn), 4.74 (d, 1H, -O-CH2-Bn), 4.70 (dd, 1H, J = 11.2, 
3.2 Hz, H3), 4.65 (m, 1H, H2), 4.60 (s, 2H, H6/H6), 4.55 (d, 1H, CH2-Bn), 1.25 (bs, 9H, 
tBu), 0.71 (bs, 3H, tBu, 0.65 (bs, 3H, tBu).  13C NMR (CDCl3) δ 171.12, 152.14, 137.97, 
137.37, 133.98, 131.65, 128.34, 128.26, 127.88, 127.51, 127.47, 127.20, 102.06, 94.68, 
93.46, 75.01, 74.21, 72.40, 69.81, 69.42, 69.34, 60.37, 54.75, 54.09, 25.33, 22.63, 21.03, 
17.57, 14.18, -4.28, -5.47.  MS (ES, Na+): m/z (relative intensity) 638.2 (100).  HRMS 
(M + Na+) calcd for C35H41NO7Na, 638.2550; found 638.2562. 
 
t-Butyldimethylsilyl 4-O-benzyl-3-O-[(benzyloxy)methyl]-2-deoxy-5, 6-epoxy-2-







To a stirred 0 °C solution of 117 (0.03 g, 0.05 mmol) in 1.5 mL of CH2Cl2 was 
added DMDO (approximately 8 mL).  After 1 h, the solution was dried with Na2SO4, 
filtered and the filtrate concentrated to afford a 1:1 diastereomeric ratio 118 (0.027 g, 
90%) as a colorless oil:  1H NMR (CDCl3) δ 7.48 (m, 4H, Pht), 7.31-7.09 (m, 8H, ArH of 
ArH of BOM/Bn), 6.84 (d, 2H, Bn), 6.20 (d, 1H, J = 8.3 Hz, H1), 5.65 (d, 1H, J = 8.1 Hz, 
H1), 5.52 (dd, 1H, J = 11.3, 8.3 Hz, H3), 5.33 (dd, 1H, 11.3, 3.0 Hz, H4), 5.16 (dd, 1H, 
11.3, 8.1 Hz, H3), 4.88 (d, 1H, -O-CH2-Ph), 4.70-4.41 (m, 8H, -O-CH2-Ph/CH2-
Bn/H2/H2), 3.50 (m, 1H, H6), 3.34 (m, 1H, H6), 2.77 (m, 1H, H6), 2.16 (m, 1H, H6), 
0.82 (bs, 18H, tBu), 0.21 (bs, 3H, tBu), 0.15 (s, 3H, tBu), 0.09 (s, 3H, tBu), 0.00 (s, 3H, 
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tBu).  13C NMR (CDCl3) δ 139.01, 138.53, 138.29, 134.12, 132.64, 128.94, 128.88, 
128.83, 128.76, 128.29, 128.12, 127.98, 127.81, 123.50, 95.09, 94.73, 94.42, 93.63, 
79.93, 77.62, 76.57, 75.66, 75.62, 74.70, 74.31, 72.52, 70.19, 70.01, 55.78, 55.11, 52.56, 
43.33, 26.01, 25.91, 18.18, -3.42, -3.83, -4.75, -4.92.  MS (ES, Na+): m/z (relative 
intensity) calcd for C35H37NO8Na, 654.2; found 654.2 (100). 
 
Octyl 4-O-benzyl-3-O-[(benzyloxy)methyl]-2, deoxy-5-fluoro-∃-D-glucopyranoside 






To a stirred -78 °C solution of 107b (0.035 g, 0.064 mmol) in a Schlenk tube in 1 
mL of CH2Cl2 was added HF·pyridine (7 drops).  After 40 min, the reaction was 
quenched with 5 drops of NEt3 and the resulting light yellow solution was concentrated to 
afford 119b:  1H NMR (CDCl3) δ 7.37-7.26 (m, 10H, ArH of BOM/Bn), 5.82 (d, 1H, J = 
8.3 Hz, NH), 5.10 (s, 1H, O-CH2-O-Bn), 4.75 (d, 1H, J = 7.1 Hz, CH2-Ph), 4.65 (d, 1H, J 
= 7.0 Hz, CH2-Ph), 4.57-4.48 (m, 5H, H4/H1/H3/H2/ CH2-Ph), 4.42 (d, 1H, J = 10.6 Hz, 
CH2-Ph), 4.18 (s, 1H, O-CH2-O-Bn), 3.79 (m, 2H, CH2-octyl), 3.53 (m, 2H, H6/H6), 2.90 
(bs, 1H, -OH), 1.74 (s, 3H, NHAc), 1.56 (bs, 3H, CH2-octyl), 1.24 (bs, 9H, CH2-octyl), 
0.85 (t, 3H, CH3-octyl). 19F NMR (CDCl3) δ 52.47.  MS (ES, Na+): m/z (relative 
intensity) calcd for C31H44NO7FNa, 585.0; found 585.0 (100). 
 








To a stirred -78 °C solution of 107c (0.021 g, 0.043 mmol) in a Schlenk tube in 1 
mL of CH2Cl2 was added HF·pyridine (5 drops).  After 30 min, the reaction was 
quenched with 5 drops of NEt3 and the resulting light yellow solution was concentrated to 
afford 119c (0.002 g, 9%) as a colorless oil:  1H NMR (CDCl3) δ  7.37-7.26 (m, 5H, Bn), 
6.25 (d, 1H, NH), 5.21 (s, 1H, O-CH2Ph), 4.90 (dd, 1H, H4), 4.70 (d, 1H, -O-CH2Ph), 
4.57-4.28 (m, 3H, H1/H3/H2), 3.79 (m, 2H, CH2-octyl), 3.27 (m, 2H, H6/H6), 1.99 (s, 
1.99, 3H, OAc), 1.74 (s, 3H, NHAc), 1.56 (bs, 3H, CH2-octyl), 1.24 (bs, 9H, CH2-octyl), 
0.85 (t, 3H, CH3-octyl).  19F NMR (CDCl3) δ 52.58.  MS (ES, Na+): m/z (relative 
intensity) calcd for C25H38NO7Na, 506.2; found 506.2 (100). 
 
Octyl 2-acetamido-3-O-∃-D-galactopyranosyl-2-deoxy-5-fluoro-∃-D-glucopyranoside 












To a -78 °C stirred solution of 112 (0.018 g, 0.025 mmol) in 1.0 mL of CH2Cl2 
was added HF·pyridine (0.01 mL).  After 1.75 h, the reaction was quenched with 0.01 mL 
of NEt3 and the resulting light yellow solution was diluted to 5 mL of CH2Cl2 and washed 
with 5 mL of H2O and satd. NaCl solution.  The organic extract was dried with Na2SO4, 
filtered and the filtrate concentrated to afford the (5-F) glycoside (0.030 g) which was 
taken on without any purification.  NH3 was bubbled through a stirred methanolic 
solution (2 mL) of the resulting (5-F) glycoside at 0 °C.  After 10 min, the flask was 
sealed and warmed to room temperature.  After 1.5 h, the solvent and NH3 were removed 
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with a stream of nitrogen. The resulting product was purified using flash column 
chromatography (EtOAc MeOH, 5:1) to afford 13a (0.003 g, 25% 2 steps) as a white 
powder:  1H NMR (D2O) δ 3.92 (m, 1H, H1), 3.76-3.58 (d, 4H, H1’/H2’/H3/H3’), 3.42-
3.28 (m, 6H, H4’/H4/H2/H5’/H6’/H6’), 3.41-3.34 (m, 2H, -CH2-octyl), 2.19-2.06 (m, 
2H, H6/H6), 1.86 (s, 3H, NHAc), 1.48 (bs, 3H, CH2-octyl), 1.29 (bs, 9H, CH2-octyl), 
0.91 (t, 3H, CH3-octyl).  13C NMR (D2O) δ 174.73, 105.84, 90.69, 77.37, 72.32, 69.80, 
61.53, 60.38, 55.56, 46.61, 40.64, 35.13, 29.38, 25.71, 21.58, 10.79.  19F NMR (D2O) δ 
89.6.  MS (ES, Na+): m/z (relative intensity) calcd for; found 536.2 (100).  HRMS (M + 
Na+) calcd for C22H40NO11FNa, 536.2483; found 536.2457. 
 
Octyl 2-acetamido-4-O-∃-D-galactopyranosyl-2-deoxy-5-fluoro-∃-D-glucopyranoside 












To a -78 °C stirred solution of 114 (0.011 g, 0.015 mmol) in 1.0 mL of CH2Cl2 
was added HF·pyridine (0.01 mL).  After 2 h, the reaction was quenched with 0.01 mL of 
NEt3 and the resulting light yellow solution was washed with 5 mL of H2O and satd. 
NaCl solution.  The organic extract was dried with Na2SO4, filtered and the filtrate 
concentrated to afford the (5-F) glycoside (0.020 g) and taken on without any 
purification.  NH3 was bubbled through a stirred methanolic solution (2 mL) of the 
resulting (5-F) glycoside at 0 °C.  After 10 min, the flask was sealed and warmed to room 
temperature.  After 1.5 h, the solvent and NH3 were removed with a stream of nitrogen. 
The resulting product was purified using flash column chromatography (EtOAc MeOH, 
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5:1) to afford 14a (0.003 g, 37% 2 steps) as a white powder:  1H NMR (D2O) δ 4.12 (d, 
1H, J = 7.1 Hz, H1), 3.91 (m, 1H, H1’), 3.73-3.57 (m, 3H, H2’/H3/H3’), 3.44-2.93 (m, 
8H, H4’/H4/H2/H5’/H6’/H6’/-CH2-octyl), 2.00-1.95 (m, 2H, H6/H6), 2.00 (s, 3H, 
NHAc), 1.47 (bs, 3H, CH2-octyl), 1.32 (bs, 9H, CH2-octyl), 0.84 (t, 3H, CH3-octyl).  13C 
NMR (D2O) δ 173.64, 103.26, 90.68, 75.41, 72.49, 71.01, 69.31, 68.61, 61.94, 61.06, 
56.48, 42.26, 31.11, 28.49, 25.05, 22.03, 21.31, 13.42, 10.55..  19F NMR (D2O) δ 69.5.  
MS (ES, Na+): m/z (relative intensity) calcd for; found 536.2 (100).  HRMS (M + Na+) 
calcd for C22H40NO11FNa, 536.2483; found 536.2485. 
 
Octyl 3, 4-O-diacetyl-5-cyano-2-deoxy-2-phthalimido-∃-D-glucopyranoside (124a).  









To a stirred 0 °C solution of 116a (0.014 g, 0.027 mmol) in 1.0 mL of CH2Cl2 
were added TMS-CN (0.017 mL, 0.139 mmol) and AlCl3 (5.4 mg, 0.040 mmol).  The 
reaction was brought to reflux at 45 °C.  After 6.5 h, the reaction was quenched with 1 
mL of H2O and stirred for 5 min.  The organic extract was diluted to 5 mL of CH2Cl2 and 
washed with 5 mL of satd. NaCl solution, dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified using preparatory thin layer 
chromatography (hexanes:EtOAc, 1:1) to afford 124a (0.003 g, 21%) as a colorless oil:  
1H NMR (CDCl3) δ 7.85 (m, 2H, NPht), 7.74 (m, 2H, NPht), 6.13 (d, 1H, H3), 5.97 (d, 
1H, J = 8.7 Hz, H1), 5.30 (d, 1H, J = 9.4 Hz, H4), 4.68 (d, 1H, OH), 4.37 (dd, 1H, J = 8.6, 
4.7 Hz, H2), 4.18 (m, 1H, H6), 4.04 (d, 1H, J = 10.3 Hz, H6), 3.85 (m, 1H, CH2-octyl), 
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3.75 (m, 1H, CH2-octyl), 2.02 (s, 3H, OAc), 1.95 (s, 3H, OAc), 1.40 (bs, 2H, CH2-octyl), 
1.24-0.95 (bs, 10H, CH2-octyl), 0.82 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 167.82, 
158.83, 134.32, 123.52, 133.65, 93.90, 73.01, 71.86, 70.26, 68.88, 55.10, 53.49, 31.68, 
29.84, 25.71, 22.50, 14.00, 0.91.  MS (ES, Na+): m/z (relative intensity) 553.2 (100).  
HRMS (M + Na+) calcd for C27H34N2O9Na, 553.2162; found 553.2168.  The resulting 
product did not stain with DNP. 
Method (b) 
To a stirred 0 °C solution of 116a (0.010 g, 0.019 mmol) in 1.0 mL of CH2Cl2 
were added TMS-CN (0.012 mL, 0.099 mmol) and BF3·OEt2 (0.0036 mL, 0.028 mmol).  
The reaction was stirred at room temperature.  After 6.5 h, the reaction was quenched 
with 1 mL of H2O and stirred for 5 min.  The organic extract was diluted to 5 mL of 
CH2Cl2 and washed with 5 mL of satd. NaCl solution, dried with Na2SO4, filtered and the 
filtrate concentrated.  The crude product was purified using preparatory thin layer 
chromatography (hexanes:EtOAc, 1:1) to afford 124a (0.003 g, 27%) as a colorless oil 
with identical 1H NMR, 13C NMR and mass spectrum data as identical to those reported 
for 6.4Aa prepared by Method (a).  The resulting product did not stain with DNP. 
 









To a stirred 0 °C solution of 116b (0.014 g, 0.023 mmol) in 1.0 mL of CH2Cl2 
were added TMS-CN (0.014 mL, 0.116 mmol) and AlCl3 (4.6 mg, 0.034 mmol).  The 
reaction was brought to reflux at 45 °C.  After 6.5 h, the reaction was quenched with 1.0 
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mL of H2O and stirred for 5 min.  The organic extract was diluted to 5 mL of CH2Cl2 and 
washed with 5 mL of satd. NaCl solution, dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified using preparatory thin layer 
chromatography (hexanes:EtOAc, 5:1) to afford 124b (0.005 g, 35%) as a colorless oil:  
1H NMR (CDCl3) δ 7.65 (m, 4H, NPht), 7.36-7.20 (m, 6H, Bn), 7.09-6.84 (m, 4H, Bn), 
6.35 (d, 1H, H4), 5.70 (d, 1H, J = 8.8 Hz, H1), 4.97 (d, 1H, O-CH2Ph), 4.77 (d, 2H, -O-
CH2Ph/H3), 4.65 (d, 1H, O-CH2Ph), 4.42 (d, 1H, O-CH2Ph), 4.21 (dd, 1H, J = 10.9, 8.8 
Hz, H2), 3.96 (m, 1H, H6), 3.81 (d, 1H, H6), 3.64 (m, 1H, CH2-octyl), 3.64 (m, 1H, CH2-
octyl), 1.54 (bs, 2H, CH2-octyl), 1.25-1.13 (bs, 10H, CH2-octyl), 0.86 (t, 3H, CH3-octyl).  
13C NMR (CDCl3) δ 167.89, 158.13, 137.61, 133.87, 133.65, 128.55, 128.20, 127.82, 
127.34, 123.23, 100.20, 94.58, 81.42, 75.02, 74.95, 73.03, 69.88, 56.14, 31.62, 29.30, 
29.04, 25.71, 22.55, 14.03, 0.01.  MS (ES, Na+): m/z (relative intensity) 649.2 (100).  
HRMS (M + Na+) calcd for C37H42N2O7Na, 649.2890; found 649.2885.  The resulting 
product did not stain with DNP. 
 
Method (b) 
To a stirred 0 °C solution of 116b (0.010 g, 0.016 mmol) in 1.0 mL of CH2Cl2 
were added TMS-CN (0.010 mL, 0.083 mmol) and BF3·OEt2 (0.0034 mL, 0.024 mmol).  
The reaction was stirred at room temperature.  After 6.5 h, the reaction was quenched 
with 1 mL of H2O and stirred for 5 min.  The organic extract was diluted to 5 mL of 
CH2Cl2 and washed with 5 mL of satd. NaCl solution, dried with Na2SO4, filtered and the 
filtrate concentrated.  The crude product was purified using preparatory thin layer 
chromatography (hexanes:EtOAc, 5:1) to afford 124b (0.001 g, 10%) as a colorless oil 
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with identical 1H NMR, 13C NMR and mass spectrum data as identical to those reported 
for 6.4Ab prepared by Method (a).  The resulting product did not stain with DNP. 
 
Octyl 3, 4-O-diacetyl-2-acetamido-5-cyano-2-deoxy-∃-D-glucopyranoside (124c).  









To a stirred 0 °C solution of 1238 (0.037 g, 0.089 mmol) in 2.0 mL of CH2Cl2 
were added TMS-CN (0.050 mL, 0.445 mmol) and AlCl3 (17 mg, 0.133 mmol).  The 
reaction was brought to reflux at 45 °C.  After 15.5 h, the reaction was quenched with 5 
mL of H2O and stirred for 5 min.  The organic extract was diluted to 5 mL of CH2Cl2 and 
washed with 5 mL of satd. NaCl solution, dried with Na2SO4, filtered and the filtrate 
concentrated.  The crude product was purified using preparatory thin layer 
chromatography (hexanes:EtOAc, 1:1) to afford 124c (0.013 g, 33%) as a colorless oil:  
1H NMR (CDCl3) δ 6.77 (d, 1H, J = 9.4 Hz, N-H), 4.94 (d, 1H, H3), 4.79-4.65 (d, 3H, 
H1/H4/OH), 4.33 (m, 1H, H2), 4.18 (m, 1H, H6), 3.94 (d, 1H, H6), 3.23 (m, 2H, CH2-
octyl), 2.20 (s, 3H, OAc), 2.12 (s, 3H, OAc), 1.96 (s, 3H, NAc), 1.63 (bs, 2H, CH2-octyl), 
1.26 (bs, 10H, CH2-octyl), 0.87 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 170.46, 170.15, 
100.45, 69.70, 67.90, 65.85, 64.32, 50.99, 46.63, 31.77, 29.46, 25.88, 22.80, 21.01, 14.09.  
MS (ES, Na+): m/z (relative intensity) calcd for; found 465.2 (100).  HRMS (M + Na+) 





Octyl 3, 4-O-diacetyl-2-acetamido-5-methyleneamino-2-deoxy-∃-D-glucopyranoside 









To a solution of 124c (0.010 g, 0.022 mmol) in 10 mL of MeOH was added PtO2 
(50 mg, 0.180 mmol).  The mixture was hydrogenated at 40 PSI.  After 25 h, the reaction 
mixture was filtered through Celite and concentrated.  The crude product purified using 
flash column chromatography (hexanes:EtOAc, 2:1) to afford 126 (0.09 g, 90%) as a 
colorless oil:  1H NMR (CDCl3) δ 5.99 (d, 1H, H3), 5.73 (d, 1H, J = 9.1 Hz, N-H), 5.22 
(m, 1H, H4), 4.85 (d, 1H, J = 4.0 Hz, OH), 4.23-4.17 (m, 2H, H1/H2/CH2), 3.90 (m, 2H, 
H5/CH2), 3.65 (d, 1H, CH2-octyl/NH2), 3.61-3.49 (m, 3H, H6/H6/CH2-octyl), 2.12 (s, 
3H, OAc), 2.06 (s, 3H, OAc), 1.94 (s, 3H, NAc), 1.59 (bs, 2H, CH2-octyl), 1.26 (bs, 10H, 
CH2-octyl), 0.86 (t, 3H, CH3-octyl).  13C NMR (CDCl3) δ 172.43, 170.13, 166.46, 98.50, 
79.21, 73.24, 70.48, 69.34, 66.58, 52.35, 40.64, 31.68, 29.61, 26.17, 22.73, 21.12, 14.00.  
MS (ES, Na+): m/z (relative intensity) calcd for; found 469.2 (100).  HRMS (M + Na+) 
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